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Preface
Every dissertation about the science of stress needs at least one remark about stress being a part of 
the PhD process, so here it is. Stress is a healthy and necessary aspect of life, signalling to us a 
challenge that needs to be met by stretching above and beyond what we thought we were capable of. 
You hold in your hands a product of such a protracted response, and the irony of it also being the 
topic of this thesis has not escaped the author.
With that matter out of the way, I want to thank you for your interest in this piece of work. Given the 
high prevalence of stress-related psychiatric disorders, each person present at the public defence of 
this thesis or reading it afterwards is likely to know at least one affected person. In fact I’m sure you 
do. This work is dedicated to those who, despite working up the courage to seek help with the ever-
looming demons of anxiety or depression, did not receive it. Perhaps you were not taken seriously, 
or perhaps you were but did not get relief. These experiments do not provide a solution by themselves,
but hopefully they will be a drop in the ocean of a solution to come. I promise; we are working on it.
Abstract
Psychiatric disorders are very common, with anxiety disorders being the most prevalent (16 % 
lifetime prevalence). While moderately heritable, their incidence is also strongly influenced by 
environmental risk factors, chiefly psychosocial stress. However, our knowledge of how, in 
neurobiological terms, these disorders arise is lacking, slowing down the development of efficient
treatments. 
The aim of this thesis was firstly to identify which brain regions are recruited by chronic psychosocial 
stress, by using mice as model organisms. To model psychosocial stress we used chronic social defeat 
stress (CSDS), which involves short confrontations between intruder and resident-aggressor male 
mice, repeated daily for 10 consecutive days. A week after stress exposure C57BL/6NCrl (B6) mice 
had a higher number of cells expressing ΔFOSB, a marker of repeated neural activation, in several 
stress-related brain regions. These included the bed nucleus of the stria terminalis (BNST) and ventral 
hippocampus (vHPC). We also found significant correlations in the numbers of ΔFOSB+ cells 
between medial prefrontal cortex (mPFC) subregions (infralimbic and prelimbic cortices) and the 
vHPC of stress-exposed but not non-stressed control mice.
Our second aim was to discover, by using unbiased RNA-sequencing (RNA-seq) of stress-related 
brain regions (the mPFC and vHPC), biological pathways perturbed by CSDS. Additionally, we used 
mice from two inbred strains, representing different levels of baseline anxiety-like behaviour: B6 
(low-anxiety) and DBA/2NCrl (D2, high-anxiety). This enabled us to explore how genetic 
background modulates the response to stress. While some mice exposed to CSDS show social 
avoidance (called stress-susceptibility), others are behaviourally similar to non-stressed control mice. 
This phenomenon, known as resilience, is also observed in humans. We found that B6 and D2 mice 
showed vastly different behavioural responses to CSDS. B6 mice displayed a predominantly resilient 
phenotype (66.1 % of CSDS-exposed mice across several cohorts), while the majority (85.0 %) of 
D2 mice were susceptible. Pathway analysis of RNA-seq data suggested that differentially expressed 
genes (DEGs) were enriched in genes related to oligodendrocytes (OLGs), the myelin-producing cells 
of the CNS. For example, genes encoding myelin components were downregulated in the mPFC and 
vHPC of B6 susceptible mice compared to controls. Myelin is a lipid-rich ensheathment around 
axons, and it enables both fast nerve conduction and adjustment thereof via myelin plasticity. We 
followed up the gene expression findings with a structural analysis of myelinated axons using 
transmission electron microscopy (TEM). We found that in the vHPC, B6 susceptible mice had 
thinner myelin sheaths than controls. In the mPFC, B6 resilient mice had thicker myelin than controls, 
restricted to axons with small diameters. By contrast, D2 resilient mice had thinner myelin in this 
region than susceptible mice, indicating potential bidirectional dynamics of myelin plasticity in 
resilience.
Lastly, we performed RNA-seq of enriched OLGs and myelin from the mPFC. The aim of this 
experiment was to identify pathways affected by CSDS specifically in these cells and in myelin.
Additionally, we used this dataset to identify genes (24.8 % of all genes and 18.8 % of expressed 
micro-RNAs [miRNAs]) which were enriched in the myelin fraction compared to OLGs in non-
stressed control mice. This suggests selective transport of certain mRNAs and microRNAs into the 
myelin sheath, potentially for local regulation. When comparing CSDS-exposed mice and controls, 
we found lower expression of myelin-related genes in B6 susceptible, D2 susceptible and D2 resilient 
mice compared to same-strain controls. In the B6 strain this was found in the myelin fraction, while 
in the D2 strain these genes were differentially expressed only in OLGs. Ingenuity Pathway Analysis 
(IPA) predicted TCF7L2, a transcription factor, to be an upstream regulator of these DEGs.
In summary, we showed involvement of a broad but selective network of brain regions in CSDS. 
Genetic background had a large influence on the response to stress, highlighting a source of individual 
variation with implications for understanding human stress-resilience and -susceptibility. This 
moderation by genetic background was also seen at the level of gene expression in the brain. Finally, 
our findings suggest that myelin plasticity is an important part of the chronic response to stress. Future 
work will identify by which mechanisms stress influences myelin, and how this could be best 
harnessed for improving therapeutic strategies.
Tiivistelmä
Mielenterveyden häiriöistä erityisesti ahdistuneisuushäiriöt ovat erittäin yleisiä (16 % 
elämänaikainen esiintyvyys). Ahdistuneisuushäiriöt ovat kohtalaisen periytyviä, mutta myös 
ympäristötekijät vaikuttavat niiden puhkeamiseen. Erityisesti psykososiaalinen stressi lisää 
ahdistuneisuushäiriön riskiä. Ymmärrämme näiden häiriöiden neurobiologisista taustoista vielä hyvin 
vähän, mikä on hidastanut tehokkaiden hoitomenetelmien kehitystä.
Tämän väitöskirjan ensimmäinen tavoite oli tunnistaa, mitkä aivoalueet krooninen psykososiaalinen 
stressi aktivoi, käyttäen hiirtä malliorganismina. Mallintaaksemme psykososiaalista stressiä
käytimme kroonista sosiaalista alistamista (eng. chronic social defeat stress, CSDS). CSDS:ssä
uroshiiri asetetaan sitä vanhemman alistavasti käyttäytyvän uroshiiren kotihäkkiin lyhyeksi ajaksi.
Nämä alistavat kohtaamiset toistetaan päivittäin 10 päivän ajan. Tutkimme aivoalueiden aktivaatiota 
värjäämällä aivonäytteitä vasta-aineella, jonka kohde oli solun toistuvasta aktivaatiosta indusoituva
ΔFOSB proteiini. Viikko stressin jälkeen C57BL/6NCrl (B6) kannan hiirillä oli enemmän ΔFOSB-
positiivisia soluja usealla aivoalueella, kuten bed nucleus of the stria terminaliksessa (BNST) sekä 
ventraalisessa aivotursossa (eng. ventral hippocampus, vHPC), kuin stressille altistamattomilla 
verrokkihiirillä. Lisäksi ΔFOSB-positiivisten solujen lukumäärät korreloivat useiden eri aivoalueiden 
välillä, muun muassa etuaivokuoren (eng. medial prefrontal cortex, mPFC) ala-alueiden 
(infralimbinen sekä prelimbinen aivokuori) ja vHPC:n välillä.
Toinen tavoitteemme oli selvittää genominlaajuisen RNA-sekvensoinnin avulla, mihin biologisiin 
toimintoihin CSDS mPFC ja vHPC aivoalueilla vaikuttaa.  Tämän lisäksi selvitimme, miten 
perinnölliset tekijät muokkaavat näitä vaikutuksia käyttämällä hiiriä kahdesta eri kannasta.
Valitsimme sellaiset hiirikannat, jotka eroavat ahdistuneisuustyyppisen käyttäytymisen suhteen: B6 
(vähäistä ahdistustyyppistä käyttäytymistä) sekä DBA/2NCrl (D2; korkeaa ahdistustyyppistä 
käyttäytymistä). CSDS:n jälkeen osa hiiristä on stressialttiita (eng. susceptible), mikä tarkoittaa 
niiden välttelevän sosiaalista kanssakäymistä verrattuna stressille altistamattomiin verrokkihiiriin.
Osa stressille altistetuista hiiristä on resilienttejä, eli ne käyttäytyvät sosiaalisessa tilanteessa samoin 
kuin verrokkihiiret. Resilienssi on myös ihmisillä havaittava piirre. Osoitimme, että B6 ja D2 hiirten 
käyttäytyminen erosi huomattavasti CSDS:n jälkeen. B6 hiiret olivat pääasiallisesti resilienttejä (66.1
% CSDS:lle altistetuista), kun taas suurin osa (85.0 %) D2 hiiristä oli stressialttiita. Käytimme 
bioinformatiivista polkuanalyysiä selvittääksemme, ovatko resilienttien, stressialttiiden ja 
verrokkihiirten välillä eritasoilla ilmentyneet geenit rikastuneet joidenkin tiettyjen biologisten 
toimintojen osalta. Oligodendrosyyttien (OLG) toimintaan liittyvät geenit olivat näissä vertailuissa 
rikastuneet. Oligodendrosyytit tuottavat myeliiniä eristeeksi hermosyiden ympärille, mikä nopeuttaa
aktiopotentiaalien kulkua. Myeliini muovautuu myös aikuisiällä, ja pienetkin muutoksen myeliinissä 
voivat säätää hermosolujen välistä viestintää. Havaitsimme esimerkiksi, että myeliiniin kuuluvia 
proteiineja tuottavat geenit ilmentyivät alhaisemmalla tasolla sekä mPFC:ssä että vHPC:ssä B6 
kannan stressialttiilla hiirillä verrokkeihin nähden. Tutkimme näiden tulosten perusteella myeliiniä
transmissioelektronimikroskopialla (TEM). Osoitimme, että B6 stressialttiilla hiirillä oli vHPC:ssä 
ohuemmat myeliinitupet kuin verrokeilla. B6 resilienteillä hiirillä puolestaan oli verrokkeihin nähden 
paksummat myeliinitupet mPFC:n ohuissa hermosyissä. D2 kannan resilienteillä hiirillä oli samalla 
aivoalueella ohuemmat myeliinitupet kuin stressialttiilla hiirillä. Nämä löydökset viittaavat siihen, 
että molemman suuntainen muovautuminen myeliinissä voi liittyä stressivasteeseen.
Viimeisessä osatyössä eristimme stressille altistettujen hiirten mPFC:stä OLG:t ja myeliinin.
Tavoitteemme oli selvittää, mitkä geenit erityisesti OLG:issä reagoivat stressiin, sekä miten OLG:t ja 
myeliini eroavat toisistaan geenien ilmentymisen osalta. Tunnistimme useita geenejä (24.8 %
ilmentyvistä lähetti-RNA:ista ja 18.8 % mikroRNA:ista [miRNA]), jotka olivat merkitsevästi 
rikastuneet myeliinissä verrattuna OLG:ihin verrokkihiirissä. Tämä voi johtua valikoivasta lähetti-
sekä miRNA:iden kuljetuksesta tumasta myeliiniin paikallista säätelyä varten. Verratessamme 
CSDS:n kokeneita ja verrokkihiiriä totesimme myeliiniin liittyvien geenien ilmentyvän alemmalla 
tasolla B6 stressialttiissa, D2 stressialttiissa sekä D2 resilienteissä hiirissä samojen kantojen 
verrokkeihin nähden. B6 kannassa tämä ero näkyi myeliinissä, mutta D2 kannassa erot näkyivät 
ainoastaan OLG:issä. Ingenuity Pathway Analysis (IPA) ohjelman avulla selvitimme, että näiden 
eritavoin ilmentyvien geenien mahdollinen säätelijä on TCF7L2, OLG:ssä tunnetusti ilmentyvä 
säätelyproteiini.
Osoitimme laajan mutta erikoistuneen aivoalueiden verkoston aktivoituvan CSDS altistuksessa. 
Hiirten geneettinen tausta vaikutti merkitsevästi stressinjälkeiseen käyttäytymiseen, mikä voi liittyä 
myös ihmisyksilöiden välisiin eroihin resilienssissä ja stressialttiudessa. Geneettisen taustan vaikutus
näkyi myös aivoissa geenien ilmentymisessä. Löydöksemme viittaavat myeliiniplastisuuteen 
tärkeänä stressivasteeseen kuuluvana tekijänä. Jatkotutkimuksia tarvitaan tunnistamaan, minkä 
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While navigating a world with more or less perilous threats waiting for us at many corners, a 
well-functioning capacity to feel anxious is an advantage. If we can anticipate a problem, we 
have a good chance of dealing with it successfully. However, as with many functions, the 
anxiety system can dysfunction, giving rise to anxiety disorders. Suffering from an anxiety 
disorder involves disproportionate worry about and vigilance towards threats, sometimes even 
intense feelings of fear where none are warranted. As a collective term in the Diagnostic and 
Statistical Manual (DSM-5) and International Classification of Diseases (ICD-11) these 
disorders are the most common psychiatric ailment, with 16 % of people experiencing one or 
several of them during their lifetime [1]. Specific, curative treatments for patients with anxiety 
disorders are not yet available, although symptoms can be managed with pharmaco- and 
psychotherapeutic options. The reasons for this are complex, but an important hurdle in this 
quest is that we know surprisingly little about what the key pathology in anxiety disorders, and 
many other CNS disorders, is. Big questions in the field include why some people develop an 
anxiety disorder while others do not, and which aspects of neurobiology are involved in either 
vulnerability to or protection from them.
What we do know is that genetic factors matter; these disorders are heritable at least to a 
moderate degree (30-40 %, [3]), with much of the genetic risk shared with other psychiatric 
disorders such as major depressive disorder [4, 5]. Specific causal variants have not been found, 
and for such a common disorder it is unlikely that a high-penetrance causative allele would 
exist. Rather, the field today agrees that the genetic risk is composed of several small-effect 
variants, which likely interact and affect various biological pathways. Another reason why 
describing the genetics of anxiety disorders is a complex endeavour is that environmental 
factors also play a significant role. The best known environmental risk factor is the exposure 
to chronic psychosocial stress, particularly in early life [6]. However, it remains largely 
unknown how or why such a relationship between stress and psychiatric disorders exists. What 
does stress do to the brain, and why does stress do different things to different brains?
Researching these matters in the human brain is limited in many ways. For example, we do not 
have access to brain tissue at selected time points, nor precise knowledge of when and what 
types of risk factors an individual experiences. Because addressing these questions is necessary 
for improving our understanding of disordered anxiety, many researchers select alternative 
model systems in which the required features are evolutionarily conserved to a sufficient 
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degree. Mice (Mus musculus) share a considerable number of genes with us [7] due to 
conservation from our shared ancestry, along with a highly similar stress response system (such 
as the hypothalamic-pituitary-adrenal axis, [8]) and the capacity to display anxiety-like 
behaviours on specifically designed tests [9]. The commercial availability of inbred strains of 
mice, with innate variability in anxiety-like behaviour, also enables to the study of influences 
by genetic background. This makes mice a suitable model system for the study of the 
neurobiology of anxiety and stress. Species-specific features, such as the extended evolution 
of the human cortex and the capacity to verbally express subjective anxiety, limit the ability to
generalise from animal models to human populations. However, with these limitations in mind 
we can still meaningfully enhance understanding of the mechanisms of disordered anxiety.
Such studies have over the years pointed to the importance of brain plasticity in the 
development of and recovery from psychiatric disorders [10]. Until quite recently, the concept 
of plasticity was rarely extended beyond that occurring in neurons, specifically at synapses.
However, experience-related alterations in another part of the nervous system has been 
proposed to operate alongside this, including myelin plasticity [11]. Myelin provides insulation 
and sites of optimal ion channel placement for axons, enabling fast action potential 
propagation. Optimally timed action potentials are at the core of brain function, which involves 
networks of neurons in near and far regions communicating in a synchronous manner [12].
Indeed, synchronous inputs are even critical for synaptic plasticity [13]. The discovery of 
experience-related myelin plasticity broadened our conceptualisation of adaptive brain 
plasticity, but also raised the possibility of maladaptations. Anxiety disorders and other 
psychiatric disorders are today seen as occurring from maladaptive processing across networks, 
rather than within single brain regions. Mechanisms affecting such network-level processes, 
such as myelin plasticity, are thus attractive candidates in the search for neurobiological
underpinnings of anxiety disorders.
In this thesis we first mapped which brain regions within the network are engaged by chronic 
psychosocial stress in mice. To then explore more deeply what happens in some of these 
regions, we performed RNA-sequencing of tissue collected from stress-exposed and control 
mice from two different genetic background. We identified myelin-related genes as
differentially expressed following stress. Finally, we used structural (transmission electron 
microscopy) and genomic (RNA-sequencing of enriched OLGs and myelin) approaches to
study how myelin is involved in stress-resilience and -susceptibility, with implications for 




2.1 Anxiety & Stress
2.1.1. Anxiety and anxiety disorders  
In order to avoid danger, our ancestors adapted the capacity to anticipate threats and respond 
in preventive ways before the threats manifested. In psychological terms we call this anxiety, 
which refers to a broad range of both subjective and objective experiences with the goal of self-
preservation. The word anxiety has its roots in the Greek word angh referring to a state of 
physical or philosophical constriction. The Finnish word for anxiety (ahdistus, the root 
word ahdas translates to “restricted/tight space”) also captures the feeling of anxiety. The 
connotations of anxiety are often negative, as the subjective feelings that arise with it are 
generally unpleasant. We feel worried, hypervigilant and agitated, and may start ruminating 
over the possible threat, such as an upcoming course deadline or interpersonal conflict. When
experiencing anxiety we are influenced by much of the same physiological response as we are
when facing stressful situations in broader terms (discussed in detail below). Colloquially the 
term fear is sometimes used interchangeably with anxiety, but strictly speaking these two 
feelings are distinct, albeit often intertwined [14]. Fear refers to a threat response directed at an 
imminent, certain threat, while anxiety is directed at ambiguous or merely potential threats.
Although these responses provide an animal with an adaptive edge, such as avoiding novel 
environments not because there definitely is a predator, but because there might be, anxiety
comes at a cost. This cost is the loss of opportunities to, for example, gain resources or new 
mates. Thus, the anxiety system needs to be active in a balanced way, keeping us safe from 
harm while allowing us to take appropriate risks to survive and advance.
Like most of our bodily systems, the anxiety system can become disordered. This refers to a 
state where an individual’s drive to avoid risk comes at a significant and disproportionate cost
to well-being, both as resources lost and as subjective suffering. Clinically speaking, anxiety 
disorders is an umbrella term for a heterogeneous group of syndromes with both shared and 
distinct symptoms. In the Diagnostic and Statistical Manual (DSM-5, [15]) and International 
Classification of Diseases (ICD-11, [16]) this includes generalized anxiety disorder (GAD), 
social anxiety disorder (SAD, also called social phobia), panic disorder, specific phobias, 
agoraphobia, separation anxiety disorder and selective mutism. The common feature of these 
disorders is that the patient experiences prolonged and disproportionate anxiety, which may be 
targeted toward certain kinds of stimuli or without a specific target and impairs functioning.
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The symptoms should also not be attributable to other somatic or psychiatric diagnostic 
categories. Due to her or his anxiety the person is unable to partake fully or at all in many of 
life’s joys, such as social activities or spending time in public spaces. As a whole 
these disorders have the highest lifetime prevalence rate across all psychiatric disorders
globally (16 %), with women 1.7 times as likely as men to be affected [1, 17-19]. They are 
highly comorbid with both psychiatric and somatic illnesses, such as major depressive disorder
(MDD; 46 % of cases also meet criteria for an anxiety disorder during their lifetime, [20]) and 
cardiovascular disorders [18], which may in part be due to shared underlying genetic risk 
factors [21, 22].
In older revisions of the diagnostic manuals, obsessive-compulsive disorder (OCD) and post-
traumatic stress disorder (PTSD) were also included under the anxiety disorders term. While 
they share some features with today’s anxiety disorders, they have been separated into their 
own respective classes in the new revision [15]. For example, while PTSD is intimately 
connected to stress, the symptoms that cause distress to the patient stem from a very specific 
traumatic exposure [23], as opposed to the more diffuse or general worries of a patient with 
GAD.
Given that anxiety is a necessary part of life, how can we distinguish this from a disordered 
state that requires treatment? Grupe & Nitschke [24] conceptualized disordered anxiety as a 
biased anticipation of future events to be threatening rather than safe. Disorders would thus
arise from disturbances in the anticipation system. For example, a person may be hypervigilant 
to perceive signals of possible threats, hyperreactive to these signals, inflate their estimation of 
how threatening a stimulus really is, or not be able to learn that a neutral stimulus is in fact not
dangerous. These features may promote an individual to choose avoidance strategies where 
none are required, because avoidance is incorrectly thought to have prevented a negative 
outcome. Finally, Grupe and Nitschke suggest that disordered anxiety may also stem from 
deficient top-down control over behaviour and cognition when faced with potential threats. 
This provides a framework within which to understand how an adaptive response can, in some 
individuals, become maladaptive.
Clinically, the distinction between adaptive and pathological anxiety remains a point of debate. 
Some, like Wakefield and colleagues [25], have argued that the diagnostic criteria for anxiety 
disorders often capture a part of the anxiety spectrum which may be inconvenient according to 
social norms but not a medical disorder requiring intervention. They acknowledge that 
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disordered forms of anxiety do exist, but suggest that we need to consider carefully the criteria 
at which they are considered disorders. To use SAD as an example, it may not be 
disproportionate to even feel uncomfortably anxious in the face of social situations where one 
may be scrutinized. Treating such a state would thus not in every case be productive. This also 
brings us to the distinction to be made between state and trait anxiety. The former refers to a 
momentary condition elicited by an anxiogenic stimulus, while the latter refers to the tendency 
of an individual to have high state anxiety, possibly arising from the mechanisms proposed by 
Grupe and Nitschke. An anxiety disorder could thus be understood as an extreme form of trait 
anxiety. Considerable care is required on behalf of diagnosing clinicians and of researchers 
using animal models to study features of anxiety disorders. The aim of treating anxiety 
disorders is not to remove the adaptive capacity for state anxiety when the situation warrants 
it, so an understanding of the full range of anxiety-like features is necessary.
The diagnostic categories, and particularly their use in a research setting, have also been 
criticised on the basis that they assign symptoms from quite different neurobiological 
modalities under one nosological term. This implies that all different symptoms afflicting the 
patient would stem from a single common disturbance, and treating this disturbance should 
ameliorate all symptoms. Recent efforts, such as the NIMH’s Research Domain Criteria 
(RDoC, [26]), have been made to re-frame our thinking about anxiety and other psychiatric
disorders into multiple functional, continuous domains. In this framework, each disorder is 
characterised by disturbances in several different systems, and these disturbances are not 
exclusive to a particular diagnosis. On the other hand, the heritability of different anxiety 
disorders has been eloquently described as “not respecting DSM boundaries”[27], which 
suggest that the biological basis for different syndromes is at least in part shared. Specificity is 
required in both clinical and research contexts to ensure that nothing gets lost in translation in 
order to move our understanding of these conditions forward.
2.1.2. Current treatment of anxiety disorders
When a person seeks treatment for their anxiety symptoms (which have typically started at 
least months if not years prior, [28]), the first line of treatment in Finland is pharmacotherapy, 
or a combination of pharmacotherapy and psychotherapy if available [29]. Anxiolysis can be 
achieved by several compounds. The earliest ones were pharmacologically non-specific with
high risk of undesirable side effects. These include benzodiazepines, which became the first 
line of treatment at their discovery in the 1950s [30]. While acutely anxiolytic, these 
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compounds are also generally sedative as they act on several subtypes of γ-aminobutyric acid 
(GABA) receptors, and addiction, non-adherence, tolerance are also major concerns [31, 32].
The search for better options for treatment quickly became relevant, and remains an active field 
today.
Around the same time as benzodiazepines became available, the monoamine oxidase inhibitor 
(MAOI) class of drugs was observed to have beneficial effects on low mood in tuberculosis 
patients [33]. More specific promoters of the monoaminergic system, such as selective 
serotonin re-uptake inhibitors (SSRIs) became the standard for treating MDD. Later evidence 
also emerged suggesting their efficacy in treating at least some of the anxiety disorders, and 
currently they are often prescribed for certain anxiety disorders [34]. The issues with SSRIs
and the similarly implicated selective norepinephrine re-uptake inhibitors (SNRIs), MAOIs and 
tricyclic antidepressants are today also well known. They have limited effectiveness in 
achieving remission (approximately 30 %, [35]), even when they do work the therapeutic action 
comes with significant delay, and many patients experience side effects, including worsening 
of anxiety symptoms [35, 36]. A highly efficacious treatment should arguably target the core 
dysfunction(s), reversing or otherwise improving them rather than merely alleviating 
symptoms, and this is naturally the goal of ongoing preclinical and clinical research. While the 
field is looking for new ways of targeting treatment, the old ways are not forgotten. Many are
also working on understanding the non-serotonergic effects of SSRIs on, for example, neural 
plasticity [37], which could help optimise treatment protocols to benefit more patients.
Concurrent with or independently of pharmacological treatment, many patients with an anxiety 
disorder are also treated with psychotherapy. Among the plethora of different types of 
psychotherapy, cognitive-behavioural therapy is suggested to be the most efficacious approach 
[38]. Evaluating the effectiveness of psychosocial interventions is challenging because the 
response criteria are not as standardised as those used for evaluating pharmacological 
approaches [39]. Approximately half of treated patients across several trials showed signs of 
improvement. A substantial portion of patients thus respond only partially or not at all, 
similarly to pharmacological strategies. Although the hope surrounding neurobiological 
research of anxiety disorders is often phrased as providing new pharmacological treatment 
targets, such work is equally necessary for driving non-pharmacological treatments forward.
An understanding of pathobiological dynamics, the influence of environmental exposures, and 
individual differences can also be integrated to develop better-informed psychotherapies.
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No compounds with novel mechanisms of action have been approved for the treatment of 
anxiety disorders in over 10 years at the time of writing, although clinical trials are on-going 
for compounds targeting nearly all known neurotransmission and neuropeptide systems [2, 
32]. For example, the partial N-methyl-D-aspartate (NMDA) receptor agonist D-cycloserine 
has shown promising results in both preclinical animal studies and studies using human 
patients. Through its action on the glutamatergic system it is thought to facilitate the extinction 
of previously acquired fear memories, which are prevalent in e.g. SAD as well as PTSD [40].
In long-term follow-up studies the effect was not found, suggesting benefits may be short-lived 
[41]. Efforts are also made to produce more personalised treatments, underscoring the complex 
heterogeneity underlying anxiety disorders. Corticotropin releasing hormone (CRH, also called 
corticotropin releasing factor [CRF]) antagonists did not show efficacy in the early clinical 
trials, but if targeted to patients carrying specific genetic variants affecting the CRH system 
one may see more encouraging results [42]. However, while knowledge about the 
pathobiological mechanisms underlying anxiety is lacking, pinpointing an optimal drug or 
treatment target will be extremely difficult. As preclinical and clinical work proceeds to 
uncover these mechanisms, hope renews for us one day achieving this goal.
2.1.3. Aetiology of anxiety disorders  
Until very recently, the genetics of anxiety disorders were a black box; genetic factors have 
long been known to contribute, but specific variants and how they contributed to disorder 
development were not known [27]. Twin studies have demonstrated that they are moderately 
heritable (approximately 40 % of variability attributable to genetic factors, [3, 22]). For 
complex and common disorders like anxiety disorders it was never likely that one would find 
singular causative variants. Rather, the genetic risk is composed of several variants collectively 
increasing risk in small increments [43]. To detect such variants to be associated with disorder 
cases compared to healthy controls, a genome-wide association study (GWAS) needs to have 
a large sample size. Within the last two years, such sample sizes have finally been achieved.
Meier et al. 2019 [44] report a genome-wide significant association with variants in the gene 
PDE4B in a combined patient group with anxiety or stress-related disorders (n ~ 13 000). The 
homologous mouse gene Pde4b was differentially expressed in the medial prefrontal cortex
(mPFC) and ventral hippocampus (vHPC) in mice which, after exposure to chronic stress, 
displayed social avoidance. This lends support to variants within this gene possibly being 
aetiologically relevant, and future work will be needed to probe this further. Purves et al. 2019
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[5] utilized the large UK Biobank sample to define over 19 000 and 25 000 participants as 
currently experiencing anxiety symptoms or having a current or past anxiety disorder diagnosis, 
respectively. This report also produced significant associations, but not in the same genomic 
loci as Meier et al. Some of their hits, such as one in the intron of NTRK2, raised enthusiasm. 
NTRK2 encodes a receptor for brain-derived neurotrophic factor (BDNF), a critical stimulator 
of synaptic plasticity, which is perturbed by stressful life experiences [45]. The functional 
relevance of the variant found in this receptor remains unknown.
One of the major questions within the field has been how much of the genetic risk toward 
different diagnostic entities within the anxiety disorders umbrella is shared. A large twin study 
by Tambs et al. [22] suggests that the majority of the genetic risk comes from factors common 
across these disorders, with only a small portion predicting risk towards one diagnosis but not 
others. A meta-analysis [46] also found a significant hit associating with many DSM classes of 
anxiety disorders, this time in a non-coding region. Meier and colleagues additionally analysed 
correlation between the overall “genetic signature” of their patient group and found significant 
association also with other traits, including other psychiatric disorders. High correlations 
between anxiety disorders and MDD have also been reported by others [4, 5, 44]. This suggests 
that a substantial portion of the biology underlying these disorders is shared. While this may 
give hope of eventually finding a mutual actionable treatment target, it is worthwhile to note 
that within-diagnosis heterogeneity in symptoms may still represent distinct biological 
mechanisms. The study of both discrete and shared genetic factors is thus valuable.
Given the conceptual relationship between disordered and adaptive anxiety, many have chosen 
to explore anxiety as a dimensional variable. Such an analysis was carried out in nearly 200 
000 participants of the Million Veterans Program [47], which revealed 6 significant loci. Of 
note, the majority of the participants in this study were male, so potential sex-specific effects 
could not be assessed. Keeping in mind the higher female prevalence, sex differences remain 
an important avenue of study, although rarely addressed. Nagel et al. [48] quantified trait 
neuroticism, a personality parameter associated with risk of developing an anxiety disorder, in 
nearly 500 000 people. With over 100 independent variants, mostly in non-coding regions, and 
nearly 600 implicated genes derived through computational modelling, this represents the 
largest study of an anxiety-related trait to date. Among the associated variants was one within 
the encoding corticotropin-releasing hormone receptor 1 (CRHR1), an important player in the 
hypothalamic-pituitary-adrenal (HPA) axis (see below). Whether and how these variants 
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contribute to the transition from non-pathological neuroticism to an anxiety disorder will 
require further study. 
Genetic factors also interact with other factors to add to anxiety disorder risk. The 
aforementioned large GWAS studied have unfortunately not included analyses of other 
phenotypic data, such as exposure to known environmental risk factors, in order to assess 
potential gene-environment interactions. These risk factors, such as chronic psychosocial 
stress, have been shown to increase risk particularly in those with high genetic risk [49, 50].
This is the most well-characterized environmental risk factor for anxiety disorders, and for a 
host of other psychiatric disorders [51]. For example, adolescents who experienced sexual 
abuse in their childhood have 3.9 – 4.8 times higher risk of developing an anxiety disorder [52].
As stress-exposure is also a common occurrence in human life, understanding how it 
contributes to disorder aetiology is a major field of research and the focus of the next section 
of this thesis. Studies focusing on stress interacting with specific variants in candidate genes 
(genes which are of interest because of prior hypotheses regarding pathophysiology) have been 
performed but with very limited sample size. For example, Nestor et al. [53] report an 
interactive increase in risk for a range of psychiatric symptoms, including anxiety, in students
reporting childhood trauma who also carry the short allele of the 5-HTTLPR gene. A significant 
challenge in this and other similar studies relates to measurement timing. Retrospective reports 
of trauma may be biased by current affective state; a person currently suffering from anxiety 
may be more likely to recall early traumatic experiences than those without anxiety. 
Longitudinal follow-up studies shield against this, but require large sample sizes to capture 
affected persons and are extremely lengthy to conduct [51]. The study of how environmental 
and genetic factors may interact in anxiety disorder aetiology is still in relative infancy, but 
hopes are high for future break-throughs.
There is hope that the study of psychiatric genetics will eventually provide benefits for patients 
in various ways. A lesson in how this can be achieved can be learned from another common 
and heterogeneous disease state: cardiovascular disease [43]. Despite its complexity, 
accumulating data on both genetic and environmental risk factors has enabled the generation 
of personalized prediction tools which inform treatment selection, and the development of 
treatments based on novel biological mechanisms discovered via genetics (e.g. PCSK9). There 
is no logical hindrance as to why, with sufficient data, these paths could not be followed by 
psychiatric genetics at some point in time. 
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2.2. Stress as a risk factor for anxiety disorders 
2.2.1. What is stress?
Since the primordial pool, organisms have needed to contend with various threats to their 
existence. When, for example, a predator approaches, many species employ what we today call 
the stress response. It is also often referred to as the fight/flight(/freeze) response, as the goal 
is to adjust available resources to deal with the acute threat to survival; either confronting it, 
fleeing from it, or in some cases minimize the chance of being spotted and waiting for the threat 
to pass. Anxiety is conceptually related to stress as they both pertain to dealing with threats. In 
this context, stress refers to a general response to any challenge that requires an individual to 
respond, while anxiety is a response specifically to a non-imminent and/or potential threat. By 
contrast, fear describes the response to an imminent, certain threat [14]. Experimentally stress,
fear and anxiety are notoriously difficult to separate, and many of their neurobiological and 
endocrine features are shared.
The term fight or flight response dates back to Walter Cannon’s notion of organisms needing 
an emergency response system to deal with external threats to internal balance [54]. Despite 
being limited in terms of available methods to determine the molecular components of this 
response, Cannon reasoned that it should exist to guide metabolic processes towards either 
fleeing from the approaching threat, or aggressive confrontation of it. Hans Selye [55] posited 
that the same system becomes activated even when faced with quite different stimuli, such as 
cold temperatures and imminent predators, prompting his theory of a general adaptation 
syndrome (GAS). Cannon’s emergency response is essentially the first stage of Selye’s GAS, 
also called the alarm reaction. Capturing the transient nature of the response, Selye suggested 
that the alarm reaction is followed by a resistance phase, where the body attempts to terminate 
the response, which succeeds if the cause of the alarm reaction is no longer present or 
threatening. Interestingly, Selye also pointed out that the GAS seems to be relevant for a host 
of somatic illnesses, such as hypertension and inflammatory conditions. To explain this 
relationship, he suggested that the third phase of GAS is exhaustion, caused by depletion of 
resources necessary for resistance. In situations with consistent and relentless stress triggers, a 
person would be vulnerable to exhaustion, and thus to a host of health problems. This matter is
discussed below in more detail.
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2.2.2. Physiology and neurobiology of stress and anxiety 
Physiologically, the alarm reaction portion of the stress response consists of activity of two 
parallel systems; the HPA axis and the sympathetic adrenomedullary (SAM) system. Both 
involve the coordinated systemic release of hormones (glucocorticoids [GCs] and 
adrenaline/epinephrine, respectively) which enable optimal allocation of resources, such as 
glucose and blood flow, to systems which are necessary for immediate survival [56]. Many of 
these hormones, such as GCs, are also stimulated by non-threatening stimuli, such as physical 
exercise, the ingestion of food, and simply variation in circadian time.  These endocrine events 
have self-regulatory capacity, and are initiated and coordinated by the brain. Decades of work 
in both animals and humans has corroborated evidence that stress and anxiety (at least as a 
state) involve largely overlapping neural circuits, and these will thus be discussed in parallel. 
 
In order for the stress and anxiety responses to be initiated, several interlinked circuits of the 
brain are involved (Figure 1, [2, 57]). These circuits are not organized in a linear manner, where 
one region receives input from another, processes it and moves it forward to the next target 
region. Rather, the processing is layered and composed of several bidirectionally connected 
loops, allowing feedback regulation and updating new information. This ensures that an 
appropriate early, potentially life-saving response is generated as fast as possible, but the 
response is adjusted by the involvement higher cognitive functions. 
 
 
Figure 1. Illustration of critical nodes of the brain’s stress and anxiety network. The same regions 
are depicted in the human (top) and mouse (bottom) brains. mPFC = medial prefrontal cortex, BNST = 
bed nucleus of the stria terminalis, vHPC = ventral hippocampus. 
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Firstly, most obviously in the case of external threats, sensory systems need to convey a 
perception of the stimulus. At this level most stimuli are arguably processed as neutral in 
valence, although exceptions exist in terms of innately threatening stimuli [58]. For both innate
and non-innate stimulus processing to proceed towards the stress response, the stimulus must 
be interpreted as potentially threatening. The amygdala, specifically the basolateral nucleus 
(BLA), is critical for assigning a stimulus as threatening, as well as learning about novel 
threatening stimuli [59, 60]. Chronic stress in animals has been shown to increase dendritic 
branching in this region, in addition to an adjacent structure called the bed nucleus of the stria
terminalis (BNST, historically also called the extended amygdala, [61, 62]). While also 
involved in threat assessment, the BNST’s role has been suggested to apply more to uncertain 
threats, such as those eliciting anxiety, rather than immediate ones [63, 64]. The central nucleus 
of the amygdala (CEA) receives input from the BLA and can in turn stimulate the 
hypothalamus to activate the HPA axis and the periaqueductal grey (PAG) to elicit behavioural 
responses, such as freezing in rodents [57, 65]. The BNST is similarly connected with regions 
mediating the outward stress response [64]. Within these regions lie several distinct neuronal 
populations, some of which when active promote anxiogenic responses to new situations while 
others suppress them [66]. Dissecting the roles of these regions and their internal and projecting 
connections has revealed a lot about the complexity of initiating the stress response
For a proportional response to occur, a well-working brain also evaluates the level of the threat
to modulate the intensity and duration of the stress response. This includes processing
memories of similar past stimuli, what responses they elicited, and with how much success. 
Memories of the stimulus are also formed or updated to inform response selections on potential 
re-encounters in the future. This regulation of the stress response is critically mediated by the 
prefrontal cortex (PFC), a region also associated more generally with executive control [67].
Hernan and Cullinan [68] review evidence suggesting that innate/non-learned stressors, such 
as hypoxia, produce HPA-activation with little input from the PFC, while the response to
stressors involving learning or integration of signals from multiple sources depends on PFC 
involvement. Joseph LeDoux has also argued that cortical processing is fundamental for the 
subjective experiences of states like anxiety and fear, operating to a degree separately from the 
limbic structures controlling physiological states [14]. Owing to this being one of the last 
regions of the brain in mammals to reach maturity, it is argued to be particularly sensitive to 
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insults such as chronic exposure to stress [69]. Subregions of the PFC, such as the prelimbic 
cortex (PrL) in rodents and ventromedial PFC in humans, are intricately connected with the 
amygdala, providing top-down modulation of its activity and facilitating the learning of 
threatening and safety stimuli [57]. This level of processing enables online regulation of the
stress response as it is carried out.
Some minutes after the stress response has been initiated the self-regulatory negative feedback 
loop of GCs guides the system to return to a homeostatic state, ready to deal with the next 
incoming crisis. The hippocampus (HPC) contains a high density of GC receptors (GRs), and 
early lesion studies demonstrated its role as an inhibitor of HPA activation [70]. Unlike the 
amygdala and BNST, where chronic stress produces more complex dendritic morphology, in 
the rodent HPC chronic stress causes atrophy and simplification of neurons and their dendrites 
[62]. Reduced hippocampal volume is also seen in humans with extensive stress-related 
psychopathology, such as MDD [71]. In addition to its established role in memory and 
cognition, which are also altered by stress exposure [72], this complex structure also involves 
circuits which interact heavily with the mPFC and the amygdala to moderate anxiety-like 
responses to situations with novel, uncertain stimuli. Lesioning the ventral, but not the dorsal, 
HPC reduces the expression of anxiety-like behaviour [73]. Specific kinds of oscillatory 
activity becomes increasingly synchronised between the ventral HPC (vHPC) and mPFC in 
mice while performing an anxiogenic task [74]. Exogenously induced activation of the vHPC-
mPFC connection, achieved by viral targeting of specific artificial receptors and delivery of a 
specific activating ligand, also increases anxiety-like behaviour in mice [75].
These circuits orchestrate the selection of appropriate responses, including behavioural 
(ceasing irrelevant behaviours, re-directing attention), emotional (feeling uneasy, anxious or 
frightened), and physiological (HPA-axis activity) responses. Many of the critical nodes of the 
circuit have been demonstrated to be functionally altered in patients with anxiety disorders.
One frequent finding is that compared to healthy controls, participants with an anxiety disorder
show exaggerated amygdala reactivity when presented with threatening stimuli during 
functional magnetic resonance imaging (fMRI). Similarly to genetic risk factors, this finding 
applies across diagnostic categories, representing a general feature of disordered anxiety [76].
This hyperreactivity relates at least in part to lower activation of PFC subregions during a threat 
perception task in people who score higher on measures of anxiety than those who score lower 
[77]. Interestingly, high anxiety relates to increased functional connectivity when viewing 
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angry or fearful faces between some regions (right amygdala and dorsomedial PFC) but
decreased connectivity between others (left amygdala – anterior cingulate cortex). In this and 
many similar studies it is difficult to separate the influence of state and trait anxiety on outcome 
measure. Imaging studies of clinical populations, which have high trait anxiety, typically have 
small sample sizes of heterogeneous patients and often lack coverage of the whole disorder 
process from a presymptomatic stage through treatment responses. Hence it is difficult to 
entangle if imaging features represent pre-existing vulnerabilities, the disorder process itself, 
or adaptations to treatment. 
In terms of cortisol, the major endocrine output of HPA activation, links to anxiety disorders 
are inconsistent. Some report an increase in daytime cortisol [78, 79], while others report a 
decrease [80]. In the latter, the decrease is only observed in anxiety disorder patients with a 
history of childhood maltreatment; patients with no known maltreatment history show a trend 
for increased cortisol. A more recent study reports no differences in constant levels (as 
measured from hair) or responsivity to a stressful task in generalized anxiety disorder compared 
to non-anxious controls [81]. These data suggest that disordered anxiety does not involve
alterations in all nodes of the stress system, but associates with disturbances in certain brain 
regions. How these disturbances develop, and the role chronic stress plays in this development,
are an area of active enquiry.
2.2.3. Chronic stress and implications for health  
The described stress response is best suited for dealing with acute and transient stressors. As 
opposed to a homeostatic system, which aims to maintain a specific adaptive state, the stress 
response system is allostatic [82]. Allostasis refers to an adaptive change in the system intended 
to respond to a change in the demands placed on the organism to survive, such as encountering 
a threat. An allostatic system is responsive and dynamic, but ultimately it aims to return the 
system to a state where homeostasis can once again be achieved and maintained. When an 
organism is continuously exposed to stress-inducing stimuli, the system is not able to return to 
a homeostatic state, as noted by Selye when he described the state of exhaustion. Instead, as 
Bruce McEwen proposed, the organism starts to incur damage from an allostatic load [83]. On 
repeated encounters with the same stressor, provided it was successfully dealt with and hence 
deemed non-threatening, it is advantageous for the organism to habituate. Habituation refers to 
a gradual diminishment of the response to repeatedly encountered stimuli, and it acts as a 
resource conservation mechanism, saving the strong responses to either unfamiliar or known 
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severe threats. Habituation of HPA activation has been consistently observed across species 
and triggering stimuli [84]. Thus, allostatic load can be caused by a failure to habituate to 
continuous stressors or to appropriately downregulate the allostatic response [83, 85].
As noted before, exposure to stress poses a major risk factors for anxiety disorders as well as 
other harmful outcomes in terms of psychiatric health and brain development. This is 
particularly true of stress experienced in early life, possibly because of ongoing development 
during sensitive periods which close later in life [6, 86]. For example, myelination of cortical 
regions is largely incomplete during adolescence and early adulthood [87, 88], a period of 
significant potentially stressful life experiences as well as the most common period of onset for 
mood and anxiety disorders [89]. Subjective recall of early life trauma is a superior predictor 
of adult internalizing psychopathology (such as mood and anxiety disorders) than objective 
records of traumatic events, suggesting that how an individual experienced the event is critical 
for downstream consequences [90]. Biases in recollection of earlier trauma, caused by current
symptoms, may also account for this relationship. Brody et al. [91] reported that physiological 
indicators of allostatic load (high resting blood pressure and morning cortisol) in an adolescent 
sample were related to previously reported adversities, but these indicators were high even in 
those without current depressive symptoms. This suggests that the mechanisms by which 
chronic stress affects certain physiological measures may not be the same as the mechanisms 
responsible for the association with psychiatric disorders. These findings raise important 
questions about how stress could have such long-term detrimental effects on mental health; 
while the relationship is well-established, the mechanisms underlying it have remained elusive.
We now know that Selye’s resistance phase on the molecular level involves a negative 
feedback loop of GC signalling. The binding of GCs to GRs at the hypothalamus and HPC
initiates a signalling cascade that inhibits the release of further GCs [70]. Chronic stress 
curiously associates with a reduced density of GRs at the HPC [92]. This in turn arguably 
lowers the capacity for negative feedback, leading to perpetually elevated levels of GCs [93]
and reduced ability to downregulate the stress response [94] seen in for example MDD. In 
addition to the immediate fight/flight response, GCs produce various effects on our cells via 
GRs which, when activated, alter gene transcription. Adaptations at the level of GRs and their 
actions may in part mediate the effects of chronic stress on health, and while statistically this 
mediation has been reported it remains unknown whether there is a true causal chain 
particularly when it comes to psychiatric health [95].
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Chronic stress also affects fine structural features of the brain, but whether these effects are 
due to GCs or other factors remains unknown. For example, as mentioned above, neurons in 
the HPC and PFC of rats have fewer dendritic branches after chronic stress compared to non-
stressed rats, while dendritic arborisation was increased by chronic stress in the amygdala and 
BNST [61, 62, 96]. Given that these regions are critical nodes of the stress and anxiety 
networks, such structural changes may be relevant for disordered stress responses and anxiety.
Indeed, both traditional and novel treatments for MDD, such as fluoxetine and ketamine
respectively, act on synapses in at least the HPC as part of their antidepressant effect [97-99].
However, the varied patterns on synaptic effects of stress seen between different brain regions 
may explain why these mechanisms have yet to be fully harnessed as efficacious treatment 
targets. To this end, we need to expand our understanding of how these effects arise in different 
brain regions as a function of stress exposure. 
2.2.4. Behavioural neuroscience in the study of anxiety and stress  
Due to the aforementioned high evolutionary conservation of threat detection and survival 
systems, stress and anxiety can be studied in multiple different organisms, each with unique 
advantages and disadvantages. Human subjects can be recruited to study the effects of 
experimentally simulated stress or anxiety disorder status on parameters like GC responses, 
subjective feelings of stress or anxiety, and brain-wide metabolic and electrical activity. 
However, in humans we cannot access brain tissue for the study of how particular cells respond 
to stress or other molecular-level endeavours. We also lack the ability to control the nature and 
timing of naturalistic stressors as well as the genetic make-up of the study sample, which adds 
considerable variability to output measures. To complement human research, we thus turn to 
animal models where these limitations can be addressed at least to an extent.
For an animal model to be useful, one must carefully consider how its features match its 
purpose, all while considering ethical constraints and animal well-being. When it comes to 
psychiatric phenotypes, it is widely agreed that non-human models cannot fully recapitulate 
every feature of the disorder [100]. Rather, an animal model is used to capture some specific 
feature or dimension involved in the disorder, thus building on the knowledge base. When 
selecting an appropriate model system for a desired feature it is critical to consider the validity 
of the model. Broadly speaking, validity refers to the accuracy with which a test or model 
targets what it is intended to target. A good animal model system would need to share key 
features (construct validity), appear similar on observation (face validity), and respond to the 
20 
 
same manipulations, such as pharmacology (predictive validity) [101]. A challenge for animal 
models of complex psychological phenomena is that validity can only be determined against 
current knowledge about the target construct, such as disordered anxiety. However, our 
knowledge about these phenomena are also limited until expanded upon by work from both the 
clinical and preclinical sides [9].
Two additional aspects of validity are external and internal validity. The former refers to the 
generalizability of knowledge gained from the model, such as the ability to apply findings from 
a non-human animal species to human patients. The more similar the study sample thus is to 
humans, the higher its external validity. However, human populations are highly 
heterogeneous. A heterogeneous research sample poses many challenges such as added 
variability, which in turn necessitates the use of larger numbers of animals. It also risks 
lowering internal validity, i.e. the consistency of the model. This is at odds with prevailing 
initiatives to reduce the numbers of animals used, such as the 3Rs [102]. To improve internal 
validity, one strategy is to make use of a highly homogenous study sample. Inbred mouse 
strains, commercially available in over a hundred varieties, have become a standard tool in 
behavioural neuroscience. Mice belonging to the same strain are genetically isogenic, thus 
considerably reducing variability and improving the consistency, but potentially reducing 
generalizability of the data across other strains and even species. Selecting a model system is 
thus a balancing act between achieving a high internal validity without losing external validity.
Another advantage of inbred mouse strains as models is that each strain has unique features.
Employing several different strains in the same study provides a way to model how genetic 
background moderates the effect of an independent variable, such as a genetic mutation, on an 
outcome variable like anxiety-like behaviour. Sittig et al. [103] demonstrated this beautifully 
by producing a heterozygous knock-out of TCF7L2 in 30 different inbred strain crosses. In the 
A/J strain the effects of this haploinsufficiency included higher startle response to a sudden 
sound. By contrast, in the DBA/2J strain the effect was reduced startle response compared to 
wildtype littermate control mice. Research involving several strains has also demonstrated 
notable differences between even naïve mice from different strains. For example, mice from 
the C57BL/6J strain show low tendency for anxiety-like behaviour across several tests (see 
below), while DBA/2J mice behave in a manner consistent with a high-anxiety state [104].
Thus, considerate use of multiple inbred mouse strains with carefully selected features can 
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provide several improvements both in terms of internal and external validity compared to using 
just one strain.
2.2.5. Animal models of anxiety-like behaviour and chronic stress
For the study of anxiety, one common approach is to measure the degree to which an animal 
in a specific environment expresses relevant behavioural, metabolic, sympathetic or endocrine 
responses. Self-report of subjective sensations like worry or rumination cannot be collected, 
but the aforementioned factors are critical also in human anxiety and can thus be used as valid 
indicators of animal anxiety-like phenomena [9]. Tests of anxiety-like behaviour in rodents 
place the animal in a novel context with a conflict; approach a potentially dangerous part of the 
environment (e.g. an open, brightly lit area) or remain in a dark confined part (Figure 2). These 
tests are useful for detecting anxiolytic properties (at least of GABAergic compounds; they 
may not be optimal for detecting novel compounds) and for examining the effects of a genetic 
modification on anxiety-like behaviour [32]. As evidence for their external validity, in a 
naturalistic study of human behaviour Walz et al. [105] showed that patients with an anxiety 
disorder were more likely to avoid walking across an open market place than healthy controls. 
When conducting these tests it is critical to note that they are susceptible to various 
confounding factors, such as alterations in locomotor, sensory or motivation systems caused 
by pharmacological compounds or genetic modifications of interest, as well as stress [106, 
107]. Most tests are also sensitive to habituation; repeated exposure to an environment or
stimulus affects how the animals behave on subsequent trials. Particularly in the elevated plus 
maze (EPM) rodents typically show low motivation to explore the open arms on consequent 
trials, unless a considerable delay is introduced, at which point the readout cannot be reliably 
interpreted to reflect anxiety [108, 109]. Other tests relying less on motivational or locomotor 
factors, such as operant conflict conditioning (also known as the Vogel Conflict Test, [110]),
novelty-suppressed feeding [111] and hyponeophagia [112], are becoming increasingly utilised 




Figure 2. Illustrations of common approach-avoidance tests of anxiety-like behaviours for 
rodents. The safe/enclosed area is shaded in green. The open areas of the apparatuses is considered 
anxiogenic, and the more time the animal spends in these areas the less anxiety-like behaviour they are 
considered to display. From left to right, open field test (OFT [113]), light-dark box (LD [114]), elevated 
plus maze (EPM [115]) and elevated zero maze (EZM [116]). 
 
As also noted before, anxiety is, to a point, a normal and necessary feature. Based in this many 
have called to question to what extent a difference between two experimental groups on tests 
measuring anxiety-like behaviour can be said to have relevance for disordered anxiety. 
Ethologically speaking, a lack of anxiety-driven avoidance of novel open spaces would be life-
threatening for a rodent, so removing this response with pharmacological means is not a 
desirable end point. However, high trait anxiety does pose a risk for later disordered anxiety 
[117]. Current conceptualisations of anxiety disorders (and most other psychiatric disorders) 
also highlight their dimensional nature [118]. Thus an understanding of basic mechanisms 
across the whole spectrum should, unless significant nonlinearity can be shown, advance our 
understanding of the dysfunctional state as well.  
With this said, a model with high construct validity should also capture anxiety which meets 
some degree of maladaptivity, similarly to our requirement for a human being diagnosed with 
an anxiety disorder. Inducing such a condition can be done by exposure to chronic stressors. 
Such procedures include early (maternal separation [119], altered maternal care [120]) and later 
(acute or chronic restraint stress [121, 122], chronic unpredictable/variable stress [CUS/CVS, 
[123, 124]], chronic social defeat stress [CSDS, [125]]) life stress. CSDS involves 
confrontations between resident aggressor mice and younger less dominant intruder mice, 
which makes it primarily a psychosocial stressor as opposed to the physical and environmental 
stressors used in models like CUS (for example wet cage bedding and altered light cycles). 
Following a confrontation, the intruder mice are housed in an adjacent compartment of the 
aggressor’s cage, with continuous sensory contact but without physical contact. The 
confrontation and housing arrangement is repeated for typically 10 days, each day with a novel 
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aggressor to minimize habituation, creating a chronic source of predominantly psychosocial 
stress.
Rodents exposed to CSDS often develop both acute and chronic signs of increased anxiety-like 
behaviour, but also despair-like behaviour (an endophenotype of MDD) and social avoidance
[126]. Firstly, this is interesting because the same environmental risk factor also predisposes 
humans to a broad range of psychiatric symptoms. Anxiety disorders and MDD are highly 
comorbid [20, 127], suggesting possible common underlying pathophysiology, so a stress 
model that recapitulates the comorbidity has good construct validity. Secondly, much like 
humans vary in their response to stress, so do rodents. Many people experience significant 
traumatic events but do not develop later psychiatric symptoms, a phenomenon known as 
resilience. Similarly, many mice exposed to CSDS demonstrate resilience; their behaviour 
resembles that of non-stressed controls. Resilience is an active process rather than a lack of 
effect by stress [128]. These features make CSDS a suitable system for studying the complex 
consequences of stress on the mammalian brain and body.
In addition to affecting the behaviour of rodents long-term, CSDS also has neurobiological 
effects. Induction of activity-related protein FBJ murine osteosarcoma viral oncogene homolog 
B (FOSB), and particularly its truncated highly stable isoform (ΔFOSB) has been shown 24 
hours after the end of CSDS in brain regions including the mPFC, BNST and PAG [129].
Several groups have reported effects on neuronal plasticity, such as long-term potentiation and 
–depression of synapses (LTP & LTD, [130, 131]). Specifically, in hippocampi of stress-
exposed rodents ex vivo electrical stimulation is not able to produce hallmarks of LTP as it 
would in non-stressed animals [132]. BDNF, a critical factor for promoting plasticity, is 
reduced by CSDS exposure in the PFC [133] but increased in the nucleus accumbens (NAc), a 
reward-related brain region [45]. Such dynamic regionally varying effects on plasticity are 
thought to underlie many of the behavioural maladaptations, as intervening with them directly 
or by using antidepressant compounds have been shown to rescue the maladaptive responses
[45, 133]. Long-term bidirectional plasticity in stress is a major avenue of research today, but 
different effects observed in different brain regions have rendered it a difficult direct treatment 
target. This highlights the need for simultaneous molecular and network level studies of stress 
and its consequences; only with a complete understanding of the process will we be able to 




2.3.1. What is myelin?  
As noted above, neural plasticity mechanisms have become increasingly the focus of research 
efforts when it comes to stress-related psychopathology [10]. However, the notion of plasticity 
to many neuroscientists still primarily refers the plasticity of neurons and their synapses (e.g. 
LTP or LTD), while plastic properties are also found in terms of adult neurogenesis [134] and 
angiogenesis [135]. The neurobiological features in anxiety and depression are largely 
considered to be circuit-level rather than single neuronal populations within selected regions
[136, 137], and thus a circuit-level form of long-term bidirectional plasticity could reasonably 
be expected to play a critical role. Through the next chapters I hope to convince you that myelin 
plasticity represents such a mechanism, and that this is a novel frontier from which to tackle 
the challenges we have faced in understanding these disorders.
Myelin is to most synonymous with a lipid insulator of axons, enabling fast conduction of 
action potentials. Myelin is produced by specialised cells (oligodendrocytes [OLGs] in the 
brain and spinal cord, and Schwann cells on peripheral nerves) as enormous extensions and re-
organizations of their cellular membranes (Figure 3). The largely cholesterol-based membrane 
is wrapped around nearby axons in several layers (called lamellae), and specialised proteins 
compact the membrane tightly and form channels necessary for transporting components from




Figure 3. Illustration of the relationships between neurons, OPCs and OLGs. OPCs during 
development and even in adult brains can differentiate into OLGs, which ensheath axons with multi-
layered (lamellae) myelin sheaths. Key parameters include myelin thickness, axon diameter, and their 
relative ratio expressed as the g ratio. 
Unlike the insulators applied in engineering settings, which tend to be complete, a critical 
property of myelin is that it is interspersed with gaps called nodes of Ranvier. These gaps 
enable localised ion flow between the axon and the extracellular space, triggered by the arrival 
of a depolarizing action potential. The result is an even faster mode of signalling called saltatory 
conduction. In addition to being fast, most brain processes require tight temporal control of the 
signals involved. For example, for the auditory cortex to provide sensible processing of 
localised incoming auditory signals, action potentials originating at vastly different parts must 
arrive simultaneously at their projection targets [138, 139]. Adjusting the speed as well as intra-
circuit timing can be achieved by adjusting myelin along the tracts.  
The mammalian brain follows a developmentally orchestrated programme of myelination close 
to and after birth, resulting in largely predictable patterns of high myelin content in axon-rich 
areas (also known as white matter) and sparse myelination in other regions such as the cortex 
where cell bodies dominate (grey matter). A computationally optimal g ratio (ratio of the 
diameter of the axon to the diameter of the whole fibre, including myelin, see Figure 3) for fast 
conduction has been determined to be 0.6, but most axons in both grey and white matter have 
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considerably larger (indicating relatively thinner myelin sheaths) and more variable g ratios 
[140]. Given that speed is ultimately not as important as synchrony, it is imperative that the 
developmental programme leaves some room for variation.
2.3.2. Developmental myelination  
Myelination is a highly conserved feature of cephalised organisms. Much of what we know 
today both about developmental myelination comes from studies opting for non-mammalian
models. For in vivo imaging, the preferred organism for many is the zebrafish (Danio rerio),
particularly at the early postnatal larval stage. Zebrafish larvae are practically transparent, 
and combined with their efficient production and ease of genetic modification they lend 
themselves exceptionally well to developmental biology. We have learned from these 
organisms that during early development, similarly to synapse dynamics, there is an 
overproduction of myelin [141]. This is followed by later retraction of some sheaths and 
stabilisation of others, a process which involves Ca2+ signalling in the OLGs [142], at least in 
part initiated by activity of the neuron which signals via the wrapped axon [143]. Of note, 
neuronal activity is not a requirement for myelination initiation, as evidenced by the OLGs’ 
tendency to wrap even inorganic nanofibers [144]. Vesicular glutamate release promotes initial 
myelination on at least some types of axons, although how these events may relate to the Ca2+
signals is to date not known [145]. Many proteins which have traditionally been considered 
synaptic, such as post synaptic density protein 95 (PSD95), also localise in clusters along the 
myelin sheath, making contact with the axon membrane. Although the exact signals exchanged 
between the neuron and myelin through these domains are not yet known, disrupting them also 
disrupts myelin formation in zebrafish [146]. A complex, bidirectional interaction between 
neurons and OLGs thus impact how specific axons get myelinated de novo.
In order for the OLG to be able to produce myelin, a network of transcription factors (TFs) are 
employed to both determine lineage progression and coordinate the production of myelin 
components. Two critical TFs expressed throughout the lineage, from proliferating 
oligodendrocyte progenitor cells (OPCs) to the postmitotic mature OLGs, are oligodendrocyte 
transcription factor (OLIG2) and SRY-box transcription factor 10 (SOX10). They regulate the 
expression of both stage-specific and non-stage-specific genes. Whether a cell remains as a 
proliferating OPC or differentiates into an OLG depends largely on other TFs. These include 
SOX6 and HES5 maintaining the OPC state, which are silenced upon initiation of 
differentiation [147]. During this switch, a TF called transcription factor 7-like 2 (TCF7L2)
27 
 
plays an important role. In the OPC state it is expressed at a low level and interacts with the 
Wnt/β-catenin pathway. Via currently unknown mechanisms, differentiation initiation causes 
TCF7L2 to instead interact with Kaiso, which also alters its DNA binding sites. Finally, when 
myelination is initiated, TCF7L2 interacts with SOX10 [148]. For proper transcription of 
myelin component genes (see below), SOX10 in maturing OLGs promotes the transcription of 
myelin regulatory factor (MYRF), a quite recently discovered TF with several unknown 
functions. The N-terminal of MYRF is cleaved at the endoplasmic reticulum by an additional 
unknown mechanism, and the trimerised N-terminal translocates to the nucleus and binds to 
DNA [149-151]. To maintain the expression of myelin components throughout the long life 
span of the OLG, TFs like MYRF and SOX10 remain active at high levels, and many have 
postulated they may also have a role in myelin plasticity, although this function is as of yet 
unproven [147].
The myelin sheath consists of specialised proteins and lipids. Myelin basic protein (MBP) is a
highly abundant CNS myelin protein, and it is critical for compaction of the lamellae [152].
Mice lacking this protein have a very severe and early phenotype involving motor deficits, 
nearly absent myelin, and early lethality [153]. Other structural proteins include proteolipid 
protein 1 (PLP1) and 2',3'-cyclic nucleotide 3' phosphodiesterase (CNP), the latter of which is 
known to oppose the actions of MBP in order to maintain channels passing through the sheath. 
These channels allow the shuttling of components, such as proteins, nutrients and lipids, from 
the OLG cytoplasm through the myelin layers into the growth zone located adjacent to the 
axonal surface called the inner tongue [154]. At least in vitro, neuronal activity promotes 
myelin formation via inducing the translation of mRNAs localised at the distal processes of the 
OLG [155]. The lipid composition on the myelin sheath relies on locally synthesised 
cholesterol, glycosphingolipids and phosphoinositides. Each lipid type appears to have specific 
functions, including interaction with local proteins and insulation [156]. The molecular 
complexity of myelin is what enables its specialised function, but it also provides several 
avenues for adaptations or malfunctions to occur. Whether and how the same components are 
important for early developmental and adult myelin continues to be an active area of research.
2.3.3. Adult myelin plasticity  
Curiously, while other aspects of brain development such as the number of neurons reaches a 
plateau rather early in life, myelin is still highly malleable in early adulthood and retains this 
capacity at least until the 4th decade of life [87, 157]. For a structure whose purpose would be 
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merely to provide a pre-programmed amount of insulation to enable neuronal function, this 
type of protracted development seems out of place.  
In terms of adjusting action potential speed, even subtle alterations in myelin parameters, such 
as thickness and length, can have functionally relevant consequences, with relatively low 
metabolic cost to the cells [158, 159]. While zebrafish have illuminated the basic mechanisms 
of myelin dynamics [160], it has taken rodents to start grasping how these dynamics may be 
relevant for behaving, adult animals. The lack of transparency of their organs introduces 
technical challenges when moving from zebrafish to rodents, so other clever manipulations 
have been used to address the dynamic nature myelin plasticity. 
While de novo myelination during development proceeds in a reasonably straight-forward way, 
adult myelin plasticity is by nature bidirectional and complex. Several parameters of the 
established myelin sheaths and their parent OLGs are subject to modification (Figure 4). 
Sheaths can lengthen or retract, they can become thicker or thinner, more or less numerous, or 
disappear altogether. These changes likely occur interactively, with similar events eliciting 
changes in several parameters rather than just one [161]. It is possible that these alterations are 
orchestrated by different kinds of molecular events and a collaboration between the OLG and 




Figure 4. Types of myelin plasticity. Illustrations of the different parameters of myelin sheaths 




Recent advances in longitudinal imaging have demonstrated that pre-existing myelin sheaths 
can be remodelled (extended or retracted) in adult mice [164, 165]. Experiences such as 
learning a motor task induce a burst in remodelling events. Bacmeister et al. [164] showed that 
this type of learning causes retraction of a portion of myelin sheaths in the motor cortex of 2-3
month old mice along with generation of new OLGs. Hughes et al. [165] used environmental 
enrichment in older adult mice to demonstrate a similar increase in oligodendrogenesis, but no 
evidence of remodelling of existing sheets was observed, possibly due to age- or brain region-
related features. Neuronal activity, even of the artificially induced kind, also promotes myelin 
formation and oligodendrogenesis [166, 167]. Optogenetically promoted activity-related adult 
myelin generation is dependent on BDNF signalling on OPCs, but the role of this signalling 
pathway in OLGs remains unknown [168]. Using elegant labelling techniques, it has been 
established that the myelin-promoting effect of pharmacogenetically driven neuronal activity 
is specific to the axons being activated, leaving adjacent axons with unaltered activity also 
without myelin alterations [167]. The aforementioned studies also demonstrated that the 
changes in myelin parameters associated with performance improvement. McKenzie et al. 
[169] further demonstrated the necessity of oligodendrogenesis on motor learning by knocking 
out the Myrf gene from OPCs selectively at learning. The capacity for myelin plasticity is also 
necessary for the stabilisation of fear memories, showing a potential downside to an otherwise-
adaptive process in that fear generalisation is relevant for several anxiety disorders [170].
Plastic, bidirectional alterations in myelin properties can thus occur even in adult animals, with 
relevance for learning and adapting to one’s surroundings.
While neuronal activity has been consistently pinned as a causal factor, this is more of a 
description than an explanation. A mechanistic explanation would need to encompass the 
factors that transmit the activity signal from the axon to the myelin, and in adult mammals this 
mechanism is yet to be recognized. Unlike OPCs, mature OLGs and their myelin sheaths do 
not express de facto synapses, but they do express glutamatergic α-amino-3-hydroxy-5-methyl-
4-isoxazolepropionic acid (AMPA) and NMDA receptors. When activated by release of 
glutamate along the active axon, Ca2+ waves in the myelin sheath are triggered [171]. However, 
this event has not yet been associated with dynamic changes in myelin parameters like sheath 
thickness or internode length. Genetic tools have also been used to identify some relevant 
signalling pathways, but their relationship to upstream neuronal activity is not known. For 
example, conditionally activating extracellular signal-regulated kinase (ERK1/2) signalling 
pathway in existing mature OLGs caused them to increase the thickness of their myelin sheaths 
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[172]. Overall we still lack many of the pieces needed to understand how myelin plasticity 
occurs, and how it can malfunction.
Another major question in the field is what effect each of these parameter changes has on the 
neuronal circuit. Computational modelling has been used to estimate how incremental changes 
could be expected to affect axonal conduction velocity [158] and self-organised synchrony 
[159]. Altering activity of retinal neurons (via either visual deprivation or exogenous 
interference with local glutamatergic signals) also alters myelin internode length and 
conduction velocity along the optic tract [173]. However, in vivo confirmation of such effects
in other circuits is extremely difficult because of technical limitations to observe myelin at a 
sufficient resolution while simultaneously recording activity, and the heterogeneity of 
myelination even along single axons which is poorly captured by simulations [174]. Kato et al. 
[175] used a transgenic mouse overexpressing the Plp1 gene with mild but global defects in 
myelin, and showed concurrent deficits in motor learning and abnormally large variation in 
spike timing at thalamocortical projection targets. Optogenetic stimulation of these axons was 
able to improve both motor performance and firing synchrony, but concurrent improvements 
in myelination were not shown. Development of in vivo methods allowing measurement of 
both myelin and conduction parameters from the same axons are necessary to truly understand 
the contribution of activity-related adaptations in myelin on axon and circuit function.
2.3.4. Evidence of myelin plasticity in humans
Due to practical limitations, acquiring evidence of myelin plasticity in humans has been 
challenging. The earliest evidence of such structural and experience-dependent plasticity came 
from neuroimaging studies. Repeated diffusion tensor imaging (DTI) sessions interspersed 
with training in a new motor skill, such as piano-playing or juggling, showed changes in 
relevant sensorimotor tracts which were indicative of adaptive changes in myelin [176, 177].
Similarly, cognitive reasoning training associated with decreased mean diffusivity (generally 
associated with improved white matter tract integrity) in a performance-related manner [178].
These indicators rely on the diffusive permissiveness of the tissue to water molecules, the 
vibrations of which are sensed by their magnetic resonance. In white matter tracts, consisting 
primarily of myelinated and unmyelinated axons rather than cell bodies, the degree and amount 
of myelination is one parameter which affects the diffusivity readouts. Intact white matter is 
highly restrictive in some directions (across axon/myelin membranes) but not others (along the 
axons lengthwise), while diffusion in demyelinated or otherwise harmed white matter is less 
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directionally restricted. For example, in demyelinating diseases such as multiple sclerosis
(MS), a key finding in patients is lower fractional anisotropy (FA, [179]), which indexes how 
directionally specific the restriction of the movement of water molecules is within an imaged 
voxel. The findings of Sholtz and Bengtsson and their colleagues [176, 177] suggest that 
learning-related experience increased FA, possibly indicative of thicker or more frequently 
myelinated axons post-training compared to pre-training. The resolution of DTI is far outside 
the nanometer scale at which many myelin plasticity events take place, and thus the 
explanatory power of these findings remains limited. In rodents a considerable correlation 
between experience-related changes DTI parameters and myelin gene expression has been 
demonstrated, lending some validity to deductions made from imaging data [180]. However, 
changes in imaging parameters can also occur via other mechanisms, such as changes in axon 
diameter or the extracellular environment, and as such the recommendation is to merely 
consider these readouts as proxies of myelin, rather than direct evidence of it [181].
Currently the only option for studying myelin at the cellular resolution in humans is to use post 
mortem donations, and indeed the growing data banks of brain tissue have been employed for 
the study of myelin and OLGs. Samples tend to be small and heterogeneous, and unlike 
imaging study designs, system dynamics cannot be gauged as the only time point available 
is post mortem. Nevertheless, recent publications have compared tissues from groups with 
myelin abnormalities, such as MS to healthy control groups. Despite extensive myelin 
degradation seen in these patients, there is also evidence of remyelination, i.e. the generation 
of new myelin sheaths in lesion sites [182, 183]. Throughout the course of the disease this 
process is not sufficient to rescue the pathological phenotype, but it is suggested to delay it and 
retain some level of functioning [184]. However, here it is not possible to draw direct parallels 
between the pathology-associated changes and those also occurring in adaptive myelin 
plasticity. Indeed, animal work suggests that remyelination after cuprizone-induced injury and 
myelin plasticity occur via at least somewhat non-overlapping mechanisms [164]. In terms of 
myelin plasticity, post mortem analyses may reach a suitable resolution, but lack the ability to 
gauge its dynamic nature.
In an elegant study, Yeung and colleagues [185] managed to combine the cellular resolution 
of post mortem research with an element of timing, capturing the lifetime dynamics of 
oligodendrocytes and myelin. They used the known high incidence of carbon isotope 14 
occurring around the time of frequent nuclear detonation testing as a marking pulse, as the 
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isotope would be integrated into us carbon-based life-forms. The isotope would decay both as 
a result of the passage of time but also the biological turnover rates, and thus it could be used 
as a marker of (at least relative) age of specific biological components. The authors deduced 
that while there seems to be very little turnover of the oligodendrocytes in the adult corpus 
callosum (CC), the myelin sheath is renewing much more dynamically. This capacity of 
protein-level turnover indirectly suggests the capacity for plasticity; if parts of a system can be 
replaced, they can presumably also be altered. Later work using animal models has also shown 
that different components of the myelin proteome turn over at different rates [186, 187]. While 
impossible to replicate in an empirical setting, this work managed to combine molecular-level 
analysis with available human post mortem techniques, showing that in a non-clinical sample 
myelin is subject to alterations even in adulthood.
2.3.5. Myelin and its plasticity in stress and psychopathology  
Myelin plasticity has in recent years been repeatedly associated with chronic consequences of 
stress exposure, including both molecular animal studies and human neuroimaging with 
parameters sensitive to variations in myelin [188]. Among the earliest demonstrations that 
stress could influence myelin thickness and relevant gene expression even in adult animals was 
a study of social isolation. Both juvenile and adult mice showed thinner myelin sheaths and 
lower expression of myelin-related genes in the mPFC after prolonged isolation from peers
[189-191]. The behavioural consequences of stress could be reversed with a compound that 
promotes OLG differentiation, with consistent recovery of myelin thickness [192]. To date 
there have been numerous studies utilizing different stress models, associating changes in 
myelin or its components with maladaptive consequences of stress. Findings from such studies 
are summarised in Table 1. Generally, the data suggest that stress associates with lower myelin 




Table 1. Summary of studies linking myelin and chronic stress in rodent models. HPC =
hippocampus, (m)PFC = (medial) prefrontal cortex, OLGs = oligodendrocytes, (ic)KO = (inducible-
conditional) knock-out, OPCs = oligodendrocyte progenitor cells, wt = wild type, NAc = nucleus 









Alttoa et al. 
2010 [193]




None Lower Mbp in the HPC and 
PFC of low-exploring rats 
compared to high-exploring.







None Higher expression of myelin-
related genes and more OLGs 
as pups, fewer OPCs as adults.
Chen et al. 
2020 [195]
Mouse, Cnp-Cre+/−







Olig2 cKO in 
OLGs
Socially isolated cKO mice had 
lower social interaction and 
higher anxiety-like behaviour 
compared to isolated wt mice. 








Ednrb cKO in 
OPCs.
Vascular endothelin signals to 
OLGs reduced after social 
isolation, promoting this 
rescued hypomyelination and
social interaction deficits.








isolation (2 or 
8 weeks, 
adults)
None Thinner myelin in PFC (2 and 8 
weeks isolation), and lower 
expression of e.g. Mbp (only in 
those isolated for 8 weeks). No 





line on a B6/CBA 
background, male
Social 





Higher g ratios and lower 
expression of e.g. Mbp in the 
PFC of socially isolated wt 
mice. icKO in group-housed 
mice replicates effects of social 
isolation (reduced social 
interest, myelin defects). 












Smaller MBP+ area and higher 
g ratios in socially isolated 
vehicle-treated mice in the PFC. 
Clemastine rescued myelin 
defects and social behaviour.






None Lower expression of e.g. Mbp
in the PFC after 4 weeks of 
CVS, and in the NAc already 
after 1 week of CVS.
Zhang et al. 
2016 [197]





None Smaller MBP+ area in the 











CVS (4 weeks, 
adults)
Cnp1 KO Lower composite score of
emotionality (depressive and 
anxiety-like behaviours) in KO 












None Smaller MBP+ area in the 















Thinner myelin, fewer OLGs 
and more OPCs in mice 
susceptible to CSDS in the 
mPFC compared to controls, 
MBP+ area unaltered. 












Cnp1 KO Lower myelin gene expression 
in the PFC and amygdala, 
abundance of myelin proteins 
and the number of OLGs 
unaltered by CSDS.






None Lower abundance of 17 and 21 
kDa isoforms of MBP and 
OLIG2 in the HPC, partially 
restored by physical exercise.
Transcriptome-wide investigations, without pre-existing myelin-related hypotheses, of the 
effects of CSDS on the mouse brain have also flagged myelin-related genes. Pena et al. [203]
compared RNA-sequencing (RNA-seq) findings from male CSDS-exposed mice to female 
mice exposed to another form of stress (sub-threshold variable stress), with or without 
additional exposure to early life stress (ELS). Analysing the enrichment of genes specific for
certain cell types, they report that OLG genes were enriched among the genes affected by ELS
in males and a double-hit of early and adult stress in females in the PFC. An additional analysis 
of biological pathways (Gene Ontology [GO]) suggested an enrichment of myelination-related 
genes in the male PFC after ELS. Ingenuity Pathway Analysis (IPA) was used to search for 
potential upstream regulators of differentially expressed genes (DEGs), and the top predicted 
regulator in this group was TCF7L2, a regulator of OLG maturation. In the female PFC, 
TCF7L2 was the top predicted regulator in the double-hit group. While this analysis did not 
separate resilient and susceptible mice, another publication from the same research group has 
implicated myelin-related genes (GO term “Nerve ensheathment”) in the PFC in successful 
response of CSDS-susceptible mice to the antidepressant effects of ketamine [204]. Together 
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these findings implicate broad biological pathway-level involvement of OLGs and myelin in 
the mouse stress response, with relevance for eventual recovery.
Evidence for the role of myelin in stress and psychopathology in humans has also emerged. 
Aston et al. [205] used a microarray to survey gene expression in the temporal lobes on post 
mortem samples from patients with MDD and psychiatrically healthy controls, revealing a 
cluster of myelin-related genes to be expressed at a lower level in the patients. Nagy et al. [206]
report RNA-seq of single cells gathered from the mPFC of male suicide victims with 
concurrent MDD and psychiatrically healthy control males. By comparing the numbers of 
DEGs across identified brain cell types they conclude that the largest number DEGs are seen 
in immature OPCs. To get clues about the potential biological meaning of this finding, Nagy 
et al. analysed enrichment of known biological pathways and found classes related to synaptic 
plasticity to be implicated among the DEGs in OPCs. Considering the emerging findings about 
synaptic genes potentially having novel functions in myelin discussed above, this finding may 
implicate similar pathways in MDD-related myelin pathology. Lutz et al. [207] also performed 
both transcriptomic and electron microscopic profiling of PFC tissue of suicide victims with 
MDD, with or without a family-reported history of childhood maltreatment and severe stress. 
The patients with a maltreatment history had lower expression of myelin-related genes and 
higher g ratios, indicative of lower relative myelin thickness. These findings implicate myelin 
both on the gene expression and structural level to psychiatric disease and stress, but leave 
open many questions still. There are currently no reports of similar analyses from patients with
an anxiety disorder. It is also possible that the differences seen post mortem were pre-existing 
vulnerabilities, part of the disease aetiology, a chronic adaptation to disease, or a response to 
failed or successful treatment, with next to no possibility to untangle these scenarios.
In vivo assessment of myelin in humans by neuroimaging, as noted above, lacks the resolution 
and specificity of molecular-level work. Additionally, much of the work on white matter 
structure in stress and psychopathology is done retrospectively, at a stage when the patients 
have had at worst years of symptoms as well as treatments, making it again difficult to parse 
what the role that differences in myelin-related features may be. In a group of healthy 
participants reporting some degree of early life stress, Poletti et al. [208] found lower FA in the 
cingulate cortex compared to participants with low to no history of childhood stress. This effect 
was seen in the cingulate gyrus, a white matter region in the PFC, and was more pronounced 
in males than females. In a male-only sample, early childhood and adolescent stress associated 
with higher magnetization transfer ratio (MTR) in distinct parts of the CC when imaged in 
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early adulthood [209]. MTR is sensitive to the proportion water in a semisolid medium, such 
as compacted myelin, versus water in an aqueous medium, such as the intra-axonal space, but 
like FA it cannot be used to specifically quantify myelin. McCarthy-Jones et al. [210] report 
lower FA in several white matter tracts including the CC and uncinate fasciculus (UF) in
participants reporting a history if childhood adverse events. The UF connects limbic structures 
like the amygdala with the PFC, and lower structural integrity is hypothesised to reflect 
compromised top-down control of amygdalar reactivity by the PFC. Of note, as the participants 
in both of these studies were adults currently reporting no psychiatric symptoms, it is possible 
that the observed white matter differences relate to resilience to stress rather than stress 
exposure. In another study, participants rated as high in harm avoidance, an anxiety-related 
trait and risk factor for anxiety disorders, showed lower FA and higher radial diffusivity along 
several white matter tracts connecting limbic and cortical regions [211]. As participants were 
screened based on any lifetime history of psychiatric symptoms, the authors interpret the result 
as a marker of vulnerability to anxiety disorders. However, as the participants were also past 
the peak anxiety disorder incidence age, it remains possible that the participants with high harm 
avoidance harboured some protective/resilience factors, which may or may not include the 
white matter differences compared to the low harm avoidance group. Thus, in addition to 
technical limitations, when studying humans we have limited ability to determine which 
features of two groups of people truly associate with an observed difference between them.
DTI studies of patients with one or more anxiety disorder diagnoses are to date sparse, and 
typically conducted with very small sample sizes rendering them underpowered [212, 213].
Despite these shortcomings, a consistent finding across diagnoses (at least GAD and SAD) is 
reduced FA along the UF. This finding is not anxiety-specific a similar findings have been 
reported for MDD [214] and PTSD [215]. Prospective studies managing to catch patients in 
the years prior to symptom emergence as well as after would be needed to separate structural 
vulnerability factors from disorder progression-related myelin plasticity. The present evidence 





The overarching aim of this work was to determine the effect of environmental and genetic risk
factors of anxiety disorders on brain structure and function. To investigate the effects of stress 
we employed a mouse model of chronic psychosocial stress (the chronic social defeat stress
paradigm; Studies I-III). To study how genetic factors moderate these effects, we used mice 
from two inbred strains (C57BL/6NCrl and DBA/2NCrl; Studies II-III).
The specific aims of this thesis were:
1. To investigate which regions in the mouse brain are repeatedly engaged by CSDS by two
complementary methods; manganese-enhanced magnetic resonance imaging (MEMRI) and 
immunohistochemical staining of a chronically inducible marker protein (ΔFOSB).
2. To determine major biological pathways differentiating between stress-resilient, -susceptible 
and control mice from two different genetic backgrounds using unbiased RNA-seq. Moreover, 
to follow up the discovered pathways by structural of functional analyses.
3. To identify molecular mechanisms underlying CSDS-related myelin plasticity via RNA-seq
of cortical oligodendrocyte- and myelin-enriched samples from resilient, susceptible and 
control mice. Furthermore, to assess the influence of genetic background on this gene 





4.1.1. Ethics statement (Studies I-III)
Animal procedures were approved by the authorization board of the Regional State 
Administration Agency for Southern Finland (ESAVI/2766/04.10.07/2014 and 
ESAVI/3119/04.10.07/2017). All experiments were carried out in accordance with directive 
2010/63/EU of the European Parliament and of the Council, and the Finnish Act on the 
Protection of Animals Used for Science or Educational Purposes (497/2013).
4.1.2. Animal husbandry (Studies I-III)
All animals were ordered from a commercial breeder (Table 2). On arrival, mice were housed 
in groups of 3-5 (B6 and D2) in open Makrolon III cages, or singly (CD1) in individually 
ventilated cages. Single housing was used when necessary to prevent conspecific aggression. 
All cages included bedding material, nesting material, and wooden sticks for enrichment 
(Tapvei Oy), and cages were changed once per week (except during CSDS). The animal facility 
was temperature (22 ± 2 °C) and humidity (50 ± 15 %) controlled, with a 12-hour light cycle 
(lights on: 6:00, lights off: 18:00). With the exception of active behavioural experiments, 
animals had ad libitum access to food and water.
Table 2. Details about mice used for experiments.
Mouse strain/stock Sex Age (on arrival) Provider
C57BL/6NCrl (B6) Male 5 weeks Charles River, Sulzfeld, Germany
DBA/2NCrl (D2) Male 5 weeks Charles River, Sulzfeld, Germany
Clr:CD1 (CD1) Male 13 weeks
Charles River, Sulzfeld, Germany or 
Envigo, Horst, The Netherlands
A summary of conducted experiments and included animals can be found in Table 3.
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Table 3. Summary of experiments. Summary of the number animals included, in total, in each of the 
Studies in this thesis and the unpublished data, separately for the B6 and D2 strains and for mice in the 
control condition (non-stressed) and stress-exposed condition (exposure to CSDS). B6 = C57BL/6NCrl,
D2 = DBA/2NCrl, CSDS = chronic social defeat stress, MEMRI = manganese-enhanced magnetic 





Control Stress-exposed Control Stress-exposed









6 13 6 18
Unpublished 
data
CSDS, IHC 8 15 10 15
4.1.3. Chronic social defeat stress (CSDS, Studies I-III)
Following a 7-day acclimatization period we screened the CD1 aggressor mice for appropriate 
levels of aggressive behaviour. We did this by assessing their latency to attack a novel intruder 
B6 or D2 mouse in the home cage on three consecutive days. Appropriate aggressors attacked 
no sooner than 10 seconds on more than one test day, or later than 90 seconds on more than 
one test day. Both aggressor screening and CSDS took place at the end of the light phase. 
Twenty-four hours before CSDS each screened aggressor mouse was placed alone into a cage 
to be used for CSDS to facilitate home cage behaviour.
To allocate B6 and D2 mice to CSDS or control conditions we balanced them for body weight 
before the start of the first defeat session. Each group cage contributed at least one mouse to 
each of the conditions to ensure a random distribution. Each defeat session consisted of an 
intruder (B6 or D2) mouse being placed into the home cage compartment of a CD1 mouse 
(Figure 5 A). During the ensuing maximum 10-minute interaction the CD1 mice behaved 
dominantly towards the intruder. To prevent and minimize physical injury to the intruder a 
trained experimenter monitored each interaction closely. Persistent attacks were prevented by 
separating the mice from each other. If any degree of wounding occurred, the interaction was 
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stopped, and the wound was treated with an antiseptic (Dermacool Vet, Biofarm, Karkkila, 
Finland).
 
Figure 5. Chronic social defeat stress (CSDS). A) Illustration of the CSDS procedure. B) 
Illustration of the housing of control mice. C) Illustrations of the two trials of the SA test. CSDS = 
chronic social defeat stress, SA = social avoidance test, IZ = interaction zone.
Once the defeat session was over, the intruder mice were moved to a separate compartment of 
the CD1 cage they were just in. This compartment was separated from the CD1 mouse by a 
perforated plexiglass divider, allowing only sensory contact. Both compartments had the same 
bedding, nesting and enrichment materials as the previous home cages. The cages were 
maintained in Scantainers (Scanbur, Karlslunde, Denmark) in the same room as the defeat 
sessions took place in, minimizing sensory exposure to other cages undergoing CSDS. After 
24 hours of this paired housing, each B6 and D2 mouse was removed and taken to a new cage 
with a novel CD1 aggressor, and the physical interaction + paired housing procedure was 
repeated. These 24 hour cycles were repeated for a total of 10 consecutive days.
Mice allocated to the control condition were housed in similar paired cages, but always paired 
with another control mouse (Figure 5 B). House pairs were exchanged daily, and no control 
mouse stayed in the same home cage for more than three consecutive days. This equalised the 
experience of moving to a novel home cage and handling incurred by the CSDS mice, without 
the aggressive physical encounter. The control cages were kept in the same room as the CSDS 




Mice were weighed on the first day of defeat (for group allocation) and on every even numbered 
defeat day to monitor health and well-being.
Twelve hours after the last physical encounter phase, all mice were separated into single cages 
containing the same enrichment items as above. The same evening, at the beginning of the dark 
phase (17:00 – 20:00), we performed the social avoidance (SA) test (Figure 5 C). This allows 
phenotyping the CSDS-exposed mice as resilient or susceptible. The test room was dimly lit
(15 lux) during the entire test, and the mice were brought into the test room 30 minutes prior 
to the start to acclimatise. The test consisted of two trials (no-target [NT] and target), always 
in the same order. In the first (NT) trial, the mouse was placed in the centre of an open arena 
(42 x 42 cm) with dark plexiglass walls and a perforated plexiglass cylinder next to one of the 
walls. Surrounding the plexiglass cylinder was a virtually drawn interaction zone (IZ). To 
quantify how much time the mouse spent interacting the cylinder, the number of seconds spent 
in the IZ was recorded from a video tracking using EthoVision XT software (versions 10 and 
13, Noldus, Wageningen, the Netherlands). Total distance travelled and the amount of time 
spent in the corners opposite to the IZ were also calculated. After 2.5 minutes the test was
stopped, the mouse returned to the home cage, and the arenas cleaned from any feces and urine. 
The cylinder was then replaced with a new cylinder containing an unfamiliar CD1 male mouse 
for the second trial (target). The CSDS-exposed or control mouse was returned to the arena for 
another 2.5 minutes, during which the same parameters are measured. After each target trial 
the arena was cleaned with 70 % EtOH and water to remove odours.
Social avoidance was operationalized as the social interaction (SI) ratio. This was calculated 
by dividing the amount of time the mouse spent in the IZ during the target trial by the amount 
of time spent there during the NT trial, multiplied by 100. A score of 100 thus means equal 
interaction with the empty cylinder as with the cylinder containing a social target. The SI ratio 
was calculated for both control and CSDS-exposed mice. During several cohorts of 
experiments performed in the lab, it was noted that control mice from different inbred strains 
differed in their social behaviour. Resilience in the context of CSDS refers to a stress-exposed 
mouse being behaviourally similar to non-stressed controls. Thus, in order to phenotype the 
CSDS-exposed mice from different strains as resilient or susceptible, it would not be optimal
to use the same cut-off point for determining susceptibility for different strains. Instead we 
determined strain-specific cut-off values for the SI ratio. To do this we first determined and 
removed outliers of the control mice included in experiments up to the most recent cohort at 
the time (3 interquartile ranges above or below the median), separated by strain, and normalized 
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the values using a log transformation. The mean control SI ratio and standard deviation for 
each strain was then calculated. The cut-off value (SI ratio below which CSDS-exposed mice 
are considered susceptible) was set as the mean – 1 standard deviation. For B6 mice this cut-
off value without log transformation was 76.49, while for D2 mice it was 105.99. Consequent 
CSDS cohorts were always compared to these established values.
Following the SA test all mice were returned to single cages and housed individually until 
dissection.
4.1.4. Manganese-enhanced magnetic resonance imaging (Study I)
In Study I, manganese-enhanced magnetic resonance imaging (MEMRI) was used as a way of 
assessing chronic neural activity. Both CSDS and MEMRI for this experiment were performed 
by co-authors, and the procedures are described in detail in the publication (Study I). Briefly, 
mice were surgically implanted with a MnCl2-dispensing subcutaneous minipump prior to 
CSDS. One week after the SA test mice were anaesthetised and scanned with a 4.7 T scanner 
(Bruker, PharmaScan 47/16 US, Ettlingen, Germany). Mn2+ ions are rapidly taken in through 
voltage-gated Ca2+ channels, and accumulate in activated cells due to slow efflux kinetics [216-
218]. This chronic activation is then detected as an increase in T1-weighted signal intensity.
4.2. Tissue dissection and RNA-sequencing (Study II)
Six-eight days after the SA test, at the beginning of the light phase, all mice were dissected.
This time point was selected to reveal preferentially chronic effects of stress, rather than those 
occurring acutely but subsiding soon after stress cessation. Euthanasia was completed by 
cervical dislocation and the brain promptly removed onto a cold Petri dish. Tissue of interest 
(mPFC and vHPC bilaterally) was dissected by a trained experimenter and immediately snap-
frozen in liquid N2. The BNST was also dissected, and the data collected from the RNA-
sequencing of this structure are presented in full in Study II and the PhD dissertation of a co-
author (Dr Zuzanna Misiewicz). Although relevant for anxiety and threat processing, the 
amygdala was not dissected for this study due to limitations in the ability to separate the distinct 
subregions. Dissections were split onto three mornings to minimize circadian effects on gene 
expression while maintaining fast enough processing speed (max 7 minutes between cervical 
dislocation and snap-freezing of the tissue sample).
Procedures for RNA-seq [RNA extraction, ribosomal RNA depletion, library preparation, 
sequencing, read alignment, differential gene expression analysis, and gene set enrichment 
analysis (GSEA)] are described in detail in Study II, as performed by other co-authors. The 
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gene expression data set is available on Gene Expression Omnibus (accession number: 
GSE109315).
4.3. Magnetic-activated cell sorting (MACS, Study III)
Mice were anaesthetized 6-8 days after CSDS with a lethal dose of pentobarbital and 
transcardially perfused with 4 °C sterile saline to remove blood cells from the brain (0.9 % 
NaCl) and the mPFC dissected on ice. We dissociated the cells by incubating tissue pieces in 
papain (LK003150, Worthington Biochemical Corporation) in 37 °C under constant agitation 
for 45-90 min, in accordance with the manufacturer’s instructions. The reaction was stopped 
by the addition of DNase and the suspension triturated to fully separate the cells. The resulting 
cell suspension was washed with 4 °C Dulbecco’s PBS (14287080, ThermoFisher Scientific) 
by centrifugation. Next, we separated cells and myelin into distinct phases using a Debris 
Removal Solution (130-109-398, Miltenyi Biotec). The debris phase (containing myelin) was 
separated from the cell phase (containing OLGs), and each incubated for 15 minutes in 4 °C 
with anti-myelin (130-104-257, Miltenyi Biotec) or anti-O4 (130-094-543, Miltenyi Biotec) 
magnetic microbeads respectively. These beads label the target structures with a small 
magnetic particle. We then used the octoMACS (Miltenyi Biotec) set-up to positively select 
for the labelled myelin and OLGs separately. The collected material was immediately lysed by 
vortexing in RLT lysis buffer (RNeasy Plus Micro kit, Qiagen) and stored in -20 °C until RNA 
extraction. RNA-seq procedures are explained in detail in Study III.
To gain insight into which biological pathways were affected by CSDS in OLGs and myelin, 
we used Ingenuity Pathway Analysis (IPA v. 01-12, July 2019 release; Qiagen, Hilden, 
Germany, [219]). Focus was placed on predicted upstream regulators, as these molecules are 
positioned to mediate the effects of CSDS on gene expression and the behavioural response. 
Only interactions reported in the IPA data base for “Nervous System” tissue were included. 
Input differentially expressed genes (DEGs) were filtered by average expression level to 
restrict the analyses to robustly expressed genes (limma-normalized counts > 0). A nominal 
significance threshold p < 0.05 and effect size threshold logFC > |0.25| were used as criteria 
for including genes in the analysis. 
4.4. Immunohistochemistry (Studies I-II, and unpublished data)
Brain samples were prepared 6-8 days after the SA test by transcardial perfusion with a fixative. 
Briefly, mice were anaesthetised with a lethal dose of pentobarbital (Mebunat Vet, Orion 
Pharma, Espoo, Finland). Blood was removed by perfusion with phosphate-buffered saline
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(PBS) warmed to 37 °C, followed by perfusion with 4 % paraformaldehyde (PFA) at 37 °C for 
approximately 10 minutes. Specific treatments are listed in Table 4. All brains were sectioned 
in the coronal orientation, and a mouse brain atlas [220] was used to determine anatomical 
ROIs.
Table 4. Protocols used for immunohistochemical labelling in Studies I-III. NGS = normal goat 
serum, BSA = bovine serum albumin, NDS = normal donkey serum, TBS-T = Tris-buffered saline 
with Tween-20, PBS-T = phosphate buffered saline with Tween-20, OPC = oligodendrocyte 
progenitor cell, OLG = oligodendrocyte, DAB = 3,3′-diaminobenzidine, CC = corpus callosum
Method Study I Study II Unpublished OLG-OPC quantification




h, freezing in 2-methyl 
butane, storage at -80
°C
None None
Sectioning (thickness) Cryostat (40 μm) Vibratome (20 μm) Vibratome (40 μm)
Long-term storage -20 °C free-floating in 
ethylene glycol 
cryoprotectant
-20 °C free-floating in 
ethylene glycol 
cryoprotectant




peroxidase activity Yes (0.05 % H2O2) No No
Antigen retrieval No 0.01 M citrate buffer No
Blocking nonspecific 
antigens
10 % NGS in 0.5 % 
TBS-T
2.5 % BSA + 7.5 %
NGS in 0.5 % PBS-T
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All staining, imaging and quantification steps were done blind to the condition of each animal,
and staining batches were balanced across conditions. ΔFOSB cells were counted from a total 
of 18 brain regions, each as the average from 3-6 sections per animal. The quality of semi-
automatic quantification of cell numbers was checked for each image. For CC measurements, 
2-6 sections were acquired per animal and their average taken as a data point. OLG and OPC 
quantification accuracy of the semi-automated pipeline was controlled by comparing cell 
identity annotations to manual annotations of a randomly selected subset of images, by an 
investigator blind to the phenotype of the animal and the pipeline’s annotations (Pearson’s 
correlation coefficients (r) for number of OLGs, OPCs, or undefinable cells/field of view = 
0.858 – 0.949). The mean number of sections used per animal following exclusion of images 
of insufficient quality for quantifying the staining reliably was 6 (range: 3 – 14).
4.5. Transmission electron microscopy (Study II)
We anaesthetized the mice 6–8 days after CSDS with a lethal dose of pentobarbital (Mebunat 
Vet). Transcardial perfusion was done with PBS followed by fixation with 100 ml of 37 °C
2 % glutaraldehyde (GA) + 2 % PFA in 0.1 M sodium cacodylate (NaCac) buffer (all 
components from Sigma Aldrich). The brains were removed and postfixed in the same fixative 
for 2–4 h and maintained in 0.1 M NaCac buffer for 2–24 h, both at 4 °C. We cut 200 μm 
sagittal sections using a Leica VT-1200S vibratome (Leica Biosystems) in 0.1 M phosphate 




We additionally postfixed the samples in 1 % osmium tetroxide and 1.5 % K4[Fe(CN)6] in 0.1 
M NaCac buffer for 2 h at 4 °C. Uranyl acetate was applied for en bloc staining for 1 h at 4 °C, 
followed by dehydration with EtOH and acetone, and embedding into hard Epon. 60–70 nm 
sections were cut with an ultramicrotome and placed on copper grids. Some samples were 
additionally stained with lead citrate for increased contrast, but this step was omitted for most 
samples as the en bloc staining was deemed sufficient. We acquired images containing 
myelinated axons from grey matter using a Jem-1400 transmission electron microscope (Jeol) 
at 5000× magnification. All sample numbers were blinded for the imaging and image analysis 
steps. To capture the heterogeneity of axons present in the samples we acquired 93–104 
myelinated axons per animal from mPFC (mostly grey matter) and 54-62 myelinated axons per 
animal from the vHPC (both grey and white matter). 
Image analysis was performed manually using ImageJ. We measured myelin thickness, axon 
diameter, and g ratio using ImageJ. Myelin thickness was measured by manually drawing 
vectors at three fully compacted positions and their average length was calculated (Figure 6). 
To determine axon diameter we measured the area of the axon (inside the compacted myelin 
sheath) and calculated the diameter of the corresponding geometric circle. We calculated the g 
ratio by dividing the diameter of the axon with the diameter of the whole fibre, calculated from 
the area of the whole fibre (circumference of the compacted myelin sheath). Comparisons of 
resilient, susceptible and control mice were performed for all measured axons collectively, as 
well as divided into size groups based on axon diameter (small, medium and large, based on 
diameter distribution within the brain region). Projections of different neuronal types may have 
different typical axon diameters [221], and differences occurring selectively in one size group 
may thus be of interest. 
 
Figure 6. Illustration of quantification of myelin thickness, axon diameter and g ratio from 
TEM images. Short dashed magenta outline indicates whole fibre circumference, and the blue 
variable dashed outline indicates the axon circumference. 
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4.6. Statistical analysis (Studies I-III)
Data analysis was conducted with inferential statistical tests appropriate for the specific data 
structure (for example normality of the distribution, assessed with the Shapiro-Wilk test). Ad 
hoc determination of sample size through power analysis for CSDS experiments is challenging 
in practice. The number of resilient and susceptible animals cannot be predetermined as they 
are defined based on outcome of the SA test. Thus sample sizes were based on estimates 
derived from prior literature. Criteria for excluding animals or data points as outliers were pre-
determined as 3 standard deviations above or below the mean for normally distributed data, 
and 1.5 interquartile ranges from the median for non-normally distributed data.
Specific tests used to analyse mouse behavioural data are outlined in section 5.1, as the tests 
applied differed between outcome measures. To adjust significance levels for multiple 
comparisons we used a test-wise Bonferroni correction within each strain.
The DEG analyses of RNA-seq data, including correction for false discovery rate, are detailed 
in Studies II and III. 
Data on FOSB+ cells was compared only between control and stress-exposed mice, using either 
independent t-tests (when both groups were normally distributed) or the Mann-Whitney U-test
(when one or both groups were non-normally distributed). Correlation of FOSB+ cell quantities 
between different regions (separately for control and stress-exposed groups) was determined 
by calculating Pearson’s r coefficients for each brain region paired with each of the other brain 
regions. Because of the large number of brain regions included, Bonferroni correction was 
deemed to be overly conservative. To correct for false discovery across multiple tests we used 
the Benjamini-Hochberg method [222].
The other immunohistochemical (corpus callosum [CC] thickness measurement, OPC and 
OLG cell quantification) experiments were analysed by one-way analysis of variance 
(ANOVA) with test-wise Bonferroni corrections. Each data point represents the average 
dependent variable value for one animal, calculated as the average of all images acquired from 
that animal.
Group differences in TEM data were assessed using generalized estimating equations (GEEs) 
because the assumption of independence of ANOVAs were violated by axons imaged from the 
same animal. Averaging the axons of each animal would have produced groups too small to be 
reliably analysed by ANOVA (n = 3-6). Using each axon as a data point avoided this issue, and 
allowed us to capture the variance within an animal. GEE allows control for such within-subject 
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dependencies. This has been applied in other fields for analysing data with non-independent 
features [223, 224]. To compare groups (control, resilient and susceptible mice within a strain) 
we computed p values with Fisher’s LSD, and statistical significance was assessed against the 




5.1. B6 and D2 mice show different rates of susceptibility and resilience to CSDS
(Studies I-III)
In Studies I-III we exposed mice to chronic social defeat stress (CSDS) to study the effects of 
stress on the brain and behaviour. Additionally, in Studies II and III we used mice from two 
different inbred strains, representing high (D2) or low (B6) levels of innate anxiety-like 
behaviour [104]. In Study I we only used B6 mice. Stress-exposed and control mice were 
subjected to the social avoidance (SA) test 24 hours after the last CSDS encounter. Throughout 
CSDS exposure and control housing in Studies II and III we also tracked the weights of the 
animals. In Study III we also recorded the duration of the physical interaction phase of each 
defeat session to test whether resilient and susceptible mice were differentiated by their CSDS
ex perience.The results of behavioural measures are presented in Table 5 according to
availability. In Study I, the SI ratios between control and stress-exposed mice did not differ
(independent t test, p = 0.12). One outlier in the CSDS-exposed group was removed (> 3 * IQR 
above sample median). In Studies II and III, susceptible mice from both strains had 
significantly lower SI ratios than controls (padj = 6.33 * 10-7 – 0.0043) as tested by one-way 
ANOVAs. Resilient mice generally did not differ from controls, except for the B6 resilient 
mice in Study II which had significantly higher SI ratios than controls (padj = 0.023). Across 
Studies II and III, we found that 66.1 % of B6 mice were resilient, while only 15.0 % of D2 












































































































































































































In Studies II and III we also had access to data on the amount of time spent in the interaction 
zone (IZ) during the first trial without a social target (no-target, NT) and the second trial with 
the restrained CD1 as a social target (target, T). Within resilient, susceptible and control groups,
we compared the NT and T trials using a two-way ANOVA. Post hoc comparisons revealed 
that in Study II, within all except for the D2 resilient mice (likely due to very low N), there 
were significant differences in time spent in the IZ between trials (padj = 4.20 * 10-17 – 6.08 * 
10-6). Resilient and control mice from both strains spent more time in the IZ when there was a 
social target present than when there was not. By contrast, susceptible mice from both strains 
spent significantly less time interacting with the CD1 mouse than with the empty cylinder. In 
Study III we found a similar pattern, with significant differences in B6 resilient, B6 susceptible 
and D2 control comparisons (padj = 0.0012 – 0.029). As another angle on avoidance behaviour, 
we compared the amount of time the mice spent in the corners furthest away from the IZ 
between the two trials. In Study II, susceptible mice of both strains spent significantly more 
time in the corners when the social target was present than when it was not (padj = 1.72 * 10-6
– 3.42 * 10-6). In Study III the pattern of means was similar to Study II but no comparison 
reached significance after adjustment. As a measure of locomotor behaviour, we compared the 
distance the mice travelled during the NT trial of the SA test. The mean distances travelled by
resilient and susceptible mice from both strains were lower than the distance travelled by 
controls. In Study II this was significant for the B6 resilient, B6 susceptible and D2 susceptible 
(padj = 2.89 * 10-9 – 0.0002), while in Study III the difference was significant for D2 susceptible 
and resilient mice (padj = 0.036 – 0.047) compared to controls. 
As a measure of broad metabolic consequences of CSDS we recorded the animals’ weight 
throughout the experiment (Studies II and III). We compared the weight at the start (first day 
of defeat) and at the end of CSDS (day after the SA test). Using a two-way ANOVA we found 
that in both studies all B6 mouse groups gained weight between the two time points (padj = 1.35 
* 10-9 – 0.026). None of the D2 groups gained weight, and D2 susceptible mice in Study III 
lost weight (padj = 0.041). However, the amount of weight gained (Δ body weight) in B6 
resilient and B6 susceptible was significantly lower compared to controls (padj = 1.17 * 10-8 –
0.0023) in Study II.
For Study III, we also compared the phenotypes and strains on duration of the physical 
interaction phase of CSDS averaged across each of the 10 encounters using a two-way 
ANOVA. While there were no differences between resilient and susceptible animals within 
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either strain (padj = 0.29 – 0.39), there was a main effect of strain (F(1, 27) = 87.59, p = 5.76 * 
10-10), with D2 mice having significantly shorter defeat durations than B6 mice.
5.2. CSDS associates with a specific pattern of neural activity across brain regions 
(Study I)
In Study I our objective was to determine which of several stress-related brain regions were 
chronically recruited during 10-day CSDS in B6 mice. We used an immunohistochemical 
marker which accumulates during repeated neural (and possibly glial [225, 226]) activity called 
ΔFOSB. Although the antibody used to detect this protein has a binding site on the parent 
isoform (FOSB), this isoform degrades relatively quickly while the Δ isoform accumulates in 
the cell, thus remaining detectable several days after activation [227, 228].
We compared the numbers of ΔFOSB+ cells in several regions pre-selected for analysis based 
on prior literature on stress neurobiology. A full list on the included regions can be seen in 
Study I, Figure 3 and Table 1. Significant increases in ΔFOSB+ cell numbers were seen in the 
BNST and vHPC, among others. Although we found a trend for higher numbers of active cells 
in the IL and PrL subregions of the mPFC, the difference between CSDS-exposed and control 
mice here did not reach significance. These regions also showed significantly (padj < 0.01) 
increased MRI signal intensity, reflecting accumulation of Mn2+. In addition to relevant grey 
matter, containing largely cell bodies, increased MEMRI signal was also observed in white 
matter regions such as the forceps minor in the frontal cortex. For full activation maps refer to
Study I Figure 2.
In addition to a region-by-region activation, we explored the correlation structure of activation 
between different regions. As illustrated in Figure 7 for mPFC subregions, the BNST and 
vHPC, the correlation structures differed broadly between control and stress-exposed mice. 
The radar plot indicates the strength of the correlation (Pearson’s r) between the title region 
and each of the regions on the periphery of the radar. In control mice there were markedly few 
significant correlations, and some regions (e.g. BNST – lateral hypothalamus [LH] and 
infralimbic cortex [IL] – basomedial amygdala [BMA]) even show a trend for a negative 
correlation (r = -0.87 and -0.45, respectively). By contrast, in the stress-exposed mice several 
significant positive correlations emerge. For example, activation in the vHPC is significantly 
correlated with the IL (r = 0.79) and PrL (r = 0.84), and the PrL with the BNST (r = 0.79), in





Figure 7. Correlation of activation between stress-related brain regions after CSDS. A-D) Radar 
plots depicting the correlation (Pearson’s r) of the IL (A), PrL (B), BNST (C), and vHPC (D) and each 
of the other brain regions included in the ΔFOSB quantification study. Correlations were computed 
separately for control (left-hand panels) and stress-exposed (right-hand panels) B6 mice. Correlated 
region pairs with significant nominal p values are marked with asterisks (* = p < 0.05, ** = p < 0.01). 
Legends on the bottom right denote the magnitude of r, and the direction of the correlation (positive or 
negative). MO = medial orbital cortex, IL = infralimbic cortex, PrL = prelimbic cortex, BNST = bed 
nucleus of stria terminalis (anterodorsal), NAcC = nucleus accumbens (core), NAcSh = nucleus 
accumbens (shell), CPu = caudate putamen, LSV = lateral septum (ventral), VL = thalamus 
(ventrolateral), LH= lateral hypothalamus, BLA = basolateral amygdala, BMA = basomedial amygdala, 
CeA = central amygdala, vHPC = ventral hippocampus (ventral portions of CA1 & CA3), DG = dentate 




5.3. Myelin-related genes are differentially expressed after CSDS, with expression 
patterns varying by genetic background and brain region
To investigate how chronic stress alters brain gene expression we performed RNA-seq of tissue 
dissected from the mPFC and vHPC of CSDS-exposed and non-stressed control mice. 
Additionally, we analysed differences between stress-resilient and -susceptible mice, defined 
by their behaviour during the SA test. Susceptible mice displayed a lower SI ratio than same-
strain control mice, while resilient mice behaved similarly to the controls despite their stress 
exposure (see Table 5). Finally, we included mice from two different inbred strains (B6 and 
D2) to assess the impact of genetic background on the transcriptomic response.
The gene expression patterns were collectively analysed by other co-authors of Study II using 
GSEA, which searches for enrichment of genes belonging to known common biological 
functions among the differentially expressed genes (DEGs). This analysis revealed enrichment 
of oligodendrocyte (OLG) genes in several comparisons in both the vHPC (Table 6) and mPFC 
(Table 7, see also Study II, Figure 2 E). Due to low number of animals available, analyses of 
D2 resilient animals were not possible in this study.
In the vHPC we found significant downregulation of several myelin component genes, such as 
Mbp, Mobp, Plp1, Cnp and Opalin. These were downregulated in B6 susceptible, B6 resilient 
and D2 susceptible mice compared to respective controls (see Study II, Figure 2 D). TEM
analysis revealed that B6 susceptible mice had thinner myelin sheaths than controls, consistent 
with the gene expression findings.
Table 6. Summary of myelin-related gene expression and electron microscopy findings for the 
vHPC. The mean difference for the named comparison is given for myelin thickness, axon diameter 
and g ratio. Unless otherwise specified, the mean difference is reported for all axon diameters 
combined. Significant differences (padj < 0.05) are marked with an asterisk (*). n/a = not available,


















genes (bulk tissue 
RNA-seq)
Down Down n/a n/a Down n/a
Myelin thickness
(μm) -0.001 -0.0085* 0.0074 -0.0014 0.0019 -0.0033
Axon diameter
(μm) -0.0048 -0.024 0.020 0.00064 0.018 -0.017
g ratio -0.0014 0.013 -0.015 0.0049 0.0014 0.0036
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Gene expression was also analysed in the BNST by a co-author. This revealed upregulation of 
myelin-related genes in B6 susceptible mice, consistent with thicker myelin sheaths observed 
with TEM.
In the mPFC we also found downregulation of myelin component genes in the B6 susceptible 
mice compared to controls, but not in the other comparisons. By TEM we did not see 
differences in myelin thickness between B6 susceptible mice compared to other groups.
However, B6 resilient mice had thicker myelin on small-calibre axons than controls (see Study 
II, Figure 5 G), while D2 resilient mice had thinner myelin compared to D2 susceptible mice 
(see Study II, Figure 5 H).
While bulk tissue RNA-seq can, via pathway analysis, give clues about specific biological 
functions, it is possible that stress does not impact the same functions across all cell types. To 
understand how a particular cell type, such as OLGs, respond to stress, a cleaner starting 
material is required. To study how gene expression specifically in OLGs was influenced by 
CSDS, we performed magnetic-activated cell sorting (MACS) to enrich OLGs from mPFC 
tissue from resilient, susceptible and control B6 and D2 mice. Interestingly, the myelin fraction 
has been previously shown to differ in transcript content and protein abundance [229, 230]
from bulk tissue, suggesting possible local regulation. Thus, we assessed whether CSDS 
induced differential transcriptomic responses in the OLG and myelin fractions by separately 
sorting these with MACS.
No DEGs survived correction for multiple comparisons by the Benjamini-Hochberg method. 
For exploratory analyses we considered a threshold for nominal significance (p < 0.05, log2 
fold change > |0.25|) as a criterion for differential expression. We found that the myelin 
component genes (including Mbp, Mobp, Plp1, Opalin, Cnp, Cldn11 and Ermn) were 
downregulated in the B6 susceptible mice compared to both resilient and control mice, but only 
in the myelin fraction. The Mog gene was additionally upregulated in the myelin fraction of B6 
resilient compared to control mice. By contrast, both D2 susceptible and resilient mice 
exhibited downregulation of Mbp and Mobp in the OLG fraction (see Study III, Figure 4 B).
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Table 7. Summary of myelin-related gene expression and electron microscopy findings for the 
mPFC. The mean difference for the named comparison is given for myelin thickness, axon diameter 
and g ratio. Unless otherwise specified, the mean difference is reported for the analysis of all axon 
diameters combined. Significant differences (padj < 0.05) are marked with an asterisk (*). Δ = Mean 
difference and significance reported only for small diameter axons (mean difference for the comparison 
including all axons = 0.00069, n.s.). - = No difference in gene expression pattern, n/a = not available,
Res = resilient, Sus = susceptible, Con = control, vHPC = ventral hippocampus, B6 = C57BL/6NCrl, 
D2 = DBA/2NCrl, OLGs = oligodendrocytes.
One plausible explanation for the observation of lower myelin gene expression and thickness 
in specific groups is a global myelin atrophy, such as that seen in neurodegenerative disorders 
like MS. To address this possibility on the structural level, we measured the thickness of the 
CC in CSDS-exposed and control animals. The CC is a white matter tract which connects 
multiple regions across hemispheres. Measured at a position close to the Bregma point, we 
found no differences in CC thickness between groups within either strain (see Study II, Figure 
4).
Considering gene expression findings, differences in expression levels could reflect differences 
in cell numbers. While OLGs are postmitotic, they can undergo cell death or population 
expansion via differentiating OPCs. We performed an IHC staining study to quantify the 
numbers of OPCs and differentiated OLGs in three brain regions (mPFC, vHPC and BNST). 


























Up Down Down - - -
Myelin thickness
(μm) 0.0069*Δ 0.0010 -0.00035 -0.0084 -0.0011 -0.0073*
Axon diameter
(μm) -0.012 0.007 -0.020 -0.0081 -0.022* 0.014
g ratio -0.0079 -0.0044 -0.0035 0.015 -0.0063 0.022*
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growth factor receptor α (PDGFRA) and adenomatous polyposis coli clone CC1 (CC1) 
respectively. However, these markers are expressed at low levels also in a few other cell types 
(endothelial cells [231] and astrocytes [232], respectively), so to restrict the analysis to the 
OLG lineage we co-stained these markers with OLIG2, an OLG-specific transcription factor. 
We did not find any group differences in either strain within any of the assessed brain regions 
(padj ≥ 0.28, Figure 8). 
 
 
Figure 8. The density of OLGs and OPCs does not differ between resilient, susceptible and control 
mice in three brain regions. A-B) Box plots of OLGs (A) and OPCs (B) in three brain regions (mPFC, 
BNST and vHPC). Each data point represents one animal’s average number of cells across 3–14 images. 
Max N of animals for B6 = 21 (8 control, 7 resilient, 8 susceptible) and D2 = 25 (10 control, 5 resilient, 
10 susceptible), animals with < 3 images of a specific region were excluded from analyses of that region. 
C) Representative image demonstrating the triple-staining, showing a CC1+/OLIG2+ cell (OLG, large 




5.4. OLGs and myelin show enrichment of different genes
Past work has suggested that some mRNAs are transported from the OLG soma to myelin 
sheath for local translation [233, 234], and that the transcriptome and proteome of isolated 
myelin differs from that of bulk brain tissue [229, 230]. However, as membrane extensions of 
OLGs, a direct comparison of mRNAs found in the OLGs and myelin of the same individuals 
is needed to assess the extent of transport. We compared gene expression levels of MACS-
enriched OLGs and myelin from non-stressed control animals (B6 and D2 strains). A higher 
number of genes met the criteria for reliable detection in OLGs than myelin (1 count per million 
in at least 6 samples; 17 112 genes in OLGs and 15 648 genes in myelin). Comparing mice 
from the two strains we found that few genes were differentially expressed (372 genes in OLGs
of B6 vs D2, and 115 in myelin of B6 vs D2), so the comparison of OLG and myelin fractions 
is presented as the average of the strains (see Study III, Figure 2). Of genes expressed in both
fractions, 24.8 % were expressed at a significantly (padj < 0.05) higher level in OLGs than 
myelin. By contrast, 20.2 % were expressed at a higher level in myelin than OLGs. Using
miRNA-sequencing we also identified miRNAs enriched in OLGs (14.3 %) and in myelin (18.8 
%).
5.5. MACS-enriched RNA-seq suggests potential functional regulators of myelin 
component gene expression and myelin sheath properties
Next, we investigated whether any molecules served as predicted regulators of the stress-
related gene expression patterns in OLGs and myelin. We applied IPA on differential gene 
expression data. Across all 12 comparisons including both OLG and myelin fractions, we 
discovered that TCF7L2 was predicted to be a significant upstream regulator in four 
comparisons (Z-score range -2.67 – -5.49). These included the myelin fraction of B6 
susceptible mice compared to both control and resilient mice, and the OLG fraction of both D2 
resilient and susceptible mice compared to controls. In all of these, based on the direction of 
differential expression of predicted targets, TCF7L2 was predicted to be inhibited. Among the 
predicted target genes differentially expressed in the predicted direction (Figure 9) were several 




Figure 9. Illustration of Ingenuity Pathway Analysis (IPA) predicted targets of TCF7L2. Network 
plot showing genes DE in each contrast in which TCF7L2 was predicted to be a significant upstream 
regulator. In each of these, TCF7L2 was predicted to be inhibited, and each predicted target gene was 
downregulated. Only genes DE in the direction consistent with the one predicted by IPA are presented. 
Genes DE in several comparisons are grouped and indicated by arrows. Res = resilient, Sus = 







In this thesis we first identified brain regions repeatedly activated during chronic psychosocial 
stress (CSDS) in mice (Aim 1). B6 stress-exposed mice showed higher numbers of ΔFOSB+
cells in several regions, including the BNST and vHPC. To explore possible functional 
connections between activated regions, we analysed the correlations between ΔFOSB+ cell 
counts between regions. We found significant correlations between mPFC subregions (IL and 
PrL) and the vHPC of stress-exposed, but not non-stressed mice. This suggests functional 
connectivity between these regions may be enhanced during and after stress.
In the next experiment, we performed RNA-seq of mPFC and vHPC tissue from mice exposed 
to CSDS and phenotyped as resilient or susceptible, comparing to non-stressed control mice.
To address the role of genetic background we used two inbred mouse strains, B6 and D2. We 
found that B6 and D2 mice differed in the proportions in which they were resilient or 
susceptible to CSDS, with B6 mice being mostly resilient and D2 mice mostly susceptible. 
GSEA suggested that OLG-related genes were downregulated in the vHPC (B6 resilient, B6 
susceptible and D2 susceptible compared to controls) and mPFC (B6 susceptible vs control),
addressing the second Aim of this thesis. CC thickness was not altered by stress, suggesting 
that stress does not cause global demyelination. Electron microscopy revealed myelin thickness 
differences. In the vHPC B6 susceptible mice had thinner myelin than controls. In the mPFC, 
B6 resilient mice had thicker myelin sheaths than controls in small calibre axons. Interestingly,
resilient mice from the D2 strain had thinner myelin in this region compared to controls. These 
findings suggest myelin plasticity as a potential major component of the prolonged stress 
response. As the numbers of OPCs and OLGs were unchanged, we hypothesized that the gene 
expression differences are more likely to stem from functional differences occurring within the 
cells rather than effects of stress on their survival or differentiation.
To follow up on these findings we enriched oligodendrocytes and myelin from the mPFC of 
resilient, susceptible and control B6 and D2 mice. First, we compared the OLG and myelin 
fractions from non-stressed control mice. We found several genes enriched specifically in one 
fraction over the other, with limited influence by genetic background, suggesting transport 
signals are relatively resistant towards influence by genetic background. Furthermore, we 
replicated the bulk tissue RNA-seq finding of lower expression levels of myelin-related genes
in the mPFC in myelin of B6 susceptible compared to resilient and control mice. We also found 
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downregulation of these genes in the OLG fractions of D2 susceptible and resilient mice 
compared to controls. Bioinformatic analysis predicted that these DEG result may be 
downstream of inhibition of TCF7L2, a transcription factor (TF) with a known role in OLG 
biology. This represents a potential molecular mechanism of stress-related myelin gene 
expression differences, as per Aim 3. We propose a pathway of stress affecting OLG gene 
expression via acting on TCF7L2, with genetic background-dependent deviations from this 
path underlying resilience.
6.2. Stress-related activation of brain region and putative networks
In Study I, we demonstrated that CSDS exposure in B6 mice associated with higher levels of 
markers of chronic activation (ΔFOSB and MEMRI) in several brain regions known to be 
relevant for stress and psychopathology [2, 57, 76, 235]. Other studies utilizing rodent models 
of stress and quantifying ΔFOSB+ cells have reported higher numbers in stressed than control 
mice in several of the same regions (e.g. the BNST and dentate gyrus, [236]). However, there 
are also some differences, such as the NAc, PAG and the BLA showing higher activation after 
stress in other publications [227, 237-240] but not in our experiment. A possible explanation 
for this discrepancy is differences in the timing of measurement. Vialou et al. [236] collected
fixed brain tissue 24 hours following CSDS, while we collected samples 6-8 days after CSDS
in order to focus on more chronic features of stress exposure. Other work using a longer post-
defeat delay (20 days) has reported no differences in ΔFOSB protein abundance as measured 
by Western blotting in the mPFC and vHPC [129], which is less sensitive than IHC detection
of individual positive cells. Collectively, these and our findings indicate dynamic stress-related 
activity changes, and that some differences between controls and stress-exposed mice observed 
immediately after stress may subside. Changes remaining for substantial periods after stress 
cessation, such as weeks or months, are likely to be highly relevant for long-term consequences 
of stress, such as psychopathology.
In addition to being an activity marker, FOSB acts as a TF, altering gene expression. Chromatin 
immunoprecipitation followed by sequencing (ChIP-seq) has shown that the binding targets of 
FOSB are enriched in genes contributing to neuronal excitability and neurotransmission [241].
Interestingly, both overexpression and inhibition of FOSB in the dorsal HPC acutely affects
neuronal physiology, reducing the frequency of excitatory postsynaptic currents [242]. After 
stress, local overexpression in the PAG promotes resilience against CSDS in B6 mice [239].
In addition to variance between brain regions, the relationship between ΔFOSB and the 
response to stress can vary between neuronal subtypes. In the D2-receptor-expressing medium 
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spiny neurons (MSNs) in the NAc, acetylation of histones influencing the promoter for the 
FosB gene makes mice more susceptible to CSDS. By contrast, the same posttranslational 
modification in D1-expressing MSNs confers resilience [243]. Based on our findings, it would 
be of interest to explore the functional role of ΔFOSB specifically in regions where we find it
to be more abundant chronically after stress, possibly contributing to its long-term 
consequences.
To assess putative networks engaged by CSDS, we calculated correlations between numbers 
of ΔFOSB+ cells between regions. While in vivo neuroimaging is the gold standard for 
determining functional connectivity between regions [244], activity-related protein abundance
has also been reported to correlate between jointly recruited regions in ex vivo measurements 
[245-247]. The correlated numbers of ΔFOSB+ cells between the vHPC and mPFC subregions 
(PrL and IL) seen in CSDS-exposed mice is interesting because synchronised activity between 
these regions has previously been shown in rodents during an anxiogenic task [74]. Local field 
potential recordings from mice before and after exposure to CSDS also highlighted the mPFC 
and vHPC as part of vulnerability network, where distinct activity could predict later 
susceptibility [248]. Pharmacogenetic activation of cells residing in the vHPC and projecting 
to the mPFC is also anxiogenic [75]. The connectivity between these regions has been mapped 
across species [249, 250]. The uncinate fasciculus (UF), a major white matter tract connecting 
these regions in humans, has been implicated by neuroimaging research with MDD and anxiety 
disorder patients [213, 251]. Childhood maltreatment associates with lower fractional 
anisotropy (FA) along this tract, and lower FA also predisposes adults to stress-induced 
negative affective symptoms [252]. However, as reviewed by Ayling et al. and Bracht et al, 
there are reports for both increased and decreased FA along this tract in relation to anxiety 
disorders and MDD, possibly due to heterogeneity within and between study samples. A
combined staining of an activity marker protein with a cell-type marker would also inform the 
nature of the activated circuits. Kovacs et al. [253] showed that 14 days of restraint stress 
induced ΔFOSB in CRF-expressing neurons in the paraventricular nucleus of the
hypothalamus, but not in the CEA or BNST. Vialou et al [236] also co-stained samples from 
the PFC with a marker for GABAergic neurons and report minimal co-localisation, suggesting 
the signal stems primarily from other neuronal types, such as glutamatergic pyramidal neurons.
Animal models could shed light on factors moderating the relationship between stress, 
structural and functional connectivity, and downstream effects such as psychopathology.
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While IHC provides excellent spatial resolution, we are limited by the lack of anatomical 
landmarks in distinguishing some adjacent brain regions from one another. Recent evidence 
has also challenged the idea that these landmarks are in every instance the best strategy for 
defining functionally distinct regions. For example, the molecular atlas provides a gene 
expression-based signature for hippocampal subregions (e.g. dorsal-ventral domains of 
pyramidal cell layers CA1 and CA3, [254]), which are difficult to distinguish by any known 
anatomical borders. This information could be integrated into investigations of regionally 
specific events, such as neuronal activation, by co-staining with specific domain-defining 
antibodies. Such methods would bridge the gap between structure and function, helping us truly 
understand which neuronal network are engaged during chronic stress.
There are limitations in Study I which impact our conclusions. Firstly, using only one inbred 
strain leaves possible genetic background effects unexplored. Given the differences in 
behaviour noted in Studies II and III, the possible contribution of differential recruitment of 
brain regions could be addressed. Acutely after restraint stress there is a difference in the degree 
to which B6 and Balb/c strain mice show activation of the cingulate cortex [255]. Secondly, in 
this study it was not possible to address differential activation in resilient and susceptible mice. 
Only 1/10 of the mice allocated to the CSDS-exposure condition had an SI ratio indicative of 
susceptibility. Thus, we performed all analyses as CSDS-exposed mice compared to non-
stressed controls. Exploring the moderation by genetic background as well as differences 
between resilient and susceptible mice in the same study system, as was done for Studies II and 
III, would be highly informative. This would allow addressing the question of whether the 
differential rate of susceptibility we observed in D2 and B6 strains could relate to recruitment 
of different neuronal populations. This in turn would greatly enhance our understanding of how
individual differences in stress processing contribute to its consequences.
CSDS as a model of psychosocial stress also has some limitations, although generally 
considered to have good construct validity [256, 257]. Although mostly discussed in the context 
of MDD, arguing for the validity of any animal model for a complex diagnostic entity such as 
MDD or anxiety disorders is challenging. It is more straightforward to argue for its validity as 
a model for the principal environmental risk factor which applied to both of these, namely 
chronic psychosocial stress. The popularity of CSDS for this purpose is founded in key 
features, such as being a predominantly social stressor (as opposed to physical environmental 
stressors like CUMS) and consistently producing some individuals which respond with 
maladaptive behaviours (i.e. reduced social interest) and some which do not (resilience).
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However, it also has some shortcomings. Chiefly, the standard form of the protocol does not 
consistently work with female mice as the male aggressors typically do not attack females, and 
even when employing aggressors that do attack only 20 % of the female mice were susceptible
[258]. This is in stark contrast with what is known about human females being roughly twice 
as likely to develop an anxiety disorder or MDD [1, 17, 19], although these epidemiological 
studies have not accounted for the specific role of stress as a risk factor. With protocol 
variations it is possible to get male mice to more consistently show dominant behaviours 
toward the females and induce similar avoidance behaviours as we see in males [258, 259].
However, given that this behaviour requires a high amount of manipulation to occur, it arguably 
lacks in ethological validity. This makes it difficult to generalise from molecular level findings 
of CSDS-exposed female mice to naturalistically stressed female humans. Many have worked 
around this issue by using other rodent species where female-female aggression does naturally 
occur (such as the mandarin vole, [260]). Others use stress models with social components 
which do produce consistent results in females, such as social isolation [261], social instability 
[262] or vicarious exposure to social defeat [263]. Large leaps in our understanding of stress
pathophysiology will likely necessitate the inclusion of female subjects in preclinical work, 
and indeed this is increasingly recognized in the field [264]. Thus, while CSDS can today with 
confidence only be considered valid for males, future work will reveal whether and how these 
findings generalise across sexes.
6.3 Genetic background influences the behavioural response to CSDS
In Studies II and III we compared resilient and susceptible mice on measures of social 
behaviour. Firstly, social interaction was used to phenotype mice as either resilient or 
susceptible. Because B6 and D2 control mice displayed different SI ratios, this phenotyping 
was done with respect to a strain-specific cut-off point rather than a universal one.
Susceptibility occurred in both strains, but at vastly different rates. In Studies II and III, 33.9
% of B6 mice and 85.0 % of D2 mice were susceptible to CSDS. However, the behavioural 
profile of susceptibility was very similar between the strains in both Studies II and III. These 
mice spent less time in the IZ and more time in the corners of the SA test arena when a social 
target was present, than when the IZ only contained an inanimate object. They also moved less 
during the test overall, and gained less weight during the 10 days of CSDS than control mice.
The resilient mice of both strains were broadly similar to controls in terms of the 
aforementioned measures. The significant difference in duration of physical interaction 
between strains likely stems from D2 mice being more susceptible to incur small wounds 
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during defeat, which was a criterion for ceasing the physical interaction before 10 minutes had 
elapsed. However, resilient or susceptible status was not a result of different durations spent 
physically interacting with the aggressor CD1, suggesting that intensity of defeat is not 
causative of susceptibility.
Replicable differences in anxiety-related behaviours observed between inbred strains have led 
to propositions to consider certain strains as models of trait anxiety [265], a risk factor for 
anxiety disorders in humans [117]. Our finding that the strain demonstrating high baseline 
anxiety-like behaviour (D2) was also more susceptible to stress mirrors work in humans 
suggesting that trait anxiety mediates the effect of stress exposure on depressive symptoms 
[266]. The Balb/c strain, also considered high in trait anxiety, is also more susceptible to CSDS
than the B6 strain [267]. For animal models of disordered anxiety, capturing trait anxiety is 
arguably more relevant than state anxiety. Tests of rodent anxiety-like behaviour, such as the 
approach-avoidance conflict tests detailed in Figure 2, are suitable for assessing state anxiety, 
but by themselves have limited validity for trait anxiety. Thus, one of the factors potentially 
slowing the development of new anxiolytics is that they are primarily tested for effects on 
measures of state anxiety. The future of anxiolytic research hopefully makes better use of 
diverse genetic backgrounds as trait anxiety models than in the past.
6.4. Resilience – lessons from unboiling an egg
Although differing in frequency between B6 and D2 strains, resilience still occurred in both.
Human studies of resilience are frequently limited by cross-sectional design and reliance on 
retrospective reporting of stress, which may be subject to biases. It is also rare for the same 
study to include resilient, susceptible and control subjects [268]. However, a deep 
understanding of what makes some individuals resilient could hold the key to revealing the 
critical features of susceptibility as well. To illustrate this, consider that one is tasked with 
finding out how to unboil an egg. Boiling results in alterations in how the proteins in the egg 
interact, a disordered state caused by the application of heat. The requirements for effectively 
unboiling an egg have been described [269]. The process requires two steps; the solid mass is 
first liquified by the addition of urea, after which the dissolved proteins are induced to re-fold 
by mechanical sheer stress.
Two critical lessons can be learned from this illustration. Firstly, understanding the mechanism 
by which the disordered state was achieved gave only part of the answer for how to best achieve 
a re-ordered state. To achieve the state reversal the authors could not simply go back the same 
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way they got there, by attempting to directly unfold the proteins. Rather, a permissive 
intermediate step was required, namely the addition of urea. Similarly, when it comes to stress-
susceptibility, it may not be sufficient or even possible to simply reverse the disordered 
molecular-level feature(s) back to the non-stressed state. Rather, we need a thorough 
understanding of what the allostatic load contributing to the susceptible state is truly composed 
of, at the levels of molecules, networks, circuits, and finally the whole organism, and indeed 
new frameworks like RDoC strive to do this [26]. Many of the pieces of this puzzle are
collected, but the full picture has not yet emerged. A mechanistic understanding will hopefully 
enable the identification of what the necessary permissive state for reversing susceptibility is, 
and how to achieve it.
The second lesson is that while the unboiled state is functionally similar to the pre-boiled state, 
it is not exactly equivalent. For the purposes of Yuan et al, which was developing a fast and 
affordable way to re-fold misfolded proteins in pharmaceutical development pipelines, the 
procedure achieves what was intended. But the unboiled egg has undeniably lost some
features, such as palatability by the addition of the urea. Returning the boiled egg fully to the 
pre-boiled state may turn out to be impossible by the laws of entropy, as may returning a 
stressed brain to its pre-stress state. Instead, we should focus our efforts on finding a state that
satisfies the functional needs. In the case of psychopathology, this state would be an 
asymptomatic life for the patient. Functionally, this state is likely best captured by resilient 
subjects; those who went through a stress exposure but experienced adaptive, allostatic
consequences rather than maladaptive ones.
This is why studying resilient subjects is absolutely critical, which has also been emphasised 
in the field in recent years [270]. By truly understanding the states of susceptibility as well as 
resilience we can hopefully figure out what the functional equivalents of adding urea and 
mechanical sheering would be when it comes to the stressed brain. Our findings add a layer of 
complexity to this. Although resilient B6 and D2 mice resemble each other behaviourally,
transcriptionally they share very little (Studies II and III). This indicates that genetic 
background heavily moderates how the resilient state can be achieved after stress. 
Consequently, ideal therapeutic strategies may also vary by individual difference factors such 
as genetics. Should, for example, the rescue of myelin-related gene expression in the B6 
susceptible mice in future studies turn out to also rescue behavioural effects of stress, it is 
possible that such a treatment would have no effect in the D2 strain where resilient mice also 
have lower expression of these genes (see below). Indeed myelin-related genes do respond to 
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successful recovery of susceptible mice after ketamine treatment in the B6 strain [204], but 
other strains have yet to be tested. This potential lack of generalisability further underscores 
the need for a mechanistic understanding of how resilience arises, and how its modulated by 
individual differences.
6.5. Myelin-related gene expression differs after CSDS, with concurrent
differences in myelin structure
Across Studies II and III, we found that myelin component genes are downregulated in the 
mPFC in susceptible mice of the B6 strain in both bulk tissue and myelin-enriched RNA-seq. 
The numbers of OPCs and OLGs did not differ between resilient, susceptible and control mice 
in any of the regions assessed here. Some prior studies report a similar lack of effect of stress 
[189, 199], while others have found lower numbers of OPCs in adult mice exposed to maternal 
separation as pups [194]. Cell survival does at least not in our case explain the gene expression 
differences, but it remains possible that stress could in the long term influence OLG lineage 
cells. In the bulk mPFC RNA-seq data we did not observe downregulation of myelin-related
genes in the D2 susceptible mice, but in the OLG-enriched RNA-seq we did. This suggests that 
RNA-seq carried out on bulk tissue may not have sufficient resolution to detect gene expression 
differences occurring in restricted compartments of OLGs, which only make up approximately 
20 % of the cells in the cortex and HPC [271]. The power of cell-type enriched sequencing is 
that it enables the query of such restricted effects, revealing the downregulation of myelin 
component genes in both of the strains used here. This finding also raises the interesting 
possibility that stress could alter myelin-related gene expression in different ways in these two 
strains. Differences seen only in the myelin fraction could be due to, for example, effects of 
stress targeting the transport machinery, while differences in the soma fraction could reflect 
effects on transcription. Fraction-selective differences in gene expression can also arise from
local mRNA degradation. A wide variety of proteins involved in the regulation of either 
transcription [147] or vesicular transport and local regulation [233, 272] in OLGs are known. 
Examining how their function or abundance could be affected by stress would be highly 
interesting, as a step closer to a mechanistic understanding of how stress could influence 
myelin.
More generally, we also demonstrated that the gene expression pattern in myelin differs from 
that of OLGs in the same individuals. Previously, the transcriptome and proteome of myelin 
has been shown to be unique with respect to bulk tissue [229, 230]. The specificity of gene 
expression may stem from selective transport of mRNA into the myelin sheath. This process is 
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well described for key myelin component Mbp, which is targeted and packaged into vesicles 
and transported into the distal parts of the myelin sheath. This enables local effectors, such as 
Fyn kinase, to rapidly induce translation of MBP to produce more myelin, either to maintain 
MBP in the face of turnover or to plastically alter myelin properties [272]. Sequences targeting 
transcripts for transport have been recognized [233, 234]. Our dataset of myelin-enriched 
transcripts could be used to identify novel targeting sequences and proteins with roles in myelin 
maintenance or function. Additionally, several miRNAs have been recognized as regulators of 
OLG differentiation and myelination [273-275], but the subcellular localisation of this 
regulation is not known. In neurons, miRNAs have been shown to travel to distal dendrites and 
potentially regulate mRNAs locally [276]. We found a number of miRNAs enriched in the 
myelin fraction, representing potentially novel regulators of transported mRNAs. Localisation 
of specific mRNAs and miRNAs to the sheath need to be validated with in situ methods before 
strong conclusions can be drawn, as the MACS-enriched material may also contain
contaminating mRNAs from the axons ensheathed by the myelin we collected. Our data will 
hopefully provide a fruitful starting point for developing our understanding of myelin biology.
To our knowledge, our TEM findings are the first demonstration of myelin thickness
differences at the nanometre resolution in two mouse strains after CSDS. In the vHPC, we 
found that susceptible B6 mice had thinner myelin sheaths than controls, which mirrored their 
lower myelin gene expression compared to controls. In the D2 strain, despite these genes also 
being expressed at a lower level than in controls, myelin thickness did not differ in either 
resilient or susceptible mice compared to controls. By contrast, in the mPFC the B6 susceptible
mice had similar myelin thickness to controls, but resilient mice had thicker myelin (restricted 
to small-diameter axons). D2 resilient mice had thinner myelin sheaths than controls in this 
region. Young mice exposed to social isolation has previously also been associated with thinner 
mPFC myelin [191]. Our findings demonstrate that stress occurring in a developmental stage 
equivalent to late adolescence in humans [277] associates with differences in both myelin gene 
expression and structure, and that this is controlled by genetic background.
Adding to prior literature associating myelin with stress exposure, we showed structural 
differences associating specifically in resilience. Intriguingly, resilient mice from B6 and D2 
strains showed opposite directions of myelin thickness differences compared to same-strain 
controls or susceptible mice. While the difference in the D2 strain was seen across all axon 
diameters, the B6 difference was observed only in axons with small calibres. The identity of 
neurons projecting these axons cannot be deduced from this data, as for example pyramidal 
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and inhibitory neurons in the rodent cortex have indistinguishable diameters [278] and both 
can be myelinated [279]. Some evidence suggests that compared to other areas, prefrontal 
projection neurons have comparatively thin axons [221], but such patterns have yet to be 
verified in mice. Neuronal activity is a major regulator of adult myelin plasticity [166], so if 
the genetic background influences activity patterns it could explain the variance in myelin
related to specific axonal tracts as well. As discussed above, it remains unknown whether these 
two strains differ in stress-induced neuronal activation. This has important implications for our 
understanding of resilience; it may be achieved via different routes depending on the pre-stress 
features of an individual.
In humans, myelination patterns in different cortical regions is genetically controlled, 
implicating individual differences in relevant variants may also influence inter-individual 
variance in myelin [280]. By extension this means that to promote resilience-related myelin 
features, different methods may be best suitable for different genetic backgrounds. Most 
published mouse work uses B6 substrains, although stress-related lower myelinated area has 
also been reported for Balb/c mice [197]. Research into white matter features of human 
resilience, such as Tendolkar et al. [281], report a negative correlation between FA in the 
anterior thalamic radiation, a frontal white matter tract, and the intensity of childhood 
maltreatment. Although not explicitly phrased as a study of resilience, the study sample was 
restricted to males reporting any experience of childhood trauma but with no past or current 
psychiatric disorders. Similar studies [208, 210] have reported lower FA in the cingulate gyrus 
and UF in stress-exposed but psychiatrically healthy individuals compared to non-stressed 
controls. By contrast, Fani et al. [282] found higher FA in another frontal tract, the posterior 
cingulum, in women reporting significant trauma but not PTSD, psychotic or substance abuse 
symptoms. In both studies resilience was only studied in contrast to susceptibility, and they 
vary considerably in their definition of resilience and sample characteristics (sex). In light of 
our findings, it would also be interesting to explore whether genetic signatures, such as those 
associating with anxiety disorders [4, 5, 44], could group together with different white matter 
patterns in resilience or susceptibility. While we did not restrict the TEM analysis to 
functionally equivalent PFC tracts as these studied in humans, our findings comparing the 
strains suggest that resilience-associated myelin structure may vary based on characteristics 
such as genetic background.
An alternative explanation for the TEM findings could be that they existed before CSDS and 
rather predict vulnerability or resilience than occur as a result of stress. There are currently no 
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available methods for addressing this with longitudinal in vivo measurements in our regions of 
interest (discussed in detail below). Differences even within an isogenic inbred strain do occur, 
possibly as a result of variation in the early postnatal or even prenatal environment [283, 284].
Variability in myelin thickness within a strain thus remains a possibility. One way to explore 
the effects of myelin features on behaviour is to use a mouse model with defects in myelin.
Such defects, as achieved by KO of relevant genes, also impacts anxiety-like and stress-related 
behaviour. Cathomas et al. [201] report lower social interaction after exposure to CSDS in 
Cnp1+/- mice but not in wt controls. Olig2 KO mice display an anxiogenic phenotype on the 
OFT and high susceptibility to social isolation stress compared to wt mice, and lower ability to 
distinguish between a novel and a familiar object, indicative of memory deficits [195].
Interestingly, some studies (such as [198]) report lower anxiety-like behaviours in a myelin-
related KO model (Cnp1-/-), along with higher resilience to a chronic mild stress exposure 
protocol. However, these animal models typically affect myelination in the same direction 
across the whole brain and lifespan. This makes them less attractive for testing how regionally 
specific and bidirectional myelin thickness differences would impact the behavioural response 
to stress in early adulthood. Myelin as a vulnerability for later maladaptive responses to stress 
are an interesting possibility, and should be assessed with appropriate methods.
6.6. TCF7L2 is a potential upstream regulator of stress-related myelin plasticity
Using a bioinformatic tool based on interactions between specific molecules and gene 
expression (IPA), we discovered TCF7L2 as a potential upstream regulator of DEGs in myelin 
and OLGs of B6 susceptible, D2 susceptible, and D2 resilient mice. Myelin component genes 
were downregulated in these comparisons and were predicted to be targets of TCF7L2. 
TCF7L2 was also predicted to regulate stress-associated DEGs in the mPFC of male B6 mice
in a previous study [203], making it a very interesting target for further research in stress in 
general, but OLGs in particular.
TCF7L2 is a pleiotropic TF expressed across the body, with well-known functions in the liver
and pancreas [285, 286]. Polymorphisms at the Tcf7l2 locus have been replicably associated 
with type II diabetes in GWASs [287], but recently also with psychiatric disorders [288].
Haploinsufficiency in mice alters startle responding in a genetic-background dependent way 
[103]. B6 Tcf7l2+/- also show higher anxiety-like behaviour than wt littermates on the OFT and 
LD tests [289]. As covered in section 2.3.2 of this thesis, it is an important part of the 
transcriptional machinery across the OLG lineage. It has multiple binding partners, such as β-
catenin [290], histone deacetylases (HDAC) 1 and 2 [291], Kaiso, and SOX10 [148]. Knocking 
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the Tcf7l2 gene out in rodents with OLG lineage-specific drivers has produced mixed results.
Myelin gene expression was reduced if knock-out was done in the whole lineage with an 
OLIG2 promoter driving the expression of Cre recombinase, but not with a PLP1 promoter 
which is only active in mature OLGs. However, myelin-related gene expression was reduced 
in a line using the CNP promoter [292]. Cnp is expressed in the mature myelin-producing 
OLGs and in premyelinating cells [293]. Knocking out specifically the DNA-binding domain 
of TCF7L2 under an OLIG1 promoter also reduces myelination, OLG differentiation, and 
remyelination after injury in adult mice, without effects on OPCs [148]. Cnp-Cre mediated 
knock-out of the DNA-binding domain in vivo has shown that during early postnatal life it 
promotes OLG differentiation [290]. TCF7L2 is also highly abundant in early but not chronic 
sites of MS injury in humans [294] and cuprizone-induced lesions in mice [295]. The role of 
TCF7L2 in these lesions is disputed, with some arguing that it imposes a blockade on 
differentiation (as a marker of activated canonical Wnt/β-catenin signalling), and others that it 
is a marker of attempted (but failing) remyelination [290]. While the jury is still out regarding 
its exact role in disease progression, it is undeniably involved in the promotion of myelin gene 
expression at the point when healthy OLGs are maturing.
The IPA prediction of TCF7L2 being a regulator of DEGs would most simply be explained by 
its direct actions as a DNA-binding transcription factor. Zhao et al. [148] performed ChIP-seq 
on cultured OLGs at different stages of differentiation. They showed that TCF7L2 has much 
larger binding peaks in maturing OLGs than immature cells, although there is overlap in the 
identity of the genes nearest the binding peaks. Curiously, there is only minute overlap between 
these genes and those identified as TCF7L2 targets in hepatocytes. Myelin component genes 
like Mbp and Mobp do not appear to have significant TCF7L2 binding in these experiments. 
In immature OLGs, TCF7L2 is co-associated with Kaiso, a Wnt signalling inhibitor, which 
reduces the interaction of TCF7L2 with β-catenin. This event, occurring early in the maturation 
process, may be necessary for releasing Wnt-induced inhibition of differentiation [296], and 
promoting TCF7L2 occupancy on the Myrf gene, which in turn promotes expression of myelin 
component genes. In vitro, MYRF has been shown to bind at myelin component genes [149, 
297]. Mediation of the predicted effects of TCF7L2 inhibition by MYRF remains a possibility
as the databases utilised by bioinformatic tools like IPA are continuously updated, with much
still to add about a newly discovered TF such as MYRF. In vitro studies with perturbations of 
TCF7L2 and MYRF could be applied to address the question of whether TCF7L2 or MYRF is
the closest upstream regulator of stress-related myelin gene expression effects.
72 
 
Another question of interest is what lies upstream of TCF7L2 in OLGs. In other words, how 
would stress influence its actions? In Study III Tcf7l2 was upregulated in the OLGs of B6 
susceptible mice, and not differentially expressed in other comparisons. While the role of this 
in our system would be an interesting avenue of further research, TFs are also frequently 
regulated on the post-translational level [298]. Regulation can occur also at the level of binding 
partner, such the competing actions of HDAC1/2 and β-catenin [291]. When bound to the 
former, TCF7L2 promotes OLG differentiation. Studies on mice with constitutively 
overactivated β-catenin in the whole OLG lineage throughout development [299] or on 
remyelination following experimentally-induced injury to myelin [300] suggest that Wnt/β-
catenin activity inhibits OLG differentiation, and consequently is inhibitory of myelination. 
However, others have found that under physiological or intermittently induced Wnt/β-catenin 
activity myelination is actually promoted [301], and chronic stress exposure may reduce 
activated β-catenin mediating myelin loss [302]. Interestingly, pharmacologically inhibiting 
glycogen synthase kinase 3 β (GSK3β, silencer of β-catenin), without altering upstream Wnt 
signalling, promotes both OPC proliferation and OLG differentiation [296]. Downregulation 
of GSK3β by small interference (si)-RNA in vitro increases the transcription of Tcf7l2, which 
can be mimicked by acute lithium treatment [303]. It is possible that disturbances in different 
nodes of this molecular network can have interactive effects, and when building a detailed 
model of how this pathway is involved in stress-induced effects on OLGs it is important to 
mind this complexity.
A putative network merging our findings regarding TCF7L2, myelin gene expression and 
myelin thickness in susceptibility and resilience across strains is presented in Figure 10. As the 
only group without predicted TCF7L2 regulation of DEGs, we propose that B6 resilient mice 
escape stress-related inhibition of TCF7L2. Due to this, or some additional myelin-promoting 
effects, these mice show thicker myelin in the mPFC, potentially as a result of activity-related 
plasticity. By contrast, in the other groups stress inhibits TCF7L2, but the mechanisms of this 
are not known. In D2 mice, this could relate to the observed lower expression of myelin
component genes in the OLGs. In resilient, but not susceptible, D2 mice we observed thinner 
myelin sheaths, consistent with lower gene expression. If this occurs as an adaptive response,
it would suggest that a rapid progression from lower myelin gene expression to thinner myelin 
on mPFC axons at least in the D2 genetic background promotes resilience. This could occur 
via adjusting the processing speed of the involved neuronal networks. As for susceptible mice, 
prior work using longer stress exposures reviewed above, at least in younger mice from the B6 
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strain, suggest mPFC myelin can become thinner after stress. If this were found to be the case 
also in adult mice exposed to CSDS, our data would suggest that myelin gene expression 
downregulation precedes myelin thinning. Lower mRNA availability may over time lead to 
either reduced capacity for plastic increase in myelin thickness, or gradual loss as a result of 
failing to compensate for myelin turnover. However, this sequence of events would need to be 
verified with a longer post-stress delay. The bioinformatic prediction also does not take into 
account localised regulatory effects of molecules like TCF7L2. It is currently not known 
whether TCF7L2 has extra-somatic functions, such as regulating mRNA packaging or 
transport. It may thus be that the upstream regulator of myelin component DEGs in the myelin 
fraction is rather a factor affecting transport than transcription. Careful and thorough mapping 
of how stress interacts with this network could provide much-needed insights into the 
neurobiology of stress susceptibility and myelination. 
 
 
Figure 10. Synthesis of findings regarding TCF7L2, myelin component gene expression, and TEM 
findings. The network maps out a putative relationship between observed features of susceptibility (top 
panels) and resilience (bottom panels). The mechanisms underlying the arrows, and the features with 
dashed outlines, form targets for future research. B6 = C57BL/6NCrl, D2 = DBA/2NCrl. 
 
6.7. Implications for anxiety disorders 
Translation of our and other animal model findings linking myelin with stress and its 
consequences has some challenges. Human neuroimaging has associated several functional 
features with high or disordered anxiety, including lower activity in the mPFC [77] and higher 
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reactivity of the amygdala [76] during threat-related tasks. Interestingly, in children with a 
family history of anxiety disorders regardless of their own current anxiety levels, both the 
mPFC and HPC are more responsive to viewing emotional faces [304]. White matter tracts 
within and between these regions also show structural alterations in anxiety disorders, with 
somewhat conflicting findings across samples and specific diagnoses [212, 213]. Thus both 
functional and structural neuroimaging features have been associated with both increases and 
decreases within these regions-of-interest in anxiety. Small samples and variable definitions of 
anxiety-like traits likely contribute to these inconsistencies, but genuine individual differences 
may also exist, akin to differences seen between mouse strains even in the same experimental 
set-up. There is also a lack of published results combining functional and structural image 
acquisitions, which would help bridge the potential association between myelin plasticity and 
anxiety. The necessary longitudinal studies following patients through developing and 
recovering from anxiety disorders, such as those linking adaptations in white matter to learning 
[176-178], are also sparse. As such, direct parallels between findings from stress-resilient and 
susceptible mice and those from human patients must be drawn with caution.
The impact myelin plasticity can have on how the brain functions [11] makes it a fascinating 
candidate for explaining the functional and structural features of anxiety disorders. Perturbing 
neuronal activity can concurrently influence both myelin thickness and conduction velocity of 
white matter tracts [173], and a genetic mutation influencing myelin globally also influences 
spike timing [175]. Thus, plastic adaptations in myelin may be immediately protective against 
maladaptive behaviours, as seen in our resilient mice, possibly via promoting adaptive 
functional connectivity. Functional neuroimaging would be required to test the association 
between this and functional connectivity between regions implicated in Study I, such as the 
PFC and vHPC. As seen in our susceptible mice, structural changes in myelin are not 
necessarily seen immediately after stress. Lower expression of myelin component genes could 
be relevant for later thinning of mPFC myelin, as reported by others and discussed above. The
functional consequences of this would then be interested to assess, with respect to the 
functional alterations seen in humans with an anxiety disorder. A structural analysis of myelin 
after stress, across several brain regions and time points, would greatly inform this translational 
effort.
6.8. Future directions 
Moving forward, perhaps the most pertinent question is what the role of stress-related myelin 
plasticity is in psychopathology. As our TEM data suggests, myelin thickness may not be 
75 
 
altered in susceptibility within the time frame applied here (10 days of stress followed by one 
week of undisturbed housing). Studies using longer exposures, such as several weeks of 
isolation [189, 191], do report structural differences between stress-exposed and non-stressed 
animals, but here the relevance of the individual response (resilience of susceptibility) is not 
addressed. Human post mortem work also reports altered myelin structure at a point at which 
the person has suffered from psychiatric symptoms for many years [207]. At the time point of 
our measurement, we do still see lower expression of myelin-related genes. Integrating these 
findings (Figure 10) could suggest a model where stress, by an as-of-yet unknown mechanisms, 
in the mPFC of susceptible animals impacts the transcriptional and/or transport machinery 
necessary for myelin maintenance and plasticity. Over time, this would be expected to result 
in comparatively thinner myelin sheaths. 
Currently there are no means by which to longitudinally assess myelin thickness in deeper 
cortical regions, such as the mPFC, in living mice. Transgenic reporter lines [164] and 
specialised confocal imaging techniques like spectral reflectometry (SpeRe, [305]) have been 
used in combination with cranial windows to view dynamics of myelin sheaths in living 
animals. However, these techniques are limited in terms of depth (approximately 300 μm below 
the meninges, [164]), and while SpeRe is suggested to achieve a similar resolution to TEM, it 
may not be able to resolve the source of every type of change the myelin sheath can incur. For 
example, myelin may appear thicker also if the inner layers swell, an early precursor to myelin 
pathologies [306]. Thus, at the resolution of TEM and the depth of the mPFC, we are currently 
not able to address the question of whether the myelin thickness differences we observed were 
in fact consequences of stress, or pre-existing features which predispose an animal to develop 
resilience or susceptibility after stress.
An alternative approach to asking whether pre-existing myelin differences contribute to the 
behavioural response to stress would be to use animals with known defects in myelination.
However, transgenic models of hypomyelination (e.g. KO of Mbp, Plp1 or Cnp [153, 198, 
307]), even if temporally inducible, typically affect the whole brain. Forebrain-specific driver 
lines (such as Emx1-Cre, [308]) exist but still cover a large number of functionally distinct
regions, such as the cortex and HPC. Because CSDS appears to have regionally selective 
impacts, such a system would have undesirable confounders. These, as well as pharmacological 
models such as cuprizone-induced demyelination or focally injected lysolecithin [309],
typically also result in progressive rather than static myelin pathology, making it difficult to 
parse out the effects of another dynamic exposure such as stress. The wish list of a researcher 
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interested in dynamic myelin plasticity in stress remains unfulfilled; hopefully one day we will 
have access to a longitudinal in vivo measurement technique, measuring myelin at the 
nanometre scale across diverse brain regions.
Returning to the big question posed at the beginning of this section, a true understanding of the 
network consequences of stress-related myelin plasticity also requires knowing which specific 
connections are affected. Regions such as the mPFC contain a vast variety of neuronal types 
with both short- and long-range connections, many of which are known to be myelinated [174, 
279]. To use our D2 resilient mice as an example, we observed thinner myelin sheaths across 
varied axonal diameters. TEM data as such cannot distinguish axons belonging to distinct 
neuronal subtypes, particularly when the diameter range of affected axons is large. Immuno-
EM is a possible technique to label subtype-specific proteins with EM-compatible antibodies,
and it has been instrumental in determining subcellular localisation of specific proteins [310].
However, the processing steps required for immuno-EM leads to reduced sample quality,
critical for accurate measurement of the myelin sheath. An intriguing novel advance is the 
ascorbate peroxidase 2 (APEX2) system, consisting now of several transgenic mouse lines and 
viral vectors [311]. Importantly, this system even enables multiplexing, i.e. the simultaneous 
visualisation of several (up to 4) different tags in the same tissue. Multiplexing in APEX2 relies 
on specific subcellular targeting of the peroxidase tags, detectable by conventional TEM
preparation and imaging methods. It is also compatible with high-pressure freezing [312], a 
sample preparation protocol that optimally preserves myelin structure [313]. Thus, it would 
soon be possible to tag specific axon types, such as those belonging to parvalbumin-expressing
interneurons and glutamatergic pyramidal neurons, in the same mice, measuring myelin 
thickness along these axons post-stress. This would be the first step towards finding out which 
specific circuits are altered in terms of myelin by stress.
Lastly, there are several possible mechanisms for transmitting the effects of stress exposure to 
OLG function and myelination. Neuronal activity is a well-established regulator of adult 
myelin plasticity [165-167], and based on the regionally selective differences seen in myelin
this is a highly attractive candidate. Pushing the aforementioned imaging system further, it 
would be incredibly informative to combine the APEX2 tag with an activity-induced effector,
such as Fast Light- and Activity-Regulated Expression (FLARE, [314]). FLARE consists of 
vector-mediated expression of an engineered TF, which requires coincident calcium signalling 
(driven by endogenous neuronal activity) and light (delivered at a selected time exogenously) 
to activate detectable fluorescent proteins. Thus, one can mark neurons which were active 
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during a specific time or task. If this transcription factor could be made to drive the expression 
of the APEX2 peroxidase, we could tag CSDS-engaged axons enabling their recognition in 
TEM, assessing whether stress-related myelin thickness differences indeed depend on neuronal 
activity.
Other possible pathways by which stress exposure could modulate myelin are systemic, such 
as the exposure of OLGs to stress-induced endocrine components. OLGs in several brain 
regions, including the cortex and HPC, express GRs [315], but we know very little about how
they influence gene expression and other functions in OLGs. Steroid hormones, such as 
androgens and estrogen, can also influence myelination and are themselves influenced by stress 
[316-318]. In vitro experiments with purified OLGs would be optimal for studying this, as in
vivo exposures would affect the whole CNS and thus disable the study of cell-specific effects. 
Several types of OLGs can be relatively easily maintained in culture, including primary cells 
derived from rodents (usually pups) and immortalised cell lines of either rodent (e.g. Oli-neu, 
[319]) or human (MO3.13, [320]) origin. These lend themselves well to the study of the basic 
biology of what exposure to agents like GCs does to OLGs, but they have significant limitations 
in terms of translation to the in vivo situation. Without neurons, OPCs and OLGs lack critical 
signalling partners, which may impact read-outs of exposure experiments. Even if co-cultured 
with neurons one may not be able to fully capture the complex, dynamic state in the adult brain. 
Such studies can, however, generate testable hypotheses taken back to animal models for 
validation.
These considerations highlight the need for several types of experiments, relying on new and 
emerging techniques, to thoroughly explore the role of myelin plasticity in susceptibility and 
resilience to stress. A mere few years ago many of the described experiments would not have 
been technically possible. Today it is a matter of motivation and resources, although some 
questions remain dependent on further technical advances. The future for myelin and stress 
research is bright and will hopefully lead to eventual advancements in our ability to treat stress-
related anxiety and other psychiatric disorder much better than we can today.
6.9. Concluding remarks  
The motivation behind what we as neuroscientists at the intersection of psychiatry do is rather 
straight-forward: we wish to help people. In fact, one would be hard-pressed to find an article 
within this field where the abstract or discussion sections do not conclude with some variation 
of the idea that the knowledge acquired will hopefully be the basis of novel therapeutic 
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breakthroughs. These disorders cause immeasurable personal suffering to millions, but our 
treatment options are limited, and these are the limits we wish to push.
In the studies reported here, we showed the engagement of a putative network of brain regions 
during chronic psychosocial stress and differences in myelin within some of the nodes of this 
network. Additionally, we demonstrated that genetic background moderates both the 
behavioural and myelin-related response to stress. Mice with high baseline anxiety-like 
behaviour (D2) were also more susceptible to chronic stress than mice from the B6 strain. 
While myelin plasticity was implicated in both strains, the nature of this association also 
depended greatly on whether the mice were resilient or susceptible. Collectively, these findings 
suggest that stress robustly, but via as-of-yet unknown mechanisms, engages the myelin 
machinery, but the downstream effects are moderated by genetic background. For example, we 
found that mice with the resilient behavioural phenotype from different strains can show 
opposite myelin thickness phenotypes in the mPFC. This could arise from different neuronal 
activation patterns induced by CSDS between strains.
Additional experiments are needed to address crucial questions, such as whether stress is 
indeed causal of myelin plasticity or lack thereof, and how the observed myelin gene expression 
differences in susceptibility relate to long-term consequences of stress. Adding this knowledge 
to what we know about neuronal plasticity and system-level effects of stress will hopefully 
construct a more complete picture of how resilience and susceptibility emerge. Perhaps myelin 
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Brain activation induced by chronic 
psychosocial stress in mice
Mikaela A. Laine , Ewa Sokolowska , Mateusz Dudek , Saija-Anita Callan , Petri Hyytiä  &  
Iiris Hovatta
Chronic psychosocial stress is a well-established risk factor for neuropsychiatric diseases. Abnormalities 
in brain activity have been demonstrated in patients with stress-related disorders. Global brain 
activation patterns during chronic stress exposure are less well understood but may have strong 
pathologies. We determined neural activation induced by chronic social defeat stress, a mouse 
model of psychosocial stress. To assess chronic activation with an unbiased brain-wide focus we used 
manganese-enhanced magnetic resonance imaging (MEMRI) and immunohistochemical staining 
of ∆
and anxiety-like behaviour, including the prefrontal cortex, bed nucleus of stria terminalis, ventral 
hippocampus and periaqueductal grey in stressed compared to control mice. We further established 
that the correlation of ∆
social defeat. Chronic activation of these neural circuits may relate to persistent brain activity changes 
occurring during chronic psychosocial stress exposure, with potential relevance for the development of 
anxiety and depression in humans.
Psychosocial stress increases the risk for both somatic and psychiatric diseases and worsens their prognosis1–4. 
This term refers to a broad range of experiences, including lack of normative care, abuse, and problems in peer 
relationships such as bullying5. Stress-related mental disorders like major depressive disorder (MDD) and anxiety 
disorders are associated with altered activation of specific brain regions. For example, neuroimaging has revealed 
that resting-state activity is reduced in the prefrontal cortex (PFC)6 and increased in the hippocampus7 while 
task-related reactivity is decreased in the hippocampus8 and nucleus accumbens9 of MDD patients. Interpretation 
of the human imaging findings is difficult as activation patterns in tasks carried out during brain imaging may 
differ from those occurring during naturalistic chronic stress exposure. Because patients enrolled in these studies 
also tend to have an extensive history of symptoms and medication use, it is challenging to reveal direct conse-
quences of chronic psychosocial stress itself. In contrast, animal models allow investigation of specific stressors in 
a controlled manner to establish the mechanisms connecting chronic psychosocial stress exposure, brain activa-
tion, and subsequent emotional and social behaviour.
Chronic social defeat stress (CSDS) is a rodent model of psychosocial stress, which produces many behav-
ioural features similar to the symptoms of human anxiety and mood disorders, such as social aversion, anhedo-
nia (decreased sucrose-preference) and increased self-administration of drugs of abuse10,11. These behavioural 
phenotypes last for several weeks post-stress10, and can be reversed by chronic treatment with selective serotonin 
re-uptake inhibitors or tricyclic antidepressants12, or a single dose of ketamine13. Thus, CSDS is an excellent 
mouse model to determine psychosocial stress-induced chronically occurring neural activation patterns, which 
may underlie the behavioural outcomes of stress exposure.
We hypothesized that CSDS induces neural activation in an extensive network of brain regions, including 
those previously implicated in acute stress and stress-related psychiatric disorders. We employed a combina-
tion of two methods for assessing neural activation in mice: manganese-enhanced magnetic resonance imag-
ing (MEMRI) and ∆FOSB immunohistochemistry. MEMRI is based on the influx of paramagnetic Mn2+ ions 
into excitable cells through voltage-gated Ca2+ channels during depolarization, which increases T1-weighted 
signal intensity and thereby provides a marker of activated neurons14,15. Due to the slow efflux of Mn2+ from 
the brain, MEMRI allows functional brain imaging in anesthetized animals that have previously undergone 
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pharmacological or behavioural testing16,17. In addition, Mn2+ ions are transported along axons, released from 
the terminals into the synaptic cleft, and taken up by the postsynaptic neuron18,19, providing a global measure of 
network activation.
ΔFOSB is a truncated hyperstable splice variant of the transcription factor FOSB. While the parent isoform 
FOSB is rapidly induced and degraded, the ∆FOSB form accumulates through repeated stimuli during a course 
of a chronic treatment, with each acute stimulus inducing a low level of ΔFOSB, and the repeated stress exposure 
causing the gradual increase in its total levels20. Since the estimated half-life of ΔFOSB is 8 days it is a useful 
marker for repeatedly activated neurons20–22.
In contrast to MEMRI that enables brain-wide mapping of neural activation and activity-dependent con-
nectivity, ∆FOSB immunohistochemistry detects nuclear activation with high cellular resolution. By combining 
these methods, we compared CSDS-exposed and control mice one week after cessation of stress to determine 
brain regions activated due to chronic psychosocial stress exposure.
Results
Functional MEMRI mapping shows widespread brain activation by CSDS. We exposed mice to 
the 10-day CSDS protocol, during which MnCl2 was infused from an implanted osmotic minipump (Fig. 1). 
Socially defeated mice showed significant enhancement of T1 signal intensity in MEMRI compared to control 
mice as shown by statistical parametric maps in Fig. 2. Enhanced T1 intensity reflects accumulation of Mn2+ 
into repeatedly activated brain regions, suggesting increased brain activity in mice exposed to CSDS. We did not 
detect signal decreases in stressed mice compared to the controls. It is possible that this is due to the principle 
of MEMRI, i.e., Mn2+ influx into active neurons by voltage-gated Ca2+ channels, which renders the method less 
sensitive to deactivation than activity-induced signal increase. We observed increased activation throughout the 
brain, mostly confined to specific anatomical regions. In the PFC, increased signal was found in the orbital cortex 
(O) and forceps minor (fmi), a white matter tract. More caudally, the nucleus accumbens (Acb), caudate putamen 
(CPu), and lateral septum (LS) exhibited increased activation. Both the striatal and septal clusters were also 
activated by chronic stress in more caudal sections. In the basal forebrain, ventral parts of the bed nucleus of the 
stria terminalis (BNST) and preoptic area (LPO) were more activated in stressed compared to the control mice. 
The preoptic activation continued caudally as a distinct activation cluster encompassing the lateral hypothala-
mus (LH) with ventrolateral thalamic (VL) connections. We detected stronger MEMRI signal in the midbrain, 
Figure 1. Timeline of the experiment and illustration of the chronic social defeat stress (CSDS) protocol. 
(a) Timeline of CSDS, manganese-enhanced magnetic resonance imaging and tissue collection. Each 
perpendicular line indicates one day. Estimated timeline for detection of Mn2+ by MEMRI and ∆FOSB by 
immunohistochemical staining is indicated by red and blue lines, respectively. (b) The experimental mouse in 
the defeated group (dark grey) was placed into the cage of a resident aggressor mouse (white) for a maximum of 
10 minutes. It was then placed into the adjacent compartment of the same cage for 24 hours, retaining sensory 
contact without physical contact. The procedure was repeated for 10 days, each day in a novel resident aggressor 
mouse’s cage. (c) The control mouse was placed in a compartment adjacent to another control mouse, allowing 
sensory but not physical contact, for 24 hours. Each day the control mouse was placed into another cage with a 
novel control mouse, and the procedure was repeated for 10 days. MRI = magnetic resonance imaging.
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including the ventral tegmental area (VTA), substantia nigra (SN), periaqueductal grey (PAG), superior collic-
ulus (SuG), ventral hippocampus (vHP), dentate gyrus (DG), and reticular formation (Rt) in stressed compared 
to the control mice. Cortical activation was found in the visual cortex (V). In the hindbrain, social defeat was 
associated with increased signal intensity in the pontine (Pn) and vestibular nuclei (Ve), with connectivity with 
the cerebellum (Cb).
∆FOSB staining reveals localised cell populations with repeated activation in stressed 
mice. We counted the number of ∆FOSB-expressing cells in 18 pre-selected brain regions and compared 
the control and defeated groups with either t- or U-tests depending on normality of distributions (Table 1). We 
selected the regions based on our results from MEMRI and on prior findings on brain activation in stress and 
emotional processing23,24. As shown in Fig. 3, we observed significantly larger numbers of ∆FOSB positive cells in 
the BNST (anterodorsal), CPu, lateral septum (ventral, LSV), lateral thalamus (VL), LH, vHP and the DG (ven-
tral) in stressed compared to control mice. While no comparisons survived correction for a false discovery rate 
(FDR) of 5%, given the large number of regions examined, the aforementioned regions remained significant when 
correcting for FDR < 20%. The number of ∆FOSB positive cells in midbrain regions such as the VTA and PAG 
(dorsolateral) was overall very low, and we did not detect differences in their number between stressed and con-
trol animals in either region (Fig. 2A). Expression of ∆FOSB in the infralimbic (IL) and prelimbic (PrL) regions 
of the prefrontal cortex did not differ significantly between groups (Table 1). No differences between groups were 
observed for the negative control region piriform cortex (Pir), as expected, as it does not have a known role in 
the regulation of stress. There were very few ∆FOSB-positive cells in the CPu, VL and LH, especially in the VL, 
prohibiting calculation of the percentage change between groups.
CSDS alters the correlation of ∆FOSB expression between brain regions. To identify putative 
network-level consequences of CSDS, we took advantage of the nuclear specificity and excellent spatial resolution 
of immunohistochemistry and calculated correlation coefficients (Pearson’s r) of the number of ∆FOSB positive 
cells between each brain region, separately for defeated and control mice (see Supplementary Table S1 for full 
correlation matrix). We observed notable differences in the correlation profiles of defeated and control mice for 
specific brain regions (Fig. 4). The correlation profiles of prefrontal regions IL and PrL were similar within the 
control group and the stressed group, but the two groups differed considerably from each other. The number of 
Figure 2. Differences in brain activity between socially defeated and control mice revealed by MEMRI. 
Statistical t-maps (thresholded at p < 0.01, corrected for multiple comparisons) are superimposed on a custom-
made mouse brain template, with corresponding atlas sections58 manually overlaid using anatomical landmarks. 
Numbers indicate the positions of the sections from bregma in millimetres. Brain region abbreviations: BNST 
(bed nucleus of the stria terminalis), CPu (caudate putamen), Cb (cerebellum), CG (central grey), fmi (forceps 
minor), LH (lateral hypothalamus), LPO (lateral preoptic area), LS (lateral septum), Acb (nucleus accumbens), 
O (orbital cortex), PAG (periaqueductal grey), Pn (pontine nuclei), Rt (reticular formation), SN (substantia 
nigra), SuG (superior colliculus), V (visual cortex), VL (ventrolateral thalamic nucleus), vHP (ventral 
hippocampus), Ve (vestibular nuclei), VTA (ventral tegmental area).
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∆FOSB positive cells correlated significantly (r > 0.8, p < 0.05) in both groups with expression in the DG and 
AcbC, while in defeated mice we also observed correlation of both regions with the CPu and VL (Fig. 4a and b). 
Activation of the BNST was also significantly correlated with the activation of subcortical structures, PrL and DG 
following CSDS but not in control mice (Fig. 4c). The basomedial amygdala (BMA, Fig. 4d) shared correlated 
activation with the VTA both in control and defeated mice. For the defeated mice, the only notable change in 
BMA co-activation occurred with other amygdalar nuclei, namely the central nucleus (CeA), with no significant 
correlations with frontal and other subcortical regions. Lastly, both the vHP (Fig. 4e) and PAG (Fig. 4f) cell counts 
were significantly correlated with frontal regions in defeated mice but not in controls, despite the very low num-
ber of ∆FOSB positive cells observed in the PAG. To control for potential biases in correlation coefficients caused 
by an overall increase in ∆FOSB expressing cells in stressed mice, we tested for a correlation of mean ∆FOSB cell 
number and mean value of r for each brain region, separately for the two groups. In defeated mice there was no 
correlation between ∆FOSB and r, suggesting that the emerging correlation profiles cannot be explained by a rise 
in absolute ∆FOSB expression (see Supplementary Fig. S1).
Discussion
To determine mouse brain regions repeatedly activated due to chronic stress exposure, we carried out neuroim-
aging by MEMRI and immunohistochemical detection of ∆FOSB one week after the cessation of 10-day CSDS 
in mice. Our approach allowed unbiased covering of the whole brain, enabling the discovery of previously unre-
ported associations between repeated neuronal activity and chronic stress experience. Regions in which both 
methods revealed significantly more activation in stressed compared to control mice included subcortical struc-
tures (BNST, CPu, LSV, VL, LH), and the vHP and DG. MEMRI revealed stress-induced activation at the orbital 
cortex and fmi, an anterior portion of the corpus callosum, possibly reflecting the spread of Mn2+ along white 
matter tracts25. A stronger MEMRI signal was also observed in the midbrain regions of stressed compared to 
control mice, but without any differences in the number of ∆FOSB positive cells between the groups. To assess 
putative stress effects at the network level, we also surveyed correlations of ∆FOSB expression between brain 
regions, separately within the defeated and control groups. The correlation profiles of the IL, PrL, BNST, vHP and 
PAG were considerably altered following CSDS.
Although both ∆FOSB expression and MEMRI mapping are expected to reveal differences in brain activation 
induced by chronic psychosocial stress, the observed regional pattern of activation was not completely overlap-
ping. These findings are not contradictory, but rather reflect methodological differences, and represent comple-
mentary measures of repeated brain activation. While ∆FOSB immunohistochemistry allows measurement of 
high resolution neuronal activation, MEMRI can also reveal long-range connectivity in activated pathways due 
to anterograde axonal Mn2+ transport in addition to local activity18,19. Therefore, strong MEMRI signal can also 
be found in regions with low ∆FOSB expression levels but dense axonal tracts passing through them, as seen in 
VL, LH and midbrain regions. For example, the LH receives strong inputs from the extended amygdala, stria-
tum, septum, and hippocampal formation, which had higher numbers of ∆FOSB positive cells in stressed com-
pared to control mice. These regions also send reciprocal projections to the hypothalamus. In addition, the LH 
Brain region Full name N control N defeated % change+ t/U P
MO Medial orbital cortex 7 7 +39.7 1.072 (t) 0.315
IL Infralimbic cortex 7 8 +109.1 1.801 (t) 0.095
PrL Prelimbic cortex 7 8 +66.9 1.536 (t) 0.148
BNST Bed nucleus of stria terminalis (anterodorsal) 6 7 +306.4 2.644 (t) 0.034
AcbC Nucleus accumbens (core) 7 8 +139.4 1.389 (U) 0.189
AcbSh Nucleus accumbens (shell) 6 8 +82.3 0.645 (U) 0.573
CPu Caudate putamen 7 8 +753.7 2.083 (U) 0.006
LSV Lateral septum (ventral) 7 8 +89.0 2.142 (t) 0.035
VL Thalamus (ventrolateral) 6 7 n/a 2.448 (U) 0.035
LH Lateral hypothalamus 6 7 +153.1 2.436 (t) 0.033
BLA Basolateral amygdala 6 7 +54.2 0.886 (t) 0.394
BMA Basomedial amygdala 6 7 +73.5 1.206 (t) 0.253
CeA Central amygdala 6 7 +83.7 1.410 (t) 0.186
vHP Ventral hippocampus (CA1 & CA3) 7 8 +261.5 2.083 (U) 0.040
DG Dentate gyrus (ventral) 6 6 +153.4 2.695 (t) 0.032
PAG Periaqueductal grey (dorsolateral) 7 8 +112.8 1.582 (t) 0.138
VTA Ventral tegmental area 6 6 −22.7 0.601 (t) 0.561
Pir Piriform cortex 7 8 +16.1 0.401 (t) 0.695
Table 1. Differences in the number of ∆FOSB-positive cells between defeated and control mice in each brain 
region of interest. The number of positive cells between control and defeated mice was compared with either 
an independent Student’s t-test (normally distributed data, indicated with t) or a Mann-Whitney U-test (non-
normally distributed data, indicated with U). N = number of animals, P = nominal p-value, +change in mean 
number of stained cells in defeated mice compared to controls in percentage points. Significant p-values (<0.05) 
which also survive correction for multiple comparisons (false discovery rate < 20%) are marked in bold.
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is connected with the midbrain and brainstem26 which had widespread MEMRI signal enhancement in stressed 
mice. These regions play an important role in somatomotor, sensory, and autonomic control mechanisms that 
have been implicated in stress and anxiety27.
Neither MEMRI nor ∆FOSB mapping allows us to determine the exact time of neuronal activation giving rise 
to the observed differences between stressed and control animals. However, with the 8-day half-life of ∆FOSB21, 
the number of ∆FOSB positive cells we observe one week after 10-day CSDS likely reflects repeated activation 
that occurred during defeat and/or the time between CSDS and dissection. The half-life of Mn2+ in the brain is 
longer than that of ∆FOSB, and therefore brain activation measured by MEMRI one week after social defeat may 
partly reflect acute stress effects that occurred during the first days of social defeat. However, we have previously 
shown that activation induced by a week of alcohol exposure either largely subsided or exhibited an altered pat-
tern following a week-long abstinence from alcohol, suggesting that the changes seen during abstinence could 
not be ascribed to acute alcohol exposure alone17. Similarly, the MEMRI signal measured one week after CSDS 
could reflect neuronal activation related to long-term physiological and behavioral changes observed in defeated 
animals10.
The regions we selected for immunohistochemical analysis have been implicated in the processing of social 
and emotional behaviour in mice and humans6,23,24,28. However, we only observed repeated activation of a subset 
of these regions during chronic psychosocial stress in mice. These differences to previous publications are most 
likely due to varying nature of stress and the interval between the stress exposure and measurement of brain 
activation. Similarly to our findings, the dorsal BNST, CPu, LSV and DG were previously found to be activated 
already 24 h following CSDS in mice29, and the PFC, LH and DG were activated less than 24 h after chronic vari-
able stress in rats30. No differences were observed in ∆FOSB expression 20 days post-defeat between the control 
and defeated mice using Western blot detection of FOSB isoforms in bulk tissue samples including the whole 
PFC and whole hippocampus31. Also the Acb, basolateral amygdala (BLA) and dorsal raphe nuclei were found 
Figure 3. Chronic social defeat induces changes in brain activation as measured by expression of ∆FOSB. 
(a) The mean number of cells staining positive for ∆FOSB in defeated and control mice. Error bars ± 1 SEM, 
*p < 0.05, see Table 1 for exact statistical values. (b) Representative images of immunohistochemical staining 
for ∆FOSB, positive cells indicated by black arrows, in the infralimbic cortex (IL), bed nucleus of stria terminals 
(BNST), lateral hypothalamus (LH) and ventral hippocampus (vHP). Scale bar = 100 μm. See Supplementary 
Fig. S2 for representative images from each of the brain regions analysed.
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to be activated 24 h following stress29, but not in our study with a longer post-defeat delay. These regions could 
therefore be involved more significantly during early stress exposure, as ∆FOSB produced in the early days but 
not later days of stress exposure may have decayed by the time we measured its expression. The regions displaying 
activation in our study may mediate the effects of chronic psychosocial stress in the long term and are potential 
sites of alterations that may also contribute to the development of behavioural outcomes of stress.
When two brain regions jointly participate in a task, their activity becomes correlated as measured by func-
tional neuroimaging in humans32,33, electrical recordings in monkeys34 and staining for activity-induced proteins 
in rodents35,36. Although immunohistochemical data analysis reveals such functional connections, directionality 
of the connections remains elusive. Some regions are even known to be connected by parallel tracts with func-
tionally opposed consequences on activation37. Furthermore, regions that engage in correlated activation are 
not necessarily physically connected, but rather part of the same functional network. Despite these limitations, 
we aimed at addressing functional connectivity for establishing how chronic psychosocial stress is processed by 
specific brain networks.
The BNST is implicated in risk assessment and anxiety-like behaviour in mice38, but its activation in CSDS has 
not been extensively studied. BNST neurons mediate anxiety-like behaviour and regulate endocrine functions 
following acute stress exposure39. Some of its subregions have opposing roles in anxiety-like behaviour: the anter-
odorsal nuclei produce anxiogenic responses, while the ventral nuclei mediate anxiolysis23,37. The dorsal segment 
shows increased activation 24 h following 10-day CSDS29. We found that the anterodorsal BNST is repeatedly 
activated in stress-exposed mice, and that in the stressed mice the BNST ∆FOSB expression correlation with 
Figure 4. Chronic social defeat stress associates with alterations in ∆FOSB positive cell number correlation 
profiles of specific brain regions. Radar graphs depict the absolute value of r for the infralimbic cortex (IL, a), 
prelimbic cortex (PrL, b), bed nucleus of stria terminalis (BNST, c), basomedial amygdala (BMA, d), ventral 
hippocampus (vHP, e), and periaqueductal grey (PAG, f) comparison of the number of ∆FOSB-positive cells 
per mm3 with the other brain regions. Figure key indicates the sign and magnitude of r. Regions that correlate 
significantly with the title region are indicated by an asterisk (*p < 0.05, **p < 0.01), and correlations remaining 
significant after correction for false discovery rate (<5%) are marked with bold text. See Table 1 for brain region 
abbreviations.
www.nature.com/scientificreports/
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other brain regions, including the DG, LH, VL, CPu and PrL, was altered. The BNST has afferent and efferent 
connections with several regions, including the amygdala, LH, PAG and the PFC40–42, and neural activity of BNST 
could partly contribute to increased MEMRI signal in these areas through axonal transport. However, out of 
these established connections we only observed significant correlation of BNST activation with the LH and the 
PrL following CSDS. The observed correlation between the BNST and DG is interesting because no direct struc-
tural connections are reported for these regions in mice43, suggesting that their functional connectivity may be 
mediated by one or more other regions. Therefore, while structural and functional connections of the BNST are 
wide-reaching, only some of these connections may be involved in the response to chronic psychosocial stress. In 
particular, our data suggest that networks connecting the BNST, PFC, LH and DG are activated during chronic 
stress, and may mediate previously unprobed long-term adaptive changes after stress.
The vHP and PFC both regulate emotionality and depressive states in humans. In patients with MDD the 
vHP is less active during a memory task8, but more active at rest7 compared to healthy controls, while the PFC 
exhibits decreased activity at rest6. Both regions are activated in humans during an acutely stressful task44,45. We 
observed repeated activation of both regions and a significant correlation of ∆FOSB expression between them in 
mice exposed to CSDS. In mice these regions are connected by a monosynaptic tract46, in addition to several indi-
rect connective loops47. Temporally synchronized firing between these regions occurs during anxiety-provoking 
tasks48, and inhibiting activity along this pathway optogenetically reduces anxiety-like behaviour49. Interestingly, 
in humans the tract connecting the hippocampal region to the PFC, the uncinate fasciculus, shows decreased 
white matter integrity by diffusion tensor imaging in adults with a history of childhood maltreatment50. We 
observed that the fmi, another major white matter tract of the PFC, was more active in defeated than control mice 
as measured by MEMRI, suggesting that this connection also becomes recruited during chronic stress. White 
matter alterations have also been found in this tract in mice exposed to social isolation51 and in MDD patients52. 
Thus, chronic psychosocial stress in mice, and acute social stress in humans, both increase activity in the circuit 
involving the PFC and vHP.
We did not detect altered ∆FOSB expression in the PAG after stress, but observed marked changes in its 
correlation profile. This region contains connections to and from the cortex, basal ganglia, VL and LH53, and 
it is an important mediator of defensive behavioural responses via inputs from the amygdala54. Similarly to the 
BNST, only a subset of the regions with direct synaptic connectivity with the PAG showed significantly correlated 
activation in the stressed mice, including the PFC, AcbC, and VL. Anatomical connectivity of these regions with 
PAG may also lead to the increased Mn2+ accumulation we observed. The emergence of correlation between low 
PAG ∆FOSB expression and other regions suggests that the observed correlations were not artefacts arising from 
an increased number of ∆FOSB expressing cells (see Supplementary Fig. S1). Our finding of low ∆FOSB expres-
sion in the PAG parallel with significant functional connections may point to a small specific neuronal ensemble 
participating in chronic stress processing. Intriguingly, fewer than 10% of PAG neurons receive input from the 
cortex, and these cells mediate social behaviour following chronic stress exposure53.
In conclusion, our data suggest that a functional network of specific frontal, subcortical and midbrain regions 
is repeatedly activated by CSDS, and that chronic stress alters inter-region co-activation. These brain regions, 
including the PFC, BNST and other subcortical structures, vHP and PAG, provide targets for future studies seek-
ing to determine long-lasting effects of chronic psychosocial stress on the mouse brain.
Methods
Animals. Animal procedures were approved by the project authorization board of the Regional State 
Administration Agency for Southern Finland and carried out in accordance to directive 2010/63/EU of the 
European Parliament and of the Council, and the Finnish Act on the Protection of Animals Used for Science or 
Educational Purposes (497/2013).
We used 21 male mice (C57BL/6NCrl, Charles River, Sulzfeld, Germany), aged 5 weeks on arrival. During 
a 7-day acclimatization period they were group-housed in Makrolon type III cages. The housing facility was 
temperature- and humidity-controlled with a 12 h light/dark cycle (light phase: 6:00–18:00). Mice had ad libitum 
access to standard pellet food and water.
Aggressor mice used for the chronic social defeat stress (CSDS) procedure (see below) were male Clr:CD1 
(Charles River) mice aged between 13 and 26 weeks. Following a 7-day acclimatization period in single-housed 
individually ventilated cages we screened them for appropriate levels of aggression by assessing their propen-
sity for attacking an intruder mouse (no sooner than 10 seconds or later than 90 seconds after introduction to a 
C57BL/6NCrl test mouse). Twenty-four hours before the start of CSDS each selected aggressor mouse was placed 
alone into a cage to be used for CSDS.
Experimental design. The experimental procedures are illustrated in Fig. 1. At the end of the habituation 
period, mice were surgically implanted with osmotic minipumps for delivery of MnCl2. The mice were allowed 
to recover from the surgery for one week, after which they underwent the 10-day CSDS procedure or the control 
housing procedure. Manganese was infused constitutively during CSDS. After the end of CSDS, all mice were 
placed in single-housed cages until the MRI scan and dissections. We wanted to mainly assess chronic brain 
activation without bias from acute activation occurring at the beginning of the social defeat and therefore set the 
post-defeat delay to six days.
Osmotic minipump implantation. Subcutaneous osmotic minipumps (Alzet, model 2002) delivering 
200 μl of MnCl2 (0.5 μl/h) were implanted as described previously55. MnCl2 was dissolved into Tris-buffered saline 
(pH 7.4) and administered with osmotic minipumps during the 16-day infusion, corresponding to a total MnCl2 
dose of 160 mg/kg/week. The concentration of MnCl2 in the pumps was adjusted to the body weight of the ani-
mals. Before the surgery, the pumps were primed overnight in a 37 °C saline solution. Animals were anesthetized 
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with 5% isoflurane and the pumps were implanted subcutaneously on the dorsum, slightly caudal to the scapulae. 
For post-surgical analgesia, animals received one subcutaneous injection of carprofen (5 mg/kg) immediately 
after implantation.
Chronic social defeat stress (CSDS). Following recovery from implantation mice allocated to the defeated 
group (N = 11) were exposed to CSDS56. In short, the mouse was placed into a cage containing an aggressor 
mouse. The mice were observed for a maximum of 10 min, after which they were separated by a perforated plex-
iglass wall, exposing the experimental mouse to sensory cues from the aggressor mouse without risk of physi-
cal contact. If during the initial observation phase the aggressor mouse exhibited excessive physical aggression 
(caused a significant wound, particularly in the vicinity of the minipump) the mice were separated before the 
10-minute time had elapsed. The average contact time throughout the experiment was 6.43 min. The sensory con-
tact phase lasted for 24 h, after which the experimental mouse was placed into the cage of a novel aggressor mouse 
and the 10-min physical contact + 24 h sensory contact cycle was repeated. This procedure was repeated for 10 
consecutive days. Control mice (N = 10) were housed in similar cages but with another control mouse as a neigh-
bour and no physical contact, switching cage-mates daily. The social aversion test was performed 24 h after the 
last session of social defeat for both defeated and control mice56. Briefly, mice were placed in an arena containing 
a perforated cylinder for 150 s. The mice were placed back in the home cage, and the cylinder replaced with one 
containing a novel CD-1 mouse. The mouse was then returned to the arena for 150 s. The social preference score 
(ratio of time spent near the cylinder when it contained another mouse compared to the trial with the empty cyl-
inder) did not differ (p = 0.256) between the groups due to small sample size and large variation between animals.
MRI acquisition and data analysis. Magnetic resonance imaging was performed with a 4.7 T scanner 
(Bruker, PharmaScan 47/16 US, Ettlingen, Germany) using a 38 mm linear volume coil for transmit and receive. 
Mice were transferred from the vivarium to the scanner room, immediately anaesthetized with 5% isoflurane 
in oxygen (0.8–1 L/min) and positioned on a custom-made holder with a stabilizing tooth bar and a nose cone. 
Accurate positioning was confirmed with the help of scout images and all inaccuracies were corrected by adjust-
ing the position and angles of the field. During scanning anaesthesia was maintained with 2–3% isoflurane and 
the body temperature was kept constant at 37 °C with a heating pad. The scanning order was counterbalanced 
according to the experimental groups. T1-weighted images were acquired using a three-dimensional rapid 
acquisition-relaxation enhanced (RARE) pulse sequence (repetition time = 300 ms, effective echo time = 10.7 
ms, echo train length = 8, flip angle = 180°, number of averages = 8, field of view FOV = 12.8 × 12.8 × 12.8 mm, 
acquired matrix size = 200/200/200, reconstructed matrix size = 100/100/100, resulting in 0.128 × 0.128 × 0.128 
mm3 voxel resolution). Values for the automatically adjusted receiver gain were collected to verify that the 
observed group differences were not caused by changes in receiver gain. Total scanning time, including acquisi-
tion of scout images, was approximately 60 min per animal.
All MRI images were converted to Analyze format, scaled by a factor of 10 and spatially preprocessed with 
SPM8 software running under MATLAB (version R2015). All T1-weighted images were spatially normalized 
to a custom-made mouse brain template. Bias correction was performed to eliminate field inhomogeneity of 
the magnetic field. For creating statistical parametric maps of differential brain activation between experimen-
tal groups, the groups were compared by voxel-wise independent two-tailed t-test using SPM8. Despite careful 
adjustment of MnCl2 concentration in individual animals, systemic infusion can lead to differences in brain Mn2+ 
accumulation, causing activation-independent differences in the mean global signal intensity between subjects. 
To eliminate global effects, the mean intensity was included as a nuisance factor in the statistical model, on a 
voxel-by-voxel basis57. For the defeated < control contrast, the resulting statistical parametric maps were thresh-
olded voxelwise at the arbitrary significance of p < 0.001. Then the cluster size was thresholded with a threshold 
of k = 71 voxels, resulting in an overall significance level of p < 0.01 corrected for multiple comparisons across the 
whole brain. k was computed based on Monte Carlo simulations. Brain regions were identified by superimposing 
brain atlas sections58 on the MRI scans using prominent landmarks, including white matter tracts (e.g. corpus 
callosum, anterior and posterior commissures), the overall shape of the brain and ventricle location, and defined 
grey matter structures (e.g. caudate putamen). The observed increased MEMRI signal in stressed animals is likely 
not attributable to alterations in Ca2+ channel function as we did not observe any gene coding for Ca2+ channel 
components (GO:0005891) to be differentially expressed between stressed and control animals in RNA sequenc-
ing data from the medial PFC or vHP (data not shown).
Tissue processing and immunohistochemistry. Following the MRI scan mice were injected with a 
lethal dose of pentobarbital (Mebunat Vet, Orion Pharma) without breaks in anaesthesia. Mice were transcar-
dially perfused with 4% paraformaldehyde (PFA) in PBS. We postfixed the brains in 4% PFA for 2–24 h, cry-
oprotected them in 20% sucrose for 24 h, froze them in 2-methyl butane, and stored them in −80 °C. We then 
cryosectioned the brains with a Leica CM3050 cryostat (Leica Biosystems, Nussloch, Germany). Sections were 
stored in −20 °C submerged in cryoprotectant. One defeated animal died during MRI acquisition and was not 
further analysed.
All immunohistochemical, microscopy and quantification procedures were carried out blind to the condition 
of each animal. Five animals (3 controls, 2 defeated) were not stained due to issues with fixation. Tissue sections 
were stained in batches with balanced numbers of mice belonging to each experimental group. The sections 
were rinsed in TBS and endogenous peroxidase activity was quenched with hydrogen peroxide. We blocked 
non-specific binding with 10% normal goat serum (NGS) with 0.5% Tween-20 detergent (Sigma Aldrich) in 
TBS. Primary antibody incubation with a polyclonal rabbit anti-FOSB antibody [1:500 (0.4 μg/mL), sc-7203, 
Santa Cruz Biotechnology, Dallas, TX, U.S.A.] in TBS with 10% NGS + 0.5% Tween-20 was carried out for 18 h 
in ambient room temperature. Biotinylated affinity-purified goat anti-rabbit [1:200 (7.5 μg/mL), ABC detection 
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kit (PK-6101), Vector laboratories, Burlingame, CA, U.S.A] diluted in TBS with 1.5% NGS was used as the sec-
ondary antibody and incubated for 2 h in room temperature. The sections were incubated in an avidin-biotin 
solution prepared in PBS (ABC detection kit, Vector Laboratories), rinsed in 0.1 M PB and staining detected with 
3,3′-diaminobenzidine (DAB, Vector Laboratories). Sections were dehydrated and stored at +4 °C.
The primary antibody detects also the full-length FOSB protein, but it is induced only by acute stimulation 
with a half-life of 1.6 hours20,21 and is thus not expected to contribute to our findings. As the mice were kept anaes-
thetized throughout the scanning, which lasted approximately 60 min, and the perfusion was done immediately 
after the scan, acute stress effects incurred during transport from the vivarium to the scanning room are expected 
to be minimal. Due to the counterbalanced order of scanning, any minor acutely induced full-length FOSB did 
not impact our results. The primary antibody was tested on male C57BL/6NCrl mice receiving injections of saline 
or cocaine for 6 consecutive days (15 mg/kg daily), and naïve controls (N = 2/group). Cocaine is known to induce 
both full-length and ∆FOSB in the caudoputamen after acute exposure, but only ∆FOSB following chronic expo-
sure59. Mice receiving cocaine had significantly more ∆FOSB positive cells than both saline and naïve control 
mice (p < 0.001 in both contrasts, see Supplementary Fig. S1). Validity of staining was also ensured with test 
staining omitting the primary antibody.
Stained sections were imaged with a Pannoramic FLASH II digital scanner using a 0.8 NA objective at a reso-
lution of 0.24 μm/pixel (3DHistech, Budapest, Hungary) at the Institute of Biotechnology (University of Helsinki). 
We captured regions of interest images from the digital scans at 20x magnification using the Pannoramic Viewer 
software version 1.15.3 (3DHistech) based on anatomical landmarks indexed in the Mouse Brain Atlas58. The 
numbers of stained cells were quantified using ImageJ version 1.47 v (National Institutes of Health), using a colour 
deconvolution plugin with a vector for DAB-staining built in to this version of the software. Thresholded images 
were analysed for particles larger than 15 μm2 in size and quantified with automated measurement.
Cell count statistical analysis. ∆FOSB cell counts were acquired from 18 relevant brain regions (see 
Table 1) from 3–6 sections from each animal. The piriform cortex (Pir), an olfactory processing region60, was 
included due to its expected lack of involvement in CSDS. Exclusion criteria for single cell count data points 
was a deviation of ≥3 times the interquartile range below or above the median of the group. If half or more 
data points collected from one animal within one brain region were outliers based on this criterion, the whole 
animal was excluded from analyses concerning that region. Another criterion for excluding an animal from any 
specific test was insufficient fixation (total number of animals included per brain region is indicated in Table 1). 
Distribution normality was assessed with the Shapiro-Wilk test. For regions where the data were normally dis-
tributed the groups were compared using independent t-tests, and for non-normally distributed regions using 
the Mann-Whitney U-test.
Correlations were assessed using Pearson’s r. To assess correlated activity between regions, for each brain 
region pair we included all animals with cell count data available for both regions. Correlation coefficients were 
calculated separately for control and defeated groups, pairing each brain region with each of the other brain 
regions.
All p-values were assessed against a two-tailed α-level of 0.05 to determine significance. SPSS Statistics version 
24 (IBM) was used for all analyses. The Benjamini Hochberg procedure was used for correcting multiple compar-
isons for false discoveries61.
Data availability Statement. All data are available from the corresponding authors upon request.
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Chronic psychosocial stress is a well-established risk factor for anxiety disorders, but the development of targets for
therapeutic intervention is limited by ignorance of the underlying molecular and cellular mechanisms. We used inbred
genetically defined mice to identify neurobiological pathways that underlie stress-induced social avoidance (SA), a
type of anxiety. We found genetically controlled differences in myelin-related gene expression in stress-exposed mice,
with concurrent differences in myelin thickness, suggesting that myelin plasticity is a major stress response of the
brain. The adaptive response to stress may increase or decrease myelin thickness, depending on the demands of the
specific circuit. Our findings provide a foundation for the identification of specific genetic regulators of chronic
stress-induced myelin plasticity.
New Research
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Anxiety disorders often manifest in genetically susceptible individuals after psychosocial stress, but the mech-
anisms underlying these gene-environment interactions are largely unknown. We used the chronic social defeat
stress (CSDS) mouse model to study resilience and susceptibility to chronic psychosocial stress. We identified a
strong genetic background effect in CSDS-induced social avoidance (SA) using four inbred mouse strains: 69%
of C57BL/6NCrl (B6), 23% of BALB/cAnNCrl, 19% of 129S2/SvPasCrl, and 5% of DBA/2NCrl (D2) mice were
stress resilient. Furthermore, different inbred mouse strains responded differently to stress, suggesting they use
distinct coping strategies. To identify biological pathways affected by CSDS, we used RNA-sequencing (RNA-
seq) of three brain regions of two strains, B6 and D2: medial prefrontal cortex (mPFC), ventral hippocampus
(vHPC), and bed nucleus of the stria terminalis (BNST). We discovered overrepresentation of oligodendrocyte
(OLG)-related genes in the differentially expressed gene population. Because OLGs myelinate axons, we
measured myelin thickness and found significant region and strain-specific differences. For example, in resilient
D2 mice, mPFC axons had thinner myelin than controls, whereas susceptible B6 mice had thinner myelin than
controls in the vHPC. Neither myelin-related gene expression in several other regions nor corpus callosum
thickness differed between stressed and control animals. Our unbiased gene expression experiment suggests
that myelin plasticity is a substantial response to chronic psychosocial stress, varies across brain regions, and is
genetically controlled. Identification of genetic regulators of the myelin response will provide mechanistic insight
into the molecular basis of stress-related diseases, such as anxiety disorders, a critical step in developing
targeted therapy.
Key words: anxiety; chronic social defeat stress; inbred mouse strain; myelin; RNA-sequencing; transmission
electron microscopy
Introduction
Anxiety disorders, including panic disorder, social anx-
iety disorder, specific phobias, and generalized anxiety
disorder, are the most common mental disorders with a
prevalence of 14% (Wittchen et al., 2011). Human genetic
studies of anxiety disorders have confirmed a modest
heritability and considerable environmental component
(Hettema et al., 2001). However, identification of repli-
cated risk variants is challenging due to genetic hetero-
geneity, environmental factors that cannot be well-
controlled in human settings, and poor availability of large
patient cohorts with accurate phenotypes (Hovatta and
Barlow, 2008; Smoller, 2016). Consequently, many inves-
tigators have resorted to animal models, which allow
controlled experiments on both genetic and environmen-
tal risk factors, to reveal the biological mechanisms un-
derlying these diseases.
Chronic psychosocial stress is a well-established risk
factor for anxiety disorders (Kemeny and Schedlowski,
2007; Moffitt et al., 2007; Donner et al., 2012). It can be
modeled in mice by the chronic social defeat stress
(CSDS) paradigm, that has etiological, predictive, and
face validity for affective and anxiety disorders (Hammels
et al., 2015). It leads to social avoidance (SA) and long-
term plastic changes in the brain (Avgustinovich et al.,
2005; Krishnan et al., 2007). However, only a portion of
mice exhibit SA after CSDS, and thus the defeated ani-
mals can be divided into stress-susceptible and resilient.
Comparison of these groups allows investigation of the
mechanistic basis of stress-induced SA and anxiety-like
behavior and resilience to it. Understanding the underly-
ing risk factors and promotion of the resilience factors in
susceptible individuals should facilitate development of
secondary prevention methods of anxiety disorders after
traumatic events, and selective pharmacological treat-
ment of anxiety (Howlett and Stein, 2016).
Most insight into the molecular mechanisms of CSDS
comes from the C57BL/6 mouse strain, in which specific
genetic, epigenetic, and neurophysiological mechanisms
underlie stress susceptibility and resilience (Han and Nes-
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tler, 2017). Because genetic background strongly modu-
lates mouse behavior (Threadgill et al., 1995; Hovatta
et al., 2005; Sittig et al., 2016), hypotheses of any mech-
anisms should be tested across different mouse strains.
Such studies are also critical for translating the results to
genetically heterogeneous humans. CSDS has different
behavioral and physiologic consequences in C57BL/6J
and BALB/c strains (Razzoli et al., 2011a,b; Savignac
et al., 2011), reflecting underlying genetic, and by exten-
sion, gene expression differences between the strains.
Therefore, comprehensive unbiased transcriptomic ap-
proaches applied to mouse strains with different responses
to CSDS should reveal gene-environment interactions that
explain why some individuals are more susceptible to
stress-induced maladaptive behaviors than others.
To examine how genetic background affects the behav-
ioral response to chronic stress, we performed behavioral
testing in four inbred mouse strains after CSDS. We selected
C57BL/6NCrl (B6) and BALB/cAnNCrl (BALB) strains, which
differ in behavioral and metabolic responses to CSDS
(Razzoli et al., 2011a,b; Savignac et al., 2011), and DBA/
2NCrl (D2) and 129S2/SvPasCrl (129) as they are sensitive to
stress-induced anxiety- and depression-like behavior in
general (Ducottet and Belzung, 2005; Millstein and Hol-
mes, 2007). To identify the major underlying biological
pathways, we performed unbiased transcriptomic analy-
sis in the B6 and D2 strains that showed the largest
differences in susceptibility to stress. We studied three
brain regions, the medial prefrontal cortex (mPFC), ventral
hippocampus (vHPC), and bed nucleus of the stria termi-
nalis (BNST), which critically regulate anxiety and the
stress response (Garakani et al., 2009; Calhoon and Tye,
2015; Tovote et al., 2015), and are activated by CSDS
(Vialou et al., 2014; Laine et al., 2017). In the follow-up
gene expression and histologic analyses, we found that
myelination was significantly altered after stress in a strain
and brain region-dependent manner. Our results illustrate
that genetic background has a large effect on both the
behavioral and brain transcriptomic response to chronic
psychosocial stress. Moreover, we demonstrate that the
pattern of stress-induced myelination changes is depen-




We ordered five-week-old male mice from four inbred
strains [DBA/2NCrl (D2), 129S2/SvPasCrl (129), BALB/
cAnNCrl (BALB), and C57BL/6NCrl (B6); Charles River
Laboratories] for all CSDS experiments and let them ac-
climatize for 10 d before CSDS, housed in groups in a
temperature (22  2°C) and humidity (50  15%) con-
trolled facility on a 12/12 h light/dark cycle (lights on 6
A.M. to 6 P.M.). From the end of CSDS to the time of
dissection, all mice were single-housed. As aggressors for
CSDS, we used male Clr-CD1 mice (CD1, Charles River
Laboratories), aged 13–26 weeks. All mice had ad libitum
access to food and water throughout the experiment,
except for the durations of behavioral tests. Aspen chip
bedding (Tapvei Oy) in the cages was changed weekly
(except for the duration of the CSDS) and standard envi-
ronmental enrichment [aspen strips as nesting material
(Tapvei Oy) and an aspen brick (Tapvei Oy)] was provided
throughout the experiment. Animal procedures were ap-
proved by the Regional State Administration Agency for
Southern Finland (ESAVI-3801-041003-2011 and ESAVI/
2766/04.10.07/2014) and conducted in accordance to
directive 2010/63/EU of the European Parliament and of
the Council, and the Finnish Act on the Protection of




We conducted CSDS as previously described (Golden
et al., 2011; Laine et al., 2017). Briefly, aggressor CD1
mice were first checked for appropriate aggression levels
during a 3-d screening before all social defeat experi-
ments. The selected aggressors had to meet the following
criteria: attack in at least two consecutive sessions, had
latency to attack of 90 s and do not attack within 1–5 s
in any of the sessions. For CSDS, each defeated mouse
was placed into the cage of an aggressor mouse for max.
10 min. The mouse was then transferred to another com-
partment of the cage, separated from the aggressor by a
perforated Plexiglas wall, for 24 h. This procedure was
repeated for 10 d, and each day the experimental mouse
encountered a novel aggressor. Physical contact time
was shortened in the case of severe physical aggression.
Control mice were housed in similar cages but with an-
other control mouse as a cage-mate, and without physical
contact, switching cage-mates daily. The day after the
last defeat session, all mice were separated into single-
housed cages and maintained like this until dissection.
The order of testing for all consecutive behavioural tests
was randomized.
SA test
Twenty-four hours after the last social defeat session,
at the start of the dark phase of the light cycle, we tested
both defeated and control mice in the SA test. All animals
were brought to the experiment room at least 30 min
before the start of the test, and animals performing the
test were separated from experimenters and the remain-
ing animals by a screen. For the first trial (no-target), the
mouse was placed in the center of an open arena (42  42
cm) with an empty perforated Plexiglas cylinder located
next to one of the walls. The movements of the mouse
were tracked using a camera and EthoVision XT10 soft-
ware (Noldus Information Technology) for 150 s, after
which the mouse was placed back into the home cage.
The arena was cleaned and the Plexiglas cylinder was
replaced with another one containing an unfamiliar CD1
social target mouse. The test mouse was then placed
back in the middle of the arena and tracked for 150 s
(target trial). The amount of time the mice spent in the
interaction zone (IZ), defined as a semicircle (370 cm2)
around the perforated Plexiglas cylinder, was measured
and a social interaction (SI) ratio calculated by dividing the
IZ time of the social target trial with the IZ time of the
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no-target trial, multiplied by 100. Thus, a low SI ratio
indicates high SA.
To account for strain differences in baseline social be-
havior, we assessed the response of defeated mice in
relation to same-strain controls, following the statistical
approach previously implemented by Nasca et al. (2015).
We calculated mean SI ratios of control mice from each
strain based on several cohorts (n: 129  8, BALB  40,
B6  126, D2  114). We used log-transformation to
normalize the distribution, removed outliers (3 IQRs
from the median), and divided the defeated mice to
stress-resilient (resembling controls) and susceptible
(showing SA) based on SI ratios, with the border deter-
mined as the controls’ mean score minus 1 SD. SI ratio
border values for each strain were: 129  62.68, BALB 
81.76, B6  76.49, D2  105.99.
Body weight
Body weight was recorded at the beginning of CSDS
(day 1) and on every second day throughout the CSDS
(days 2, 4, 6, 8, and 10). The amount of body weight gain
was calculated as the difference between the first and the
last measurement.
Open field (OF) test
We assessed spontaneous locomotor activity and
anxiety-like behavior with an automatic MedAssociates sys-
tem at the start of the light phase of the light cycle. Individual
mouse cages were brought to the experimental room in two
groups. After 30 min adaptation to the experimental room (lit
at 100 lux), the mouse was released to the corner of the
experimental chamber (27  27  20 cm, transparent walls
and white floor virtually divided into a 19  19 squares grid)
and allowed to explore freely for 5 min.
Elevated zero maze (EZM)
EZM was performed at the start of the light phase of the
light cycle. All animals were brought to the experiment
room at least 30 min before the test, and animals per-
forming the test were separated from experimenters and
the remaining animals by a screen. The apparatus consisted
of plastic annular runway (diameter  50 cm, width  5 cm)
elevated 40 cm above the floor. The runway was divided into
four sectors: two open sectors opposing each other and two
opposing closed sectors protected by inner and outer non-
transparent walls (height  15 cm). After 30 min of adapta-
tion to the experimental room (dimly lit at 15–20 lux), the
mouse was placed in the middle of one of the closed sectors
and allowed to explore the maze freely for 5 min. The mouse
was video-tracked with EthoVision XT10.
Forced swim test (FST)
All animals were brought to the experiment room at
least 30 min before the test, and animals performing the
test were separated from experimenters and the remain-
ing animals by a screen. After adaptation to the experi-
mental room (150 lux), the mouse was placed in a glass
cylinder (diameter  18 cm, height  25 cm) filled with
water (room temperature) to the height of 15 cm. The
immobility time (passive floating) was detected with Etho-
Vision XT10 system for 6 min with 2-min time bins. Data
from the last 4 min were used.
Gene expression profiling
Dissections
We dissected the mPFC (B6: Con n  6, Res n  6, Sus
n  6; D2: Con n  6, Sus n  8), BNST (B6: Con n  5,
Res n  5, Sus n  5; D2: Con n  5, Res n  3, Sus n
 5), and vHPC (B6: Con n  6, Res n  8, Sus n  3; D2:
Con n  6, Sus n  5) 6–8 d after the last CSDS (mice
aged eight weeks). Mice were killed by cervical disloca-
tion between 8 and 11 A.M. to avoid circadian differences
in gene expression, and the order was counterbalanced
across groups (resilient, susceptible, and control mice).
Dissections were performed on a sterile chilled Petri dish
within 7 min, and tissue was flash frozen in liquid N2.
RNA-sequencing (RNA-seq)
Total RNA was extracted with TriReagent (Molecular
Research Center Inc.) and RNA quality was assessed with
a 2100 Bioanalyzer (Agilent Technologies) using Agilent
RNA 600 Nano Chip kit (Agilent Technologies). rRNA was
depleted with Ribo-Zero Gold rRNA Removal kit (Illumina
Inc; mPFC and vHPC) or custom Insert Dependent Adap-
tor Cleavage (InDA-C) primers (BNST). RNA was frag-
mented using the S2 ultrasonicator (Covaris Inc.) and
sequencing libraries were prepared with Nextera (Illumina;
vHPC), ScriptSeq v2 (Epicentre; mPFC), or Ovation Uni-
versal RNA-Seq System (NuGEN; BNST) RNA-seq library
preparation kits. Libraries were size-selected with Pippin
Prep (Sage Science) and sequencing was conducted
on HighSeq 2000 (vHPC, paired-end 91 bp, Illumina) or
NextSeq 500 platforms (mPFC and BNST, single-end 96
bp; Illumina).
The RNA-seq reads were trimmed for adapters with
Cutadapt v1.8.3 (vHPC) and FastX toolkit (mPFC, BNST)
and PCR duplicates were removed with PRINSEQ
v0.20.4. Reads were aligned using STARv 2.5.0c (Dobin
et al., 2013) with default settings to mouse genome
GRCm38, and annotated to gene exons with HTSeq
v0.6.1 (Anders et al., 2015) using GTF release 86 (update
2016-10).
Differential expression (DE) analysis
DE analysis was conducted using limma eBayes
(Ritchie et al., 2015; Phipson et al., 2016) comparing
resilient and susceptible mice to same-strain controls
within brain regions. RNA-seq data were filtered to re-
move low-abundance genes, keeping genes with at least
1 count per million (CPM) in at least six samples (Anders
et al., 2015). Subsequently, the data were normalized with
voom (Law et al., 2014), and adjusted for sequencing
(vHPC) and library preparation batches (vHPC, mPFC,
and BNST) with ComBat (Johnson et al., 2007). To identify
top DE genes, we calculated -log10(p)logFC for each
gene and ranked them accordingly (Xiao et al., 2014).
Gene expression data are available in Gene Expression
Omnibus (GEO; GSE109315).
Rank-rank hypergeometric overlap (RRHO) test (Plaisier
et al., 2010)
RRHO infers pair-wise similarity between two DE result
lists, where genes are ranked by DE (-log10(p)logFC)
between resilient and control, or between susceptible and
control mice, by calculating significance of overlapping
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genes at different rank bins (Plaisier et al., 2010). We used
step size of 100 genes to bin the genes and applied the
same -log(p) scale to comparisons within brain regions.
Significant overlap of genes in rank groups containing up-
and downregulated genes in both lists (lower left corner
and upper right corner of square matrix, respectively, see
Fig. 2C,D) shows a shared transcriptome-wide gene ex-
pression pattern in response to CSDS.
Gene set enrichment analysis (GSEA)
We conducted GSEA using the GSEA Preranked mod-
ule implemented in GSEA Desktop v3.0 (Mootha et al.,
2003; Subramanian et al., 2005) and the curated gene
sets (C2) of the Molecular Signature Database (MSigDB)
v6.0 (http://www.broad.mit.edu/gsea/). The pre-ranked
GSEA was performed with 1000 permutations. The top
five gene sets with the highest positive and negative
normalized enrichment scores (NESs; pFDR  0.05) within
each comparison were selected for further analysis. From
the selected top up- and downregulated gene sets, all
present in at least two comparisons and two brain regions
were visualized using Circos software (Krzywinski et al.,
2009). The overlap between the top enriched gene sets,
presented on the Circos plot, was further investigated
with the hypergeometric test implemented in the MSigDB
v6.0.
Gene ontology (GO) term enrichment
We analyzed GO term enrichment separately for top
300 upregulated and 300 downregulated differentially ex-
pressed genes from each comparison with topGO (Alexa
et al., 2006), using the weight01 model to account for GO
term dependencies. In RNA-seq, long transcripts yield
more read counts and are more easily passed through
low-abundance filtering than short genes with the same
expression level, and genes with high number of counts
have greater statistical power being detected as DE than
genes with low number of counts. To minimize these
selection biases (Young et al., 2010), we matched the
background genes, i.e., the gene universe used to com-
pare the top DE genes with, with the top DE genes using
R package genefilter (Gentleman et al., 2017), resulting in
6882 (290 SEM) background genes.
Visualizing oligodendrocyte (OLG) progenitor cell (OPC)
and OLG marker genes
We manually curated a list of OPC and OLG-specific
marker genes, based on prior publications (Zhang et al.,
2014; Marques et al., 2016). Figures were constructed
based on previously published scripts (Haarman et al.,
2014).
q-RT-PCR
q-RT-PCR was applied to validate five myelin-related
genes from RNA-seq. We used published primers to am-
plify Mobp and Plp1 (Liu et al., 2012) and designed primer




GATGGCCTGGTGAACAACGA), and Mbp (ACACAC-
GAGAACTACCCATTATGG, AGAAATGGACTACTGGG
TTTTCATCT). RNA samples of mPFC and BNST were the
same as used in RNA-seq, and for vHPC samples over-
lapped by 37.5% (12/32 samples); 250 ng of DNase I
(Thermo Scientific)-treated total RNA was converted to
cDNA with iScript select cDNA synthesis kit (Bio-Rad
Laboratories) and amplified with 250 nM primers in
CFX384 Real-Time PCR cycler using IQ SYBR Green
supermix (Bio-Rad Laboratories). Expression levels were
normalized to Ppib (GGAGATGGCACAGGAGGAAA,
CCCGTAGTGCTTCAGCTTGAA). Each reaction was run
in triplicate and relative expression level was calculated
using a standard curve (7.15, 10.0, 5.0, 2.0, 1.0, 0.5, and
0.25 ng of cDNA) present on each assay plate with CFX
Manager (Bio-Rad Laboratories). Statistical analysis
(Pearson’s r) was conducted with GraphPad Prism v7.02
(GraphPad Software Inc.).
Immunohistochemistry
Mice were anaesthetized 6–8 d after CSDS with a lethal
dose of pentobarbital (Mebunat Vet 60 mg/ml, Orion
Pharma) and transcardially perfused with 4% paraformal-
dehyde (PFA) in PBS. After postfixation in 4% PFA over-
night (4°C), the brains were cut into 20-m coronal
sections using a Leica VT-1200S vibratome (Leica Bio-
systems) and stored at –20°C free-floating in cryopro-
tectant. Sections were washed 3 in PBS and mounted
on Superfrost Ultra Plus (ThermoFisher Scientific) slides.
We performed antigen retrieval by submerging the slides
in 0.01 M citrate buffer, heated to a boil for 20 min. Slides
were blocked in 2.5% BSA in 0.5% PBST  7.5% normal
goat serum, followed by primary antibody incubation
with mouse anti-CNPase (1:250, Merck Life Science,
#MAB326R) overnight at 4°C. Slides were washed in
PBS before goat anti-mouse Alexa Fluor 488 secondary
antibody incubation (1:400, ThermoFisher Scientific, #A-
11029) for 2 h at room temerture. After washing in PBS,
we coverslipped the slides with Vectashield  DAPI
mounting medium (Vector Laboratories, #H-1200). We
acquired images with ZEISS Apotome.2 system (Zeiss)
and analyzed them with ImageJ software (National Insti-
tutes of Health). We measured corpus callosum thickness
on both sides of the midline from each section (two to six
sections per animal, distance from bregma between 0.22
and -0.10) using ImageJ, and calculated their mean.
Transmission electron microscopy (TEM)
Mice were anaesthetized 6–8 d after CSDS with a lethal
dose of pentobarbital (Mebunat Vet). We transcardially
perfused the mice with PBS followed by fixation with 100
ml 2% glutaraldehyde (GA)/2% PFA in 0.1 M sodium
cacodylate (NaCac) buffer (GA, PFA, and NaCac: Sigma
Aldrich), heated to 37°C. The brains were postfixed in
the same fixative for 2–4 h and immersed in 0.1 M NaCac
buffer for 2–24 h, both at 4°C. We cut them into 200-m
sagittal slices with a Leica VT-1200S vibratome (Leica
Biosystems) in 0.1 M phosphate buffer. Regions of the
mPFC, BNST, and vHPC were cut manually by using
anatomic landmarks (Extended Data Fig. 5-1).
We postfixed the sections in osmium tetroxide [1%,
1.5% K4[Fe(CN)6] in 0.1 M NaCac] for 2 h at 4°C,
stained en bloc with uranyl acetate for 1 h at 4°C,
dehydrated with EtOH and acetone, and embedded them
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into hard Epon; 60- to 70-nm sections were cut with an
ultramicrotome and placed on copper grids for micros-
copy and stained with lead citrate. We imaged the ultra-
thin sections using a Jem-1400 transmission electron
microscope (Jeol) and randomly selected and imaged
myelinated axons at 5000 magnification.
We measured myelin thickness, axon diameter, and g
ratio using ImageJ. We calculated the diameter by mea-
suring the area of the whole fiber and the area of the axon
(inside the compacted myelin sheath). The diameters of
geometric circles with the same areas were calculated for
both parameters. We calculated the g ratio by dividing the
diameter of the axon with the diameter of the whole fiber.
Myelin thickness was measured at three fully compacted
positions and their average calculated.
Statistical analysis
Statistical analyses were conducted with SPSS Statis-
tics 24 (IBM) or GraphPad Prism 7.02 (GraphPad Software
Inc.). Planned post hoc comparisons (control vs resilient,
control vs susceptible, and resilient vs susceptible) were
conducted by Fisher’s LSD. For these tests we report
nominal p values, evaluated for significance against an
-level adjusted for multiple corrections with test-wise
Bonferroni correction (Table 1). Only p values which sur-
vive this correction are shown.
Group differences in TEM data were assessed using
generalized estimating equations (GEEs) to control for
within-subject dependencies of individual axons mea-
sured from the same animal (ranges for each region:
mPFC  93–104, BNST  31–69, and vHPC  54–62
axons per animal). We selected this approach due to the
low number of animals per group, which could not be
reliably analyzed by ANOVA. GEE has been proposed as
a suitable approach for analyzing data with non-
independent features (Hanley et al., 2003), such as axons
measured from the same individual. Pair-wise contrasts
were computed for comparing groups with Fisher’s LSD
and significance determined against the Bonferroni cor-
rected -level as above.
Data analysis of RNA-seq data were performed as de-
scribed above. Multiple testing correction was done by
the Benjamini–Hochberg method (Benjamini and Hoch-
berg, 1995).
Results
Genetic background influences behavioral response
to CSDS
To determine whether genetic background affects the
behavioral response to psychosocial stress, we con-
ducted 10-d CSDS in mice from four inbred strains, D2,
129, BALB, and B6 (Fig. 1A). Twenty-four hours after the
last defeat session, we conducted the SA test to assess
their SA phenotype. To account for the strain differences
in baseline social behavior during SA test, we evaluated
the response of defeated mice in relation to same-strain
controls. We divided the defeated mice into stress-
susceptible and resilient groups, considering mice with SI
ratios within 1 SD, or above, of the same-strain control
mean as resilient (i.e., resembling the control mice), and
those with the SI ratio below 1 SD from the mean as
susceptible. We observed a significant difference in the
distribution of susceptible and resilient mice between the
strains (2  63.401, p  1.102  1013), with the B6
defeated mice being mostly resilient and the 129, BALB,
and D2 mice mostly susceptible to stress (Fig. 1B). During
the social target trial of the SA test, susceptible mice from
all strains spent significantly less time in the IZ (Fig. 1C)
and more time in the corners of the arena (Fig. 1D) than
during the no-target trial.
We next determined how CSDS influences other behav-
iors. To assess locomotor behavior, we measured the
distance moved during the no-target trial of the SA test
(Fig. 1E) and the OF test (Fig. 1F). B6 and D2 defeated
mice moved significantly less than control mice during
both tests. We did not observe differences in distance
traveled between defeated and control 129 or BALB mice.
For the B6 strain, we also performed the EZM and FST to
assess anxiety-like and despair behavior, respectively.
Susceptible mice showed increased anxiety-like, but not
despair behavior, compared to controls (Fig. 1G,H). To
study metabolic effects of CSDS, we measured body
weight before and after CSDS (Fig. 1I). All B6 mice gained
weight (mixed ANOVA post hoc comparison before versus
Table 1. Statistical table
Figure Data structure Statistical test
Statistical
significance ()
1B Categorical data 2 0.05
1C Normal distribution Mixed ANOVA 0.0167
1D Normal distribution Mixed ANOVA 0.0167
1E Normal distribution One-way ANOVA 0.0167
1F Normal distribution One-way ANOVA (129, BALB and B6 strains), independent t test (D2 strain) 0.0167
1G Normal distribution One-way ANOVA 0.0167
1H Normal distribution One-way ANOVA 0.0167
1I Normal distribution One-way ANOVA (group comparisons), mixed ANOVA (within-group
comparison of weight before and after CSDS)
0.0167
4A–F Normal distribution Mixed ANOVA 0.003 (B6)
0.01 (D2)
4H,I Normal distribution One-way ANOVA 0.0167
5A–L Normal distribution Generalized estimating equations (GEEs) 0.0167
Outline of statistical tests and significance levels applied for each experiment.
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after CSDS: controls p  9.98  1028, resilient p  2.21
 1026 and susceptible p  6.23  1020). BALB and
129 controls gained weight (p  4.90  105 and p 
0.012, respectively), while the weight of the defeated mice
of these strains did not change during CSDS. Both D2
resilient and susceptible mice lost weight (p  0.004 and
p  2.53  106, respectively).
Oligodendrocyte (OLG)-related genes are
differentially expressed in response to stress
To establish which biological pathways were affected
by chronic stress, we conducted RNA-seq one week after
CSDS in mPFC, vHPC, and BNST (Fig. 2A Extended Data
Fig. 2-1). We selected the B6 and D2 strains for this
analysis as they represented the phenotypic extremes in
the proportions of susceptible and resilient mice. We were
not able to analyze gene expression levels of resilient D2
mice for mPFC and vHPC due to low number of animals
in this group. We always compared the stress-susceptible
or resilient mice to the same-strain controls. We first
determined the overlap of the top 300 up- and downregu-
lated genes between the strains in each brain region (Fig.
2B; Extended Data Fig. 2-2), followed up by the RRHO
analysis, which shows the overall similarity and direction
of DE of all genes (Fig. 2C,D; Extended Data Fig. 2-3). In
the mPFC, only 26 (2.2%) of the top differentially ex-
pressed genes between the susceptible versus control
mice were shared between the B6 and D2 strains, and the
RRHO analysis confirmed the highly divergent stress re-
sponse of the two strains. In the BNST, the transcriptomic
response of the two strains was marginally more similar as
resilient B6 and D2 mice shared 67 (5.9%), and suscep-
Figure 1. Strong genetic background effect on the behavioral response to CSDS. A, Timeline of experiments. Each perpendicular line
represents 1 d. B, SI ratios of the four strains in the SA test. Pie charts represent the proportion of resilient and susceptible mice in
each mouse strain. 129, BALB, and D2 strains were highly susceptible to CSDS, while B6 strain was the most resilient to CSDS. Time
spent in the IZ (C) and the corner zones (D) of the SA test during sessions with no social target (N) and a CD1 mouse as a social target
(T). Susceptible mice of all strains spent less time in the IZ when the target was present compared to when it was not. E, Distance
traveled during the no-target trial of the SA test. In the B6 strain, both susceptible and resilient mice had lower locomotor activity, while
in the D2 strain only susceptible mice moved significantly less than controls; n (B–E, I)  129: Con  7, Res  3, Sus  13; C: Con 
34, Res  10, Sus  33; B6: Con  72, Res  70, Sus  32; D2: Con  39, Res  2, Sus  40. F, Distance traveled during the 5-min
OF test. B6 resilient and D2 susceptible mice traveled significantly shorter distances than their same-strain control mice; n  129: Con
 7, Res  3, Sus  13; C: Con  18, Res  6, Sus  19; B6: Con  20, Res  19, Sus  4; D2: Con  19, Res  1 (not analyzed),
Sus  22. G, Time B6 mice spent in the open area of the EZM. Susceptible mice spent significantly less time in the open zones
compared to controls; n: Con  20, Res  29, Sus  11. H, Immobility time of B6 mice during minutes 2–6 of the FST did not differ
between groups; n  Con  28, Res  32, Sus  21. I, Difference in body weight before and after CSDS. B6 defeated mice gained
weight during CSDS similarly to their same-strain controls, BALB susceptible mice gained significantly less weight than controls, and
both resilient and susceptible D2 mice lost weight. All figures depict mean  1 SEM; p  0.05, p  0.01, p  0.001, see
Extended Data Figure 1-1 for exact p values. D2: DBA/2NCrl strain; BALB: Balb/cAnNCrl; 129: 129S2/SvPasCrl; B6: C57BL/6NCrl;
Con: control; Res: resilient; Sus: susceptible; mPFC: medial prefrontal cortex; BNST: bed nucleus of the stria terminalis; vHPC: ventral
hippocampus.
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Figure 2. RNA-seq implicates OLG-related gene expression changes after CSDS. A, Regions dissected for RNA-seq from D2 and B6
mice (for sample and RNA-seq details, see Extended Data Fig. 2-1). B, Overlap of 300 top downregulated and 300 top upregulated
genes between stressed and control mice, separately for each brain region (see Extended Data Fig. 2-2 for top 300 differentially
expressed genes and Extended Data Fig. 2-3A,B for overlap separately for upregulated and downregulated genes). C, Key to RRHO
showing a hypothetical heatmap of two identical datasets (“FC sample 1 versus control” and “FC sample 2 versus control”). Following
differential gene expression analysis, genes were ranked by their fold change (FC) and assigned to bins of 100 genes. Overlap of
genes was then compared between each ranking matched bin of “sample 1 versus control” and “sample 2 versus control.” Heatmap
color represents the significance of the overlap [-log10(p)] of genes between bins. Thus significant p values in the bottom-left corner
indicate that the two datasets have shared upregulated genes, significant p values in the top-right corner indicate shared
downregulated genes, and significant p values in the middle indicate genes not differentially expressed or with small FC. Significant
p values in the top-left or bottom-right corner represent genes regulated in opposite directions between the two datasets. D, RRHO
shows significant similarity in the gene expression response to CSDS between resilient and susceptible mice within strains (B6 mPFC
and vHPC, D2 BNST) and between susceptible mice of B6 and D2 strains (vHPC). Scale bar  –log(p) of rank classes (n  100), for
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tible B6 and D2 mice shared 101 (9.2%) of the top genes.
We detected the greatest overlap of the gene expression
response between the strains in the vHPC, where B6- and
D2 susceptible mice shared 390 (48.1%) of the top genes.
Unlike in the mPFC or BNST, the stress effect was stron-
ger than the strain effect in the vHPC. However, in the
vHPC, several genes were downregulated both in the B6
susceptible and resilient mice.
To ask which biological pathways were affected by
CSDS, we conducted GSEA and GO term enrichment
analysis. GSEA showed significant enrichment of several
gene sets (Extended Data Fig. 2-4), of which aging- and
OLG-related sets were enriched in nearly all comparisons
in all brain regions and both strains (Fig. 2E; Extended
Data Fig. 2-3C ). Although functionally diverse, the genes
included in the aging-related gene sets were significantly
overrepresented in the “Lein OLG Markers” gene set (pFDR
 1.2  1016). In accordance with GSEA, the most
enriched GO terms were related to myelination and OLG
development, in particular among the downregulated
genes of B6 susceptible mice in the mPFC (Extended
Data Fig. 2-5). These combined results from both enrich-
ment analyses prompted us to further investigate OLG-
related genes.
Mature OLGs develop from OPCs, which persist even in
the adult brain as committed precursors. We asked
whether either OPC or OLG cell populations dominantly
contributed to the observed DE. The transcriptomic sig-
nature associated with CSDS was stronger in the mature
OLG markers (Fig. 2G) than in the OPC markers (Fig. 2F).
To validate the RNA-seq findings, we analyzed Opalin,
Ermn, Mobp, Plp1, and Mbp gene expression levels with
q-RT-PCR in mPFC, BNST, and vHPC and found high
correlation with RNA-seq and q-RT-PCR measurements
of these myelination-related genes (mean r  0.82; Fig. 3).
Myelin-related variation after stress is not observed
globally in the brain
To test whether differences in myelin-related gene ex-
pression were observed across the brain, we measured
expression levels of Opalin, Ermn, Mobp, Plp1, and Mbp
in the whole cortex (lacking the mPFC), hypothalamus,
and dorsal hippocampus (dHPC) by q-RT-PCR. Using
mixed ANOVA we determined that there was no signifi-
cant main effect by the group (control, resilient or suscep-
tible) on myelin-related gene expression in any of the brain
regions of either strain. While Opalin expression was
lower in D2 susceptible mice compared to controls in the
hypothalamus as determined by post hoc comparison (p
 0.006), the expression levels of the other genes did not
differ between the stressed and control mice in any region
(Fig. 4A–F). We also measured the thickness of the corpus
callosum in brain sections stained with a myelin-binding
antibody (anti-CNPase) (Fig. 4G). We observed no differ-
ences in stress-susceptible or resilient mice compared to
controls (Fig. 4H,I).
Myelin thickness and g ratio differ in brain region
and genetic background-dependent manner
To determine whether CSDS affects myelination, we
conducted TEM of myelinated axons in mPFC, BNST, and
vHPC. In addition to analyzing axons of different diame-
ters within each brain region and stress group together
(Extended Data Fig. 5-2), we divided the axons to three
size groups given that different types of neuronal projec-
tions may differ in axon diameter (Fig. 5; Extended Data
Fig. 5-3). We discovered several brain region- and strain-
specific differences between stress groups in g ratio, i.e.,
the ratio of the inner axonal diameter to the total outer
diameter, myelin thickness, and axon diameter. Overall,
D2 resilient mice had higher g ratio and thinner myelin in
the mPFC compared to susceptible mice. B6 susceptible
mice had thinner myelin in the vHPC compared to con-
trols and thicker myelin in the BNST compared to resilient
mice (Extended Data Fig. 5-2). In addition to these general
findings, we found significant differences between stress
susceptible or resilient mice compared to controls in ax-
ons of certain diameter (Fig. 5). We also observed mod-
estly but significantly smaller axon diameter (without the
myelin sheath) in the mPFC of D2 susceptible mice com-
pared to controls (Extended Data Fig. 5-2).
Discussion
We established that the behavioral and brain transcrip-
tomic responses to chronic psychosocial stress are ge-
netically controlled. We discovered that BALB, 129, and
D2 mice were more susceptible to chronic stress than B6
mice. We demonstrated, by unbiased RNA-seq, that after
CSDS the most significantly affected gene sets and bio-
logical pathways in the mPFC, vHPC, and BNST were
related to myelination. Consistently, we observed signifi-
cant brain region and strain-dependent differences in my-
elin thickness after stress. Neither myelin gene expression
in other cortical regions or the dHPC, nor corpus callosum
thickness, differed between stressed and control mice,
suggesting no overall white matter changes due to CSDS.
continued
each brain region separately. E, Circos plot showing the top five enriched gene sets overlapping between the brain regions in
stress-resilient and susceptible mice compared to controls. Only normalized enrichment scores (NESs) achieving significance (pFDR
 0.05) are shown. A positive (or negative) NES for a given gene set indicates its overrepresentation at the top (or bottom, respectively)
of the ranked list of upregulated (or downregulated, respectively) genes. See Extended Data Figures 2-4, 2-5 for GSEA and GO
analyses, respectively; see Extended Data Figure 2-3C for expression FC for genes in the Lein OLG Markers gene set. F, G, Merged
heat map showing the expression FC (logFC) and significance (p) of OPC-specific (F) and OLG-specific (G) genes. B6: C57BL/6NCrl
strain; D2: DBA/2NCrl strain; Res: resilient; Sus: susceptible; mPFC: medial prefrontal cortex; BNST: bed nucleus of the stria
terminalis; vHPC: ventral hippocampus; Lu Aging Brain Up: LU_AGING_BRAIN_UP; Lein OLG Markers: LEIN_OLIGODENDROCYTE-
_MARKERS; Aging Up: DEMAGALHAES_AGING_UP; KEGG Ribosome: KEGG_RIBOSOME; Cancer: GINESTIER_BREAST_
CANCER_ZNF217_AMPLIFIED_DN.
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Figure 3. Strong correlation of gene expression levels of selected myelin-related genes determined by RNA-seq and q-RT-PCR. Box
plots show the gene expression levels of five myelin-related genes (Ermn, Opalin, Mbp, Mobp, and Plp1) measured by RNA-seq (voom
normalized number of reads, left y-axis, solid fill) and q-RT-PCR (right y-axis, striped fill). Pearson correlation coefficient (r) was
calculated across the five (mPFC, vHPC) or six (BNST) group means. Box plots show distribution of values from min to max. mPFC:
medial prefrontal cortex; vHPC: ventral hippocampus; BNST: bed nucleus of the stria terminalis; B6: C57BL/6NCrl: D2: DBA/2NCrl;
Con: control; Res: resilient; Sus: susceptible.
New Research 10 of 16
July/August 2018, 5(4) e0166-18.2018 eNeuro.org
We first established the CSDS paradigm in four inbred
mouse strains and demonstrated that genetic factors
control their adaptive behavior to stress. Consistently with
prior findings (Razzoli et al., 2011a; Savignac et al., 2011),
BALB mice were more sensitive to CSDS-induced SA
than B6 mice. Additionally, innately anxious D2 and 129
mice were also highly susceptible to CSDS, suggesting
that anxious strains may in general be stress-sensitive.
CSDS did not affect locomotor activity of 129 or BALB
mice, but both resilient and susceptible mice failed to gain
weight during the defeat period. By contrast, the defeated
D2 mice had lower locomotor activity than controls, and
they lost weight during defeat. Differently to the other
strains, the defeated B6 mice had lower locomotor activity
compared to controls but they gained weight during de-
feat, similarly to controls. We also investigated other be-
haviors in this strain, and found that the stress-
susceptible mice had increased anxiety-like behavior, but
no difference in despair behavior, as in previous studies
(Krishnan et al., 2007; Razzoli et al., 2011a). We acknowl-
edge that due to limitations of our animal facility, all mice
were brought into the experimental room together before
behavioral testing, where they stayed behind a screen
during the testing of other animals, possibly introducing
confounding factors. Overall, our results suggest that the
studied strains use different coping strategies to stress,
and that such behavior has a strong genetic basis.
In addition to different behavioral responses to CSDS,
we observed large differences in the brain transcriptomic
response to stress between B6 and D2 strains. mPFC and
BNST expression patterns were more similar within
strains, between the resilient and susceptible mice, than
between susceptible or resilient mice of different strains.
However, in vHPC, the transcriptomic response of B6 and
D2 susceptible mice was highly similar. This result may
reflect the different organization and roles of these three
brain regions in processing stress-related signals. It may
be that the vHPC relays primary information regarding
stress, while the BNST and mPFC may have more inter-
preting and processing roles, and therefore little genetic
variation is tolerated within the hippocampal stress
response. vHPC gene expression is influenced by gluco-
corticoids through glucocorticoid receptors, which are
strongly expressed in the hippocampus (Ahima and Har-
lan, 1990; Ahima et al., 1991; Gray et al., 2017). BNST
receives projections from several amygdalar nuclei and
mediates anxiety-related information to hypothalamic and
brainstem targets (Davis et al., 2010). The mPFC influ-
ences stress-associated social behavior by evaluation of
perceived threats, top-down control of goal-directed be-
havior (Carlén, 2017), and emotion regulation (Etkin et al.,
2015). These differences reflected on the transcriptomic
response to stress may contribute to the distinct coping
strategies of the strains.
We found significant enrichment of OLG- and aging-
related genes within the differentially expressed genes in
both strains and all brain regions. The highly significant
overlap between both of these gene sets suggests similar
changes in OLG-related gene expression may be associ-
ated with both aging and chronic psychosocial stress.
This OLG-related signal was derived mostly from genes
expressed in mature OLGs, which are the myelin-
Figure 4. No generalized effects on OLG-related gene expression or corpus callosum thickness after CSDS. A–F, Bar graphs showing
the normalized expression levels of myelin-related genes in the hypothalamus and two brain regions not critically influenced by CSDS
[cortex (without mPFC) and dHPC]. B6 and D2 mice were analyzed 6–8 d following CSDS. Myelin-related gene expression did not
differ between phenotype groups in any of the brain regions of either strain. Only Opalin was expressed at a lower level in the
hypothalamus of D2 susceptible mice compared to controls as shown by post hoc analysis. Mean  1 SEM is shown. G, H, CSDS
does not affect corpus callosum thickness in B6 or D2 mice. Myelin visualized by anti-CNPase staining. Atlas outline modified from
Franklin and Paxinos (2008); n  B6: Con  6, Res  5, Sus  4; D2: Con  6, Res  3, Sus  8. Error bars  min – max; D2:
DBA/2NCrl strain; B6: C57BL/6NCrl strain; Con: control; Res: resilient; Sus: susceptible; dHPC: dorsal hippocampus.
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Figure 5. CSDS influences g ratio, myelin thickness, and axon diameter as measured by TEM. A–F, Scatter plots of g ratio with mean
indexed by a horizontal line. G ratio was lower in medium sized BNST axons of B6 susceptible mice compared to both control and
resilient mice, and higher in all axon size categories in the mPFC of D2 resilient mice compared to susceptible mice. G–L, Bar graphs
of mean myelin thickness. Concurrently to g ratio measurements, B6 susceptible mice had thicker myelin on medium sized axons in
the BNST compared to resilient or control mice, and D2 resilient mice had thinner myelin on medium and large axons in the mPFC
compared to susceptible mice. Additionally, myelin was thicker in the small axons of the mPFC in B6 resilient mice compared to
controls and thinner in the small and large axons of the vHPC in B6 susceptible mice compared to controls; n  B6: Con  3, Res
 4, Sus  3; D2: Con  6, Res  3, Sus  5. Error bars  1 SEM. See Extended Data Figure 5-1 for schematics of dissected regions,
Extended Data Figure 5-2 for analyses without division of axons into size categories, and Extended Data Figure 5-3 for size category division
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producing cells in the central nervous system. Myelin
plasticity, a response of OLGs to neuronal activity (Gautier
et al., 2015; Koudelka et al., 2016; Purger et al., 2016;
Mitew et al., 2018), is retained in adulthood (Bengtsson
et al., 2005; McKenzie et al., 2014). Downregulation of
OLG-related genes was especially pronounced in the
vHPC, and also in the mPFC of B6 susceptible mice. On
the structural level, vHPC myelin sheaths of B6 suscepti-
ble mice were thinner than in control mice, concurring
with the downregulation of myelin-related genes. Interest-
ingly, in the BNST, B6 susceptible mice had thicker myelin
sheaths and smaller g ratio compared to both resilient and
control mice, also concurring with the gene expression
patterns. D2 susceptible mice had an opposite gene ex-
pression pattern in the BNST, which, however, was not
supported by changes in myelin sheath thickness or g
ratio. Opposite gene expression changes in different in-
bred mouse strains in response to stress have previously
been observed in other models, but the underlying mech-
anisms are not fully understood (Mozhui et al., 2010; Malki
et al., 2015). In mice, various stressors have diverse ef-
fects on myelination, likely reflecting involvement of dis-
tinct neural processes, developmental stage at the time of
stress exposure, and duration of stress. Early life stress
affects myelin-related gene expression in the mPFC
(Bordner et al., 2011; Makinodan et al., 2012), and myeli-
nation of the amygdala (Ono et al., 2008). In adult mice,
social isolation (Liu et al., 2012) and 14-d CSDS in sus-
ceptible mice (Lehmann et al., 2017) reduce myelin-
related gene expression and myelination within the frontal
cortex. Intermittent social defeat stress leads to reduced
MBP-stained myelin area in the mPFC (Zhang et al.,
2016). Corpus callosum myelination is decreased after
chronic restraint stress (Choi et al., 2017). Also chronic
variable stress induces temporally variable myelin-related
gene expression changes, and these changes were re-
gionally selective in the mPFC, nucleus accumbens, and
corpus callosum (Liu et al., 2018). Therefore, it is likely that
alterations in gene expression and physical parameters of
the myelin sheaths occur dynamically over days and
weeks (Montesinos et al., 2015; Almeida and Lyons,
2017), possibly explaining thicker myelin in B6 resilient
mice in the mPFC, without differences in myelin-related
gene expression compared to controls. Overall, our re-
sults concur with earlier studies and suggest that stress
does not simply cause widespread downregulation of
myelin-related genes or myelin loss, but that stress-
influenced myelin-plasticity involves specific stress-
associated brain circuits.
Our strategy to divide the stressed animals to suscep-
tible and resilient groups allowed identification of specific
patterns of myelination-related differences between these
groups. We observed that chronic stress associates with
thicker myelin in the susceptible (in the BNST of B6 mice)
and thinner myelin in resilient mice (D2 mPFC). No prior
studies exist, to our knowledge, on resilience-related my-
elin thinning. Although DTI measures are only considered
proxies for myelination, in humans, baseline fractional
anisotropy has been demonstrated to correlate positively
with state anxiety, but following exposure to a traumatic
event, correlation is negative (Sekiguchi et al., 2014).
Furthermore, increased fractional anisotropy, suggestive
of enhanced integrity, has been reported in the cingulate
gray matter of panic disorder patients (Han et al., 2008).
Also, the number of mature OLGs in the ventromedial PFC
of depressed subjects with childhood abuse is increased
(Tanti et al., 2017). Our results suggest that these complex
patterns are strongly modulated by genetic factors.
Although myelination studies on human anxiety disor-
ders and chronic stress are scarce, major depression has
been consistently associated with white matter disrup-
tions (Wang et al., 2014). Depressed suicide completers
with childhood abuse have impaired myelin-related gene
expression and reduced myelin thickness in the anterior
cingulate cortex (Lutz et al., 2017). Interestingly, this effect
was only seen in small caliber axons, similarly to our
finding of mPFC myelin thickness being larger in B6 re-
silient mice compared to controls. Axons of different di-
ameter may represent specific types of neurons (Perge
et al., 2012) and therefore be differentially vulnerable to
the effects of stress. For example, in the macaque cortex,
axons which project longer distance from the point of
origin have larger diameters than those projecting to prox-
imal targets (Innocenti et al., 2014). Based on the axon
diameters measured by TEM, it is not possible to infer the
type of neurons affected in our experiment but this ques-
tion could be addressed with immuno-electron micros-
copy.
How may structural changes in myelin affect behavior?
Myelin thickness is a key component in determining ax-
onal conduction speed, thereby influencing circuit func-
tion. Myelin deficient rats have altered conduction time
and lower average synchrony levels in the cerebellum
(Lang and Rosenbluth, 2003). Mice have increased syn-
chronous activity between the vHPC and mPFC in an
anxiogenic environment (Adhikari et al., 2010). Further-
more, in primates, increased power and phase synchrony
in the theta range has been detected in the amygdala-
prefrontal circuit during aversive conditioning (Taub et al.,
2018). Altered synchrony has also been recorded in hu-
man psychiatric disorders (Schulman et al., 2011; Leuch-
ter et al., 2015). Genetic factors affect synchronous
oscillations during sleep in the inbred mouse strains
(Franken et al., 1998; Tafti et al., 2003). The role of brain
oscillations in myelination and psychiatric phenotypes are
still poorly understood, but myelin plasticity may be a
mechanism that allows regulation of axonal conduction
and spatial connectivity.
Overall, our unbiased brain gene expression analysis
suggests that myelin plasticity is among the most signif-
icant responses to chronic psychosocial stress. Our strat-
egy to divide the mice into stress-susceptible and resilient
continued
criteria. All nominal p values surviving Bonferroni correction are shown. D2: DBA/2NCrl; B6: C57BL/6NCrl; mPFC: medial prefrontal cortex;
BNST: bed nucleus of the stria terminalis; vHPC: ventral hippocampus; Con: control; Res: resilient; Sus: susceptible.
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groups allowed us to demonstrate significant differences
in myelination-related gene expression and myelin thick-
ness between these groups. Furthermore, variable myelin
plasticity across brain regions suggests that chronic
stress has localized effects on myelination. Importantly,
by using two different inbred mouse strains we demon-
strated that stress-induced myelin plasticity is genetically
controlled. Identification of the genetic regulators of the
myelin response will provide mechanistic insight into the
molecular basis of stress-induced anxiety, a critical step
in developing targeted therapy for anxiety disorders.
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Abstract
Chronic stress is a common life experience that predisposes to many health problems, such as anxiety 
disorders. Myelin plasticity has recently been associated with the mammalian response to chronic stress.
However, it remains unknown which biological pathways stress influences in the myelin-producing 
cells (oligodendrocytes, OLGs). Here we used the chronic social defeat stress (CSDS) paradigm as a 
murine model of chronic psychosocial stress. We used mice from two inbred strains (C57BL/6NCrl and 
DBA/2NCrl) to investigate the effects of genetic background on stress responses. Following CSDS-
exposure mice can be classified as stress-susceptible (lower social interest than non-stressed controls) 
or -resilient (similar social behavior to controls). We used magnetic-activated cell sorting (MACS) to 
enrich OLGs and myelin from the medial prefrontal cortex (mPFC) of resilient, susceptible and control 
mice. The OLG and myelin transcriptomes differed significantly; 20 % of detected genes were enriched 
in OLGs while 25 % were enriched in myelin. These patterns were largely similar between the two 
strains; 64 % of the OLG-enriched and 71 % of the myelin-enriched genes were shared between strains.
To investigate the stress effect, we compared resilient and susceptible mice to their same-strain controls 
and each other. We found unique patterns of CSDS-associated differential expression in OLGs and 
myelin. For example, genes encoding myelin components (Mbp, Mobp) were downregulated in the 
myelin fraction of B6 susceptible mice, and in the OLG fraction of D2 resilient and susceptible mice 
compared to controls. Using the Ingenuity Pathway Analysis we discovered TCF7L2 to be a predicted 
inhibited upstream regulator in susceptible mice from B6 and D2 strains, and in D2 resilient mice. 
Among its predicted targets were several myelin component genes, such as Mbp and Mobp, which were 
downregulated in the aforementioned comparisons. To conclude, in addition to OLGs and myelin 
having non-identical gene expression patterns, they responded differently to stress, possibly converging 
on effects on the myelin sheath via expression of its target components. Furthermore, our data suggest




Myelin plasticity refers to adjustments to the properties of myelin sheaths, such as their thickness, length 
or quantity, occurring in response to changing environmental demands (Almeida & Lyons, 2017; 
Etxeberria et al., 2016; Gibson et al., 2014). It has been suggested to play a critical role in learning in 
mammals (Bengtsson et al., 2005; McKenzie et al., 2014), but also in maladaptive processes such as 
social isolation stress (Liu et al., 2012; Makinodan, Rosen, Ito, & Corfas, 2012). We showed recently 
that myelin-related genes are strongly differentially expressed in mice after chronic social defeat stress 
(CSDS), an extensively validated model of chronic psychosocial stress in mice. This effect was also 
dependent on the genetic background of the mice, and on whether they were stress-susceptible (i.e. 
showed lower social interest than same-strain controls) or –resilient (showed similar social interest as 
controls). Susceptible mice of the C57BL/6NCrl (B6) strain had lower expression levels than controls
of genes encoding myelin components, such as Mbp, Mobp and Plp1, in the medial prefrontal cortex 
(mPFC) and ventral hippocampus (vHPC), while susceptible mice from DBA/2NCrl (D2) did not. 
Additionally, myelin gene expression levels were higher in B6 susceptible compared to controls in the 
bed nucleus of stria terminalis (BNST), a region critically involved in anxiety-like and risk assessment 
behavior. Corpus callosum thickness or myelin gene expression in the rest of the cortex and dorsal 
hippocampus did not differ after CSDS. These findings suggest that stress susceptibility is not 
associated with global de- or hypomyelination, but rather with specific adaptations within key stress-
related neural circuits, consistent with the notion of myelin plasticity (Laine et al., 2018).
Also other studies using CSDS have shown differences in myelin-related features in stressed rodents 
compared to controls. For example, stress-exposed Balb/c and B6 mice have smaller myelin basic 
protein (MBP) stained area in the mPFC compared to controls (Lehmann, Weigel, Elkahloun, & 
Herkenham, 2017; H. Zhang et al., 2016). MBP is a highly abundant myelin protein localising to the 
myelin sheath, and it is used as a proxy for the amount of myelin influenced by both the number of 
sheaths and their thickness. Cathomas et al. (Cathomas et al., 2019) reported that CSDS reduced myelin 
gene expression in the mPFC and amygdala, but the numbers of oligodendrocytes (OLGs), the myelin-
producing cells in the CNS, remained unchanged by stress. Social isolation in both juvenile and adult 
mice associates with thinner myelin sheaths and lower expression of myelin-related genes in the mPFC 
(Liu et al., 2012; Liu, Dietz, Hodes, Russo, & Casaccia, 2018; Makinodan et al., 2012). Another chronic 
stressor, chronic unpredictable stress, results in lower abundance of MBP and OLIG2 proteins in the rat
hippocampus, and this feature was at least partially restored by physical exercise (Tang et al., 2019).
Thus, several converging lines of evidence associate myelin, particularly on the level of gene 
expression, with maladaptive consequences of stress.
Understanding how stress interacts with adult myelin is relevant for several chronic stress-related 
psychiatric disorders, such as anxiety disorders. Anxiety disorders are a heterogeneous diagnostic class 
characterized by pervasive and disproportionate worry and agitation, which may occur either generally 
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(generalized anxiety disorder), in response to specific stimuli (specific phobias) or in specific 
circumstances (social anxiety disorder). Both genetic factors and chronic psychosocial stress play a role
in disorder etiology, but their interaction is particularly important (Hoppen & Chalder, 2018). They 
often manifest in adolescents and young adults (Kessler, Ruscio, Shear, & Wittchen, 2010), an age at 
which the myelination of cortical grey matter is still ongoing (Kwon, Pfefferbaum, Sullivan, & Pohl, 
2020).
A key open question is whether and how stress impacts the functions of OLGs and myelin. 
Oligodendrocytes make use of both cell-type specific transcriptional programmes (such as maturation 
and myelin production) and non-specific programmes (such as Wnt/beta-catenin pathways, (Feigenson, 
Reid, See, Crenshaw, & Grinspan, 2009). Furthermore, the myelin compartment, while being an 
extension of the OLG, has a distinct proteome (Ishii et al., 2009) and transcriptome (Thakurela et al., 
2016) produced at least in part by selective transport of mRNAs to the distal parts of the membrane for 
local translation (Torvund-Jensen, Steengaard, Askebjerg, Kjaer-Sorensen, & Laursen, 2018).
Resolving if and how these fractions are impacted by stress is optimally done in a system that allows 
their separation, such as magnetic activated cell sorting (MACS).
We hypothesized that chronic psychosocial stress influences gene expression of OLG lineage cells and 
transport of transcripts to the myelin compartment of the OLGs. We set to test this hypothesis in the 
mPFC, a brain region that regulates anxiety and where we previously identified myelin-related changes 
after CSDS (Laine et al., 2018). To assess the effect of the genetic background on gene expression, we 
used mice from two inbred strains; B6 and D2. These strains differ in both innate anxiety-like behavior 
and response to stress (Hovatta et al., 2005; Laine et al., 2018). Additionally, to understand the 
differences between OLG and myelin fraction gene expression patterns, we compared them in non-
stressed control mice. To this end, we carried out RNA-seq of enriched OLG lineage cells and myelin.
Using bioinformatic analyses, we also identified potential upstream regulators of genes differentially 
expressed in susceptible and resilient mice compared to controls.
Materials and Methods
Chronic social defeat stress
Animal procedures were approved by the Regional State Administration Agency for Southern Finland 
(ESAVI/3119/04.10.07/2017) and carried out in accordance to directive 2010/63/EU of the European 
Parliament and Council, and the Finnish Act on the Protection of Animals Used for Science or 
Educational Purposes (497/2013). Throughout the experiment mice had ad libitum access to standard 
rodent chow and filtered tap water [except during the physical interaction phase of chronic social defeat 
stress (CSDS)]. Cages were outfitted with aspen chip bedding (Tapvei Oy, Harjumaa, Estonia) and 
standard environmental enrichment items (one aspen brick and a nest of aspen strips, both from Tapvei 
Oy). Bedding and enrichment items were changed weekly, except for during 10 day CSDS/control 
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housing. The animal housing facility was temperature (22 ±2 °C) and humidity (50 ±15 %) controlled, 
with a 12 h light/dark cycle (lights on 0600 – 1800).
Male mice [6 weeks old, C57BL/6NCrl (B6) and DBA/2NCrl (D2) strains, Charles River, Sulzfeld, 
Germany] were subjected to CSDS according to standard procedures (Golden, Covington, Berton, & 
Russo, 2011; Laine et al., 2018) for 10 consecutive days following a 10-day acclimatization period at 
the laboratory animal facility (group housed 4-6 mice/cage). Briefly, at the end of the light phase, mice 
were introduced into a cage containing a resident CD1 male mouse [Clr-CD1 (Charles River), aged 13-
26 weeks, screened for appropriate levels of aggressive behaviour] for a maximum of 10 min physical 
contact, and housed in an adjacent compartment of the same cage for 24 h (separated by a perforated 
Plexiglass wall). The physical contact phase was terminated before 10 min had elapsed if the mice 
incurred visible wounds, and all wounds were treated with antiseptic cooling spray (Dermacool, Virbac, 
Carros, France). Each day for 10 days the mice were introduced to a novel resident aggressor mouse. 
The mean durations of physical contact were 464 s for B6 mice and 266.3 s for D2 (no differences 
between resilient and susceptible mice within either strain, Student’s t-test, Supplementary Figure 1). 
Control mice were handled daily and housed in similar divided cages, but always with another control 
mouse on the other side, switching cage-mates daily but with no physical contact phases.
Twenty-four hours after the last day of CSDS, and the start of the dark phase, we performed the social 
avoidance test to determine the phenotype (resilient/susceptible to stress) of each defeated mouse. The 
mice were first allowed to explore an arena (42 x 42 cm) containing an empty perforated Plexiglass 
cylinder for 150 s (no-target trial). We placed the mice back into their home cages while the cylinder in 
the arena was replaced with one containing an unfamiliar CD-1 male mouse as a social target. The mice 
were then placed back into the arena for 150 s (target trial). The time spent in an interaction zone (IZ) 
around the circumference of the cylinder when there was a social target was divided by the time spent 
in the IZ when the cylinder was empty. Multiplying this score by 100 produces the social interaction 
(SI) ratio.
Based on previous experiments (Laine et al., 2018), we define as susceptible those mice which, after 
exposure to CSDS, had SI ratios below a boundary defined as the strain-specific control mean score 
minus 1 standard deviation. The boundary score for B6 mice is 76.49, and the boundary score for D2
mice is 105.99. All other mice were defined as resilient. Two defeated mice from the D2 strain and one 
from the B6 strain did not have SI ratios due to making no entries into the interaction zone (IZ) during 
the trial without a social target. However, these mice spent considerable time in the IZ during the social 
target trial, comparably to their strain-specific resilient mice, and were thus phenotyped as resilient 
(Supplementary Figure 1). 
Following the SA test all mice were housed in single cages until dissection.
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The weights of the mice were monitored throughout the experiment. Firstly, allocation to control or 
CSDS condition was counterbalanced for weight, with each group-housed cage contributing at least 1 
mouse to each condition and overall weight distributions between conditions maintained equal. Mice 
were also weighed on the 2nd, 4th, 6th, 8th and 10th day of CSDS/control housing, 1 day after the SA test, 
and on the day of dissection (Supplementary Figure 1). One mouse (D2) was euthanized and excluded 
from analyses due to loss of weight > 15 % from the first measurement.
For all experiments, mice were dissected 6-8 days following the last session of defeat. Mice were 
counterbalanced across phenotypes and strains on the dissection days, and on each day all dissections 
were done in the morning (8 am – 12 pm) to reduce circadian effects on gene expression differences.  
Dissociation and magnetic sorting (MACS) of oligodendrocytes and myelin
Mice were anaesthetized with a lethal dose of pentobarbital and perfused with +4 °C sterile 0.9 % NaCl. 
We removed the brain and dissected the medial prefrontal cortex (mPFC) on ice using anatomical 
coordinates defined previously (Laine et al., 2018). Cells were dissociated using the Papain Dissociation 
System (Worthington Biochemical Corporation, cat.no. LK003150) according to the manufacturer’s 
instructions. Briefly, tissue pieces were incubated in 37 °C under constant agitation in a mixture 
containing papain for 45-90 minutes. Cells were suspended and washed after an inhibitor containing 
DNase was added to stop the papain reaction, after which the cells were maintained at 4 °C in 
Dulbecco’s PBS (ThermoFisher Scientific, cat. no. 14287080).
We then performed phase separation of cells and myelin using a debris removal solution (Miltenyi 
Biotec, cat.no. 130-109-398). The debris phase (containing myelin) was separated from the cell phase 
(containing OLGs), and incubated with anti-myelin (Miltenyi Biotec, cat. no. 130-104-257) or anti-O4 
(Miltenyi Biotec, cat. no. 130-094-543) microbeads respectively, according to the manufacturer’s 
instructions. We used the octoMACS (Miltenyi Biotec) system to positively select the labelled myelin 
or OLGs, which were immediately lysed by vortexing in RLT lysis buffer (RNeasy Plus Micro kit, 
Qiagen) and stored in -20 °C until RNA extraction.
RNA extraction
We extracted total RNA from the OLG and myelin samples using the RNeasy Plus Micro kit (Qiagen), 
protocol for Purification of total RNA Containing Small RNAs from Cells (Appendix D). Genomic 
DNA was removed using a spin column containing DNase. Extracted samples were run with the 2100 
Bioanalyzer Instrument with RNA 6000 Pico kit (Agilent) to estimate yield. RNA yields varied between 
13-18 ng (OLG) and 4.5-11 ng (myelin). The whole amount of RNA was used for either digital droplet 




To validate the enrichment of the isolated OLGs and myelin fractions, we performed digital droplet 
PCR (ddPCR,) using isolated OLGs, isolated myelin, bulk mPFC tissue and bulk mouse heart tissue. 
We synthesised cDNA using the iScript™ cDNA Synthesis Kit (BioRad). 20 μl cDNA was diluted in 
30 μl water and 5.5 μl of the dilution was used for each ddPCR reaction. We used the QX200™ 
ddPCR™ EvaGreen® Supermix combined with QX200 AutoDG Droplet Digital PCR System (both 
BioRad) to perform ddPCR. Primer concentrations were 250 nM and annealing temperature 60 °C. The 
following primer sequences were used (5’-3’): Sst (forward: CCACCGGGAAACAGGAACTG, 
reverse: TTGCTGGGTTCGAGTTGGC, PrimerBank ID: 6678034c1 (Spandidos, Wang, Wang, & 
Seed, 2010)), Gfap (forward: CGGAGACGCATCACCTCTG, reverse: 
AGGGAGTGGAGGAGTCATTCG, PrimerBank ID: 30692526a1), Ugt8a (forward: 
AGAGGCGCTCTCCAACT, reverse: TTCCAACAGCACTCCACAGG), and Mbp (forward: 
ACACACGAGAACTACCCATTATGG, reverse: AGAAATGGACTACTGGGTTTTCATCT). Ppib
was used for normalization (forward: GGAGATGGCACAGGAGGAAA, reverse: 
CCCGTAGTGCTTCAGCTTGAA).
Library preparation and RNA-Sequencing
RNA-seq libraries for mRNA were prepared with Ovation SoLo RNA-Seq Systems kit (NuGEN, CA, 
USA) and with TruSeq Small RNA Library Preparation kit (Illumina) for miRNA from 35 myelin 
samples and 35 OLG samples, collected from the same mice (B6: control n = 6, resilient n = 6, 
susceptible n = 6; D2: control n = 6, resilient n = 5, susceptible n = 6). Samples were selected based on 
RNA quality and balancing the number from each group. mRNA libraries were sequenced with NextSeq 
500 (Illumina, USA), in five runs containing both strains and cell fractions and all three phenotypes 
mixed, and one NextSeq 500 round for the miRNAs. Sequence quality was controlled by FastQC 
(www.bioinformatics.babraham.ac.uk/projects/fastqc/). For mRNA-seq,  we removed PCR duplicates 
based on combination of the read and the unique molecule identifier (UMI) sequences using PRINSEQ 
(Schmieder & Edwards, 2011). Unique Molecular Identifiers (UMIs) and 3’-adapter contamination 
were trimmed using FASTX-Toolkit (http://hannonlab.cshl.edu/fastx_toolkit), and low-complexity 
reads were removed (dust value < 25 using PRINSEQ). For miRNA-sequencing, we trimmed 3’-
adapters from reads and kept reads matching with known miRNA sizes (17-32 bp; miRBase v21 
(Kozomara & Griffiths-Jones, 2014). Two samples (mRNA D2 control, OLG fraction; miRNA B6 
resilient, myelin fraction) were excluded due to failed library preparation, as revealed by QC.
Differential expression analysis
We aligned the RNA-seq reads to the mmu10 genome with STAR version 2.5.3a (Dobin et al., 2013)
and annotated alignments to exons (GTF version 85) using HTSeq version 0.7.2 (Anders, Pyl, & Huber, 
2014). For miRNA-seq, we aligned the 17-32 bp reads to the mmu10 genome using miRDeep2 
mapper.pl script (Friedlander et al., 2008).
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We used the limma R package (Law, Chen, Shi, & Smyth, 2014; Phipson, Lee, Majewski, Alexander, 
& Smyth, 2016; Ritchie et al., 2015) to determine differential gene expression between groups within 
the OLG or myelin cell fraction. We first filtered expression count matrices for low abundance genes, 
requiring 1 CPM in at least 6 samples, normalized gene counts with the voom package included in 
limma, and adjusted data for library sets with ComBat (Leek, Johnson, Parker, Jaffe, & Storey, 2012).
Pairwise gene expression differences were analyzed using eBayes (Johnson, Li, & Rabinovic, 2007)
between same-strain resilient, susceptible, and control mice. 
In addition, we used Rank Rank Hypergeometric Overlap (RRHO; (Plaisier, Taschereau, Wong, & 
Graeber, 2010) to compare transcriptome level similarities of OLG and myelin fractions in controls, 
and between resilient, susceptible and control mice within strains. RRHO identifies significantly 
overlapping genes across two DE result lists after genes are ranked into bins by DE (-log10(p)*logFC) 
between comparisons. Gene bin sizes of 50 or 5 genes were used to bin RNAs or miRNAs respectively.
The same -log(p) scale was applied to comparisons within OLG and myelin fractions.
Pathway analysis
We used the Ingenuity Pathway Analysis software (IPA v. 01-12, July 2019 release; Qiagen, Hilden, 
Germany (Kramer, Green, Pollard, & Tugendreich, 2014) to determine functional pathways of gene 
expression differences in OLG and myelin fractions. Focus was placed on predicted upstream 
regulators, as these molecules are positioned to mediate the effects of CSDS on gene expression and 
the behavioural response. Input DEGs were filtered by average expression level to restrict the analyses 
to robustly expressed genes (limma-normalized log2 counts > 0). Because of the exploratory nature of 
this analysis, nominal p < 0.05 was used as the significance criterion for selecting genes for pathway 
analysis, in addition to logFC > |0.25|. Analyses were limited to interactions reported for “Nervous 
System” under “Tissues”. 
Supplementary material
The supplementary materials referred to in this manuscript can be accessed online 
(https://tinyurl.com/StudyIIISupplements, password: myeliniscool) until the publication of this data in 





Enrichment of OLGs and myelin from CSDS-exposed and control mice
To identify biological pathways from mPFC OLGs and myelin affected by chronic stress we exposed 
mice from B6 and D2 strains to CSDS (Figure 1 A). After the 10-day stress period, we measured the 
social avoidance behavior of non-stressed controls and the stressed mice to distribute the stress-exposed 
mice into stress-resilient or susceptible groups (Figure 1 B).
To enrich OLG and myelin from the mPFC we performed magnetic-activated cell sorting (MACS), and 
extracted total RNA from these samples. On a test cohort (n = 4 mice) we first used ddPCR to quantify
the expression level of neuronal (Sst), astrocytic (Gfap) and OLG-specific (Mbp and Ugt8a) genes.
Neuronal and astrocytic marker genes were significantly depleted while OLG markers were enriched 
in OLG and myelin fractions compared to bulk mPFC and mouse heart tissue as a non-CNS control 
(Supplementary Figure 2). We then conducted RNA-seq and miRNA-seq of enriched myelin and OLG 
total RNA from CSDS-exposed and control mice. By comparing the expression levels of marker genes 
of different brain cell types in our previously published bulk mPFC tissue RNA-seq dataset, we
observed enrichment of OLG- (Cnp, Mag, Mbp, Mobp and Olig2) and OPC-specific genes (Cspg4,
Pdgfra, Cacng4 and Sdc3) in the MACS enriched fractions (Figure 1 D). In contrast, markers for 
microglia (Aif1, Cd68, Cd11b and Trem2), astrocytes (Gfap, Aqp4, Slc4a4 and Aldh1l1) and neurons 







Figure 1. Demonstration of behavioral and MACS procedures. A) Timeline of experimental 
procedure. Each vertical line represents one day. B) Social interaction (SI) ratios of B6 and D2 mice. 
Cut-off lines for susceptibility illustrated by a dashed black line for B6 and a solid blue line for D2 
strains. Data points represent individual animals. C) Illustration of the enrichment of OLGs and myelin 
using the MACS procedure. D) Heatmap showing the expression levels of marker genes for myelin, 
OPCs, newly formed and myelinating OLGs, neurons, microglia and astrocytes (Bennett et al., 2016; 
Cahoy et al., 2008; Y. Zhang et al., 2014) in the mPFC (bulk tissue) of the B6 and D2 strains compared 
with OLG and myelin fractions enriched by MACS. Legend = (normalized) logCPM. CSDS = chronic 
social defeat stress, SA = social avoidance test, SI = social interaction, B6 = C57BL/6NCrl, D2 = 
DBA/2NCrl, mPFC = medial prefrontal cortex, OLGs = oligodendrocytes, MACS = magnetic activated 




OLG and myelin gene expression patterns differ from each other but are highly similar 
between the two strains
To investigate how genetic background influences the OLG and myelin transcriptomes in the mPFC,
we compared their RNA and miRNA expression profiles from non-stressed control mice from the two 
strains (B6 and D2). We first quantified the similarity of RNA and miRNA expression patterns of the 
OLG and myelin fractions within the strains. We found that, averaged between the two strains, 20.2 %
of all detected RNAs (18205) and 14.3 % of all detected miRNAs (856) were expressed at a significantly 
higher levels in OLGs than in myelin (padj ≤ 0.05, referred to as OLG-enriched genes). In myelin, 24.8
% and 18.8 % of all detected RNAs and of miRNAs, respectively, were expressed at a significantly 
higher level than in OLGs (referred to as myelin-enriched genes). A correlation matrix showing the 
Euclidean distance of the top 50 % most abundant RNAs and miRNAs between fractions revealed a 
clear clustering of the OLG and myelin fractions that was independent from the strain (Figure 2 A-B).
To further investigate the similarities of the OLG and myelin gene expression patterns between strains, 
we conducted Rank Rank Hypergeometric Overlap (RRHO) analysis based on B6 OLG vs myelin and 
D2 OLG vs myelin comparisons. This analysis enables the direct comparison of two lists of 
differentially expressed genes (DEGs) to visualize their similarities (Figure 2 C). RRHO analysis of 
DEGs in B6 OLG vs myelin and D2 OLG vs myelin comparisons revealed a high correlation of ranked 
genes with the highest p-values following the diagonal of the plot. We observed more significant p-
values in the upper right corner of the RRHO plot, suggesting that the myelin transcriptomes were more 
similar between strains than the OLG transcriptomes (Figure 2 C). Identical analysis of miRNAs 
revealed a substantial transcriptomic resemblance between fractions, and that the myelin fraction had
more overlap between strains than the OLG fraction (Figure 2 D).
To analyse how the similarities of the OLG and myelin transcriptomes are influenced by genetic 
background, we calculated the number of OLG- and myelin-enriched genes shared between the strains
(Figure 2 E, Supplementary Table 1). 70.6 % of the myelin-enriched (3637) and 63.5 % of the OLG-
enriched (2734) genes were shared between strains. The non-shared proportion in the enriched genes
are still present in OLGs and myelin but do not show a significant enrichment in one or the other. We 
also found enriched miRNAs to be shared to a greater extent in myelin compared to OLGs, with 88.5
% (145) and 65.0 % (76) of them shared in myelin and OLG, respectively (Figure 2 F, Supplementary 
Table 1). We also performed RNA and miRNA DE analysis in B6 myelin vs D2 myelin and B6 OLG 
vs D2 OLG comparisons in non-stressed animals. We found a small number of genes DE in myelin and 
OLG between strains (115 in myelin, 372 in OLGs). Similarly, only 15 miRNAs were DE between 




Figure 2. OLGs and myelin have distinct gene expression patterns that are largely shared between 
the two inbred strains. A-B) Correlation matrix and dendrogram showing the Euclidean distance 
between the top 50 % of expressed OLG and myelin RNAs (A) and miRNAs (B) in non-stressed D2 
and B6 mice. Darker color indicates stronger correlation. C) Key to RRHO showing a theoretical 
heatmap of two identical datasets (“Comparison 1 and Comparison 2”). Genes are ranked into bins by 
differential expression (-log10(p)*logFC) after differential gene expression analysis. The significance 
of the overlap -log10(p) between gene bins is showed by the heatmap color. P values in the top right 
corner and bottom left corner refer to genes that are differentially expressed (DE) in the same direction 
in both comparisons (down- or upregulated, respectively). P values located in the top left and bottom 
right corner represent genes that are DE in opposite directions. D-E) RRHO following differential gene 
expression analysis between OLG and myelin fractions in non-stressed D2 and B6 mice for RNAs (D) 
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and miRNAs (E). Genes were ranked by their fold change and assigned to bins of 50 (RNAs) or 5 
(miRNAs). Overlap of genes was then compared between each ranking matched bin. Color represents 
the significance of the overlap [-log10(p)] of genes between rank-matched bins. High -log10(p) values 
in the bottom-left quadrant indicate that the two datasets have shared OLG-enriched genes, high -
log10(p)-values in the top-right quadrant indicate shared myelin-enriched genes, and high -log10(p)-
values in the center indicate genes not DE or with small FC. The top-left and bottom-right quadrants 
represent genes regulated in opposite directions between the two datasets. F-G) Upset plots of the DE
(padj ≤ 0.05) RNAs (F) and miRNAs (G). The number of DE genes in each comparison is shown on the 
right. The number of overlapping DE genes between two comparisons (connected by a black line) is 
represented by the histogram above. B6 = C57BL/6NCrl, D2 = DBA/2NCrl, OLGs = oligodendrocytes,
RRHO = rank-rank hypergeometric overlap, DE = differentially expressed.
CSDS associates with different DEGs in OLGs and myelin
To investigate CSDS-associated gene expression differences we identified DEGs between susceptible 
and control, resilient and control, and susceptible and resilient mice in the OLG and myelin fractions. 
No gene expression difference reached statistical significance after correction for multiple comparisons 
(Benjamini-Hochberg). To conduct exploratory analyses of DEGs we used a threshold for nominal 
significance (p ≤ 0.05) and fold change (logFC ≥ |0.25|). Using these criteria, we observed the largest 
number of DEGs in the OLG fraction of B6 susceptible vs resilient mice (1406, 8.1 % of expressed 
genes, Figure 3 A, Supplementary Table 3). The comparison with the fewest DEGs was the myelin 
fraction of B6 resilient vs control mice (111, 0.7 % of expressed genes, Figure 3 A). To analyse the 
similarities between the transcriptomic response of susceptible and resilient mice between strains, we
compared their DEG (susceptible/resilient vs control) overlap within myelin and OLG fractions using 
RRHO analysis (Figure 3 B-C). We also calculated the number of shared up- and down-regulated genes, 
as well as genes DE in opposite directions between resilient vs control and susceptible vs control 
comparisons between strains (Figure 3 D). Resilient vs control and susceptible vs control comparisons 
within B6 and D2 strains shared several up- and down-regulated genes in both OLG and myelin 
fractions, with more shared genes present in the OLG fraction (Figure 3 D left). The RRHO also 
revealed overlap between resilient and susceptible mice compared to the controls in both fractions.
These findings suggest that a large number of the OLG and myelin DEGs responded generally to the
stress exposure, irrespective of susceptibility or resilience. We observed a larger overlap of DEGs in 
the OLGs after stress in D2 resilient and susceptible mice compared to B6 resilient and susceptible mice
Figure 3 B). The overlap patterns in the myelin fraction were more similar between the strains than the 
overlap in the OLG fraction (Figure 3 C), suggesting that genetic background may have less influence 
on the gene expression response to stress in myelin than in OLGs. Although the B6 OLG fraction 
showed the greatest number of shared DEGs between susceptible and resilient comparisons (Figure 3 
D), the overlap between the whole transcriptomes in these comparisons was less significant (Figure 3
B) than in the myelin fraction (Figure 3 C). This indicates that outside the DEGs, B6 susceptible and 
resilient gene expression patterns are less similar in OLGs than myelin.
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We also compared the B6 and D2 gene expression patterns within the same stress-response (for example 
B6 OLG resilient vs D2 OLG resilient, Figure 1 D middle). While there was some overlap between 
strains within a stress group (resilient or susceptible) and fraction, approximately half (31.5 – 87.1 %) 
of the shared DEGs were DE in opposite directions between the two strains. Similarly to the overlap 
within resilient or susceptible mice, most of the strain overlap was observed in the OLG fraction. In the 
RRHO plot there was very little detectable overlap between the ranks of all expressed genes between 
strains, indicating strain-specific gene expression patterns for resilience and susceptibility. Lastly, we 
compared the DEGs across fractions (e.g. B6 OLG resilient vs B6 myelin resilient) and found lower 
rates of overlap than in the other two comparison groups (Figure 1 D right). This suggests that the OLG 




Figure 3. Distinct gene expression patterns in OLGs and myelin after CSDS. A) Bar graph 
depicting the number of DEGs (p < 0.05, logFC ≥ |0.25|) within each comparison, showing the numbers 
of up- (red) and downregulated (blue) genes separately. B-C) RRHO analysis of OLG (B) and myelin 
(C) fractions within and across strains. Colour represents the significance of the overlap [-log10(p)] of 
genes between rank-matched bins. Bin size = 50. D) Upset plot depicting the overlap in DEGs between 
comparisons (indicated by dots connected by a black line). Red portions of the bars indicate genes which 
are upregulated in both comparisons, and blue portions indicate shared downregulated genes. Grey 
portions include genes which are DE in both comparisons but in opposite directions. CSDS = chronic 
social defeat stress, DEG = differentially expressed gene, B6 = C57BL/6NCrl, D2 = DBA/2NCrl, OLGs 
= oligodendrocytes, Con = control, Res = resilient, Sus = susceptible, DE = differentially expressed.
TCF7L2 predicted to regulate DEGs in B6 susceptible, D2 susceptible and D2 resilient 
mice
To explore whether CSDS-associated DEGs are over-represented in predicted targets of upstream 
regulators, we used Ingenuity Pathway Analysis (IPA). The five predicted regulators with the greatest 
absolute value of activation Z-score for each comparison are presented in Figure 4 A. TCF7L2 was
predicted to be a significant upstream regulator in 4 out of 2 comparisons. Among the predicted targets
of TCF7L2 are genes encoding myelin components (Supplementary Table 5). To examine the 
expression levels of other genes known to be involved in the differentiation, proliferation or maturation 
of OLGs, and in the production of the myelin sheath, we manually curated a list of genes and examined 
their expression levels (Figure 4 B). In the OLG fraction myelin component genes (Mbp, Mobp) were 
expressed on a lower level in both D2 resilient and susceptible mice, but not in the B6 mice compared 
to controls. On the contrary, these genes were expressed at a lower level in B6 susceptible mice 






Figure 4. Ingenuity Pathway Analysis predicts TCF7L2 as a major upstream regulator of 
differentially expressed genes (DEGs) in several comparisons. A) Bar graphs showing log10(p) and 
activation Z-score of the top 5 predicted upstream regulators (ranked by Z-score) of observed DEGs in 
each comparison. Comparisons within the myelin and the OLG fractions are shown separately. Z-scores 
are plotted as absolute values, with color indicating predicted up- (red) or downregulation (blue). The 
number of predicted target DEGs within the comparison is given for each regulator on the right of the 
bar plot. Dotted line indicates threshold for nominal significance (p = 0.05). B) Bubble plot showing 
differential expression of manually selected genes encoding myelin components, OPC proliferation, 
and OLG differentiation/maturation. The size of each bubble indicates significance of differential 
expression, and color denotes logFC. DEG = differentially expressed gene, OLG = oligodendrocyte, 
OPC = oligodendrocyte progenitor cell, B6 = C57BL/6NCrl, D2 = DBA/2NCrl, Con = control, Res = 









How chronic stress influences OLGs specifically has become a major question since the influx of studies
associating myelin-related gene expression changes in bulk tissue RNA-sequencing with stress in mice 
(Cathomas et al., 2019; Laine et al., 2018; Liu et al., 2018). Here, we extended our previous work by 
enriching the OLG and myelin fractions from the mPFC after CSDS in two inbred mouse strains to 
study specifically OLG-related stress response. We first investigated the extent to which the OLG and 
myelin transcriptomes differ from each other. We found that both the OLG and myelin fractions had 
genes which were expressed on a significantly higher level compared to the other fraction. The two 
mouse strains were more similar to each other than the two cellular fractions were to one another.
Regarding the stress effect, we observed a larger number of DEGs in resilient and susceptible mice
compared to same-strain controls in the OLGs than in myelin, and largely unique DEGs in the two 
fractions of the same comparisons. Among the DEGs in four comparisons (B6 susceptible vs control 
and vs resilient in the myelin fraction, D2 susceptible vs control and resilient vs control in the OLG 
fraction) we found lower expression levels of several myelin component genes. IPA predicted TCF7L2 
as an upstream regulator of these genes.
Overall the vast majority of the detected genes were expressed in both OLG and myelin fractions. The
20 - 25 % of expressed genes which were significantly more abundant in one fraction over the other are 
of interest because they may be related to biological mechanisms with local regulation. Prior work has 
described the myelin transcriptome in comparison to bulk tissue (Thakurela et al., 2016), but a
comparison to the transcripts in OLGs is needed to infer selective localisation. Genes enriched in the 
myelin fraction may be ones selected by the transport machinery, known to depend on recognition of
the 3’ untranslated region (UTR) and an RNA transport signal sequence (Ainger et al., 1997; Torvund-
Jensen et al., 2018). Analysis of the genomic elements of the myelin-enriched genes we identified here 
may further elucidate how this machinery selects transcripts for transport, and functional in situ analyses 
of specific mRNAs and miRNAs could reveal new biological processes important for the myelin sheath.
For example, Adcyap1 was enriched in the myelin fraction of both B6 and D2 mice. In humans, a
polymorphism within an estrogen response element sequence in this gene (encoding the protein 
PACAP) associates with PTSD symptoms in females (Ressler et al., 2011). This gene is also highly 
expressed in neurons (Y. Zhang et al., 2014). In situ hybridization and in vitro experiments would be 
required to validate its expression and function in myelin, as axonal contamination in MACS-enriched 
myelin is possible. The two strains compared here also showed highly similar profiles of myelin and 
OLG gene enrichment. This suggests that the transport machinery targets the same transcripts largely 
independent of genetic background. 
We found that myelin component genes (such as Mbp and Mobp) were downregulated in the myelin 
fraction of B6 stress susceptible mice compared to resilient and control mice, but in the OLG fraction 
of D2 resilient and susceptible mice compared to controls. In our previous bulk RNA-seq experiment 
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we showed lower expression level of myelin component genes in B6 susceptible compared to control
mice, but no differences within the D2 strain (Laine et al., 2018). This could suggest that bulk tissue 
RNA-seq lacks resolution to detect differences occurring only within the cell bodies of relatively low-
abundance cell types such as OLGs (Valerio-Gomes, Guimaraes, Szczupak, & Lent, 2018), but captures
effects taking place in the larger area of the myelin sheath. Observing the same genes DE in different 
fractions in the two strains suggests the existence of alternate ways of stress influencing myelin 
component transcripts; one occurring at the cell body (mediated, for example, by transcription factors) 
and another affecting the transport of transcripts or their local regulation. Exploring these possibilities
could be done using selective perturbation of transcription- and transport-related cellular mechanisms,
such as DNA-binding of key transcription factors or RNA-binding of key ribonucleoproteins (Hoek, 
Kidd, Carson, & Smith, 1998) respectively. This finding also highlights the importance of considering
different genetic backgrounds in preclinical studies. A greater understanding of how genetic factors 
influence processes by which stress alters myelin gene expression will be needed for development of
personalised treatments for stress-related diseases.
Furthermore, particularly in the D2 strain OLG fraction, many of the DEGs in susceptible vs control 
and resilient vs control comparisons were shared. This shared proportion of the response represents a 
general effect by stress, rather than effects differentiating resilient and susceptible mice from each other. 
To best utilize preclinical data for development of treatments for stress-related disorders, it is critical to 
understand which components are related to the maladaptive response, which ones to the adaptive 
resilience response, and which ones relate to both (Russo, Murrough, Han, Charney, & Nestler, 2012).
Optimal treatment strategies are likely those which either rescue susceptible-specific changes or 
promote resilience-related changes. Targeting a shared pathway, such as myelin-related genes in the D2 
strain, may not produce a therapeutic response, because resilience is evidently achievable without 
changes in this pathway. Much of our knowledge about resilience comes from rodent work (Murrough 
& Russo, 2019; Russo et al., 2012), although human psychobiological (Feder, Fred-Torres, Southwick, 
& Charney, 2019) and genetic (Elbau, Cruceanu, & Binder, 2019) factors have also been described.
However, our findings suggest that resilience, in addition to being an individual difference factor, is 
influenced by individual differences such as genetic background. While behaviorally similar, the 
neurobiological path to resilience is different in our two strains, suggesting a genetic influence on which 
factors provide the adaptive response to stress.
Our bioinformatic analysis predicted that inhibited activity of transcription factor TCF7L2 could be 
responsible for downregulation of several genes, including myelin component genes, in B6 susceptible, 
D2 susceptible and D2 resilient mice compared to their respective controls. TCF7L2 is expressed across 
many CNS cell types (Y. Zhang et al., 2014) and is a binding partner of β-catenin, an effector protein
in the Wnt signalling pathway (Bem et al., 2019; Ye et al., 2009). Genetic variants in the TCF7L2 gene 
have been associated with several psychiatric conditions, including schizophrenia and bipolar disorder 
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(Bem et al., 2019). Heterozygous knock-out of the mouse homolog Tcf7l2 is anxiogenic. Tcf7l2+/- mice 
had lower locomotor activity, spent less time in the center zone of the open field test (OFT) and the 
light area of the light-dark test (LD), and had higher rates of freezing in measurements of both 
contextual and cued fear conditioning compared to wildtype mice. Overexpression of Tcf7l2 did not 
alter the behavior of the mice on the OFT or LD (Savic et al., 2011). However, haploinsufficiency of 
Tcf7l2 in different inbred strains and sexes produces highly variable effects on the forced swim test,
suggesting that genetic background critically influences its function (Sittig et al., 2016). These studies 
perturbed Tcf7l2 expression across all CNS cell types, so linking the findings to its function in OLGs is 
not directly possible. OLG lineage-specific knock-out of Tcf7l2 or its DNA-binding domain has 
produced variable results, with reports of both reduced expression of myelin component genes in some 
(Hammond et al., 2015; Zhao et al., 2016) and promotion of OLG differentiation in other publications 
(Weng, Ding, Fan, Cao, & Lu, 2017). To our knowledge no OLG-specific KO studies have assessed 
behavioral effects. The mixed findings concerning myelination may stem in part from the 
developmental stage-specific actions of TCF7L2. In vitro, it has been shown to preferentially bind with 
co-activator Kaiso in immature and with SOX10 in maturing OLGs (Zhao et al., 2016). While it remains 
unknown whether TCF7L2 directly binds to and thus affects the transcription of myelin component 
genes, chromatin-immunoprecipitation (ChIP) sequencing has suggested that it strongly occupies the 
promoter region of myelin regulatory factor (MYRF). MYRF is an OLG-specific transcription factor, 
which is known to promote transcription of these genes and is critical for adult myelin maintenance 
(Bujalka et al., 2013; Emery et al., 2009; McKenzie et al., 2014). Lastly, while TCF7L2 was a predicted 
regulator in both strains, the myelin component genes were only DE in the myelin fraction of the B6 
susceptible mice. Little is known about its possible actions outside the nucleus. Some transcription 
factors, such as MYRF, have extranuclear functions as well. MYRF resides on the endoplasmic 
reticulum (ER), and an autocleavage event releases the homotrimerized N-terminal for translocation 
into the nucleus and DNA-binding. Although not confirmed, it is hypothesised that the C-terminal may 
perform some additional functions, such as protein processing at the ER (Bujalka et al., 2013; Li, Park, 
& Marcotte, 2013). Functional studies, such as OLG-specific knock-out or overexpression, are needed 
to resolve the function of TCF7L2 in stress-related myelin gene expression.
In summary, we showed that mRNAs and miRNAs in OLGs and their myelin sheaths are not present 
in equal proportions, despite the latter being a membrane extension of the former. This could be due to 
selective transport of certain transcripts to the myelin sheath or their local regulation. We also replicated 
prior findings (Laine et al., 2018) that myelin component genes are downregulated in the mPFC of 
CSDS-susceptible mice from the B6 background, pinpointing this difference to the myelin fraction.
Additionally, we showed lower expression levels of these genes in the OLG fraction of both stress-
susceptible and resilient D2 mice compared to controls. Bioinformatic predictions provided potential 
candidates upstream of these DE genes. Follow-up studies are required to validate the role of TCF7L2 
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is stress-related myelin plasticity, stress-resilience and -susceptibility. Identifying the components of 
this pathway may contribute to the development of improved treatments for stress-related disorders.
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